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Abstract
Mass spectrometric techniques have been developed recently for the ex­
amination of biological tissue samples. Tandem mass spectrometry has 
been employed for the detection of pharmaceutical compounds and also 
mass spectrometric ‘images’ have been produced which show the spatial 
distribution of peptides, proteins and drugs in tissue.
In this thesis, a programme of method development for the detection 
and imaging of topically applied pharmaceutical compounds in porcine 
epidermal tissue by MALDI-TOF-MS is presented.
Direct analysis of fresh tissue sections was compared with the analysis 
of tissue imprints formed by blotting onto a variety of substrates. The 
samples were coated with matrix material by a prototype electrospray 
deposition device. Analyses were performed on a linear time-of-flight 
(LaserTOF 1500, SAI) mass spectrometer. Direct analysis of tissue and 
analysis of the C18 blots gave irreproducible data. Problems with matrix 
layer in-homogeneity were experienced with nitrocellulose and polyvinyl 
difluoride (PVDF) membranes. Reproducible data were obtained by 
analysis of tissue imprints created on carbon and cellulose membranes.
All subsequent work was conducted using an Applied Biosystem Qstar 
pulsar i hybrid quadrupole time-of-flight mass spectrometer fitted with 
an orthogonal MALDI ion source and ion imaging software. The advant­
ages of superior mass accuracy and resolution with such an instrument 
configuration were investigated.
Electrospray and airspray methods were compared for analysis of tissue 
imprinted carbon and cellulose membranes. A novel method of pre­
coating cellulose membranes in matrix by airspray prior to the blotting 
procedure was developed. The method was found to retain the expected 
distribution of the analyte.
Ion images demonstrating the permeation of the applied compound into 
the skin were achieved by imaging a cross sectional imprint of treated 
tissue on a cellulose membrane precoated in matrix material. A calib­
ration graph for the determination of ketoconazole was prepared using 
the sodium adduct of the matrix ion as an internal standard. This en­
abled construction of a quantitative profile of drug in skin. Conventional 
haematoxylin and eosin staining and microscopy methods were employed 
to obtain a histological image of the porcine epidermal tissue. Super­
imposing the mass spectrometric and histological images revealed drug 
permeation into the dermal tissue layer.
A quantitative corneum tape stripping/HPLC method was developed 
for comparison. Useful data was acquired and further work suggested to 
facilitate a full validation of the methods presented in this thesis.
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Chapter 1 
Introduction
1.1 Mass spectrom etry
Mass spectrometry is concerned with the separation of matter according to atomic 
and molecular mass. The technique may be described as the science of ‘weighing’ 
individual atoms and molecules. This is accomplished using instrumentation that 
generates gas-phase ions from the analyte that are then subjected to electrostatic 
and/or magnetic fields. The gas-phase ions are mass measured or discriminated 
based on their interaction and trajectories within these fields. Samples may be in­
troduced in gas, liquid or solid states. In the latter two cases, volatilisation must 
be accomplished either prior to, or accompanying ionisation. Many ionisation tech­
niques are available to produce charged molecules in the gas phase, ranging from 
simple electron (impact) ionisation (El) and chemical ionisation (Cl) to a variety of 
desorption ionisation (DI) methods.
1.1.1 Desorption ionisation
The inherent restrictions of electron ionisation and chemical ionisation that limited 
applications to volatile sample molecules were overcome with the introduction of 
desorption ionisation methods in which molecules are brought to the surface (de­
sorbed) and ionised at the same time.
The development of these techniques over the past two decades has made it 
possible to produce intact, high molecular weight gas-phase ions of thermally labile 
or non-volatile compounds without derivatisation. This is generally referred to as 
soft ionisation, because of the (virtual) absence of fragmentation induced by the
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desorption/ionisation process. The various soft ionisation techniques use different 
physical approaches to produce ions:
• A high electric field is applied to the sample in field desorption (FD) mass 
spectrometry [1];
• The sample is bombarded with highly energetic atoms or ions in fast atom 
bombardment (FAB) [2], 252Cf plasma desorption (PD) [3] and secondary ion 
mass spectrometry [4];
• Short and intense pulses of laser light are used to induce the formation of ions 
in laser desorption (LD) [5] and matrix-assisted laser desorption/ionisation 
(MALDI) [6].
This thesis is concerned with the development of methods for the analysis and 
imaging of drugs in skin by MALDI-TOF-MS. Hence only the theoretical aspects of 
MALDI-TOF and mass spectrometric imaging are discussed in detail in this section.
Laser desorption and matrix—assisted laser desorption/ionisation mass 
spectrometry
The use of laser desorption (LD) for the analysis of non-volatile, organic molecules 
dates back to the 1960s when it was demonstrated that irradiation of low-mass 
organic samples with a high-intensity laser pulse produced ions that could be suc­
cessfully mass analysed. These experiments, however, revealed an upper mass limit 
of 5 — 10 kDa.
The mass limit probably arises because the energy required to cause the resonant 
excitation and successful energy transfer is greater than the dissociation energy of 
the analyte. Thus the analyte is not desorbed as the intact molecule ion in any 
significant amount resulting in a spectrum comprising only low-mass fragment ions.
Another major restriction of LD ionisation is the short duration of the ion burst 
following the laser pulse. A consequence is that the technique is unsuitable for scan­
ning analysis on sector or quadropole instruments, but means that LD is particularly 
suited to time-of-flight mass spectrometry.
In 1987, matrix-assisted laser desorption ionisation (MALDI) was introduced 
by Hillenkamp and Karas—employing an organic matrix [6], and by Tanaka and
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co-workers—who used an inorganic matrix [7]. The use of a matrix extended the 
analysable mass range up to about 350 kDa at fmol sensitivities, and thereby re­
volutionised the field of biological mass spectrometry.
1.1.2 Principles o f MALDI
In MALDI, the laser is directed at an analyte embedded in an excess of matrix ma­
terial. Optimal molar ratios are in the 1:1000-1:10000 (analyte:matrix) range. This 
results in the analyte molecules being singularised and fully surrounded (solvated) 
by matrix molecules. Thus laser photons have a high probability of encountering 
the matrix over the analyte molecules.
The laser energy is dispersed as vibrational energy within the sample. As the 
co-crystalline matrix/analyte structure becomes energised, the binding forces and 
crystal integrity are reduced. Resultant reactions in this energized state lead to 
ion formation (see page 12). The matrix molecules desorb (see page 16), leaving 
the ions. Some of the desorbed ions are still associated with the matrix molecules 
(Figure 1.1).
The ions are extracted from the MALDI plume by a strong electric field into the 
field-free drift tube of a time-of-flight (TOF) analyser. TOF analysis separates ions 
according to their mass-to-charge (m /z ) ratio. A more detailed review of the TOF 
process is given on page 16.
Ions are converted into signals using ion-to-electron conversion detectors. These 
have a flat plate surface that is exposed to the incoming ions, which strike the 
surface (either a metal or metal oxide coating). The collision results in the emission 
of electrons and small negative ions, which are accelerated to another surface that 
produces only electrons which are amplified by conventional electron multipliers to 
yield a signal.
There are numerous experimental factors that affect the outcome of any MALDI 
experiment. The matrix, method of matrix/sample preparation, and the laser 
wavelength employed are generally accepted as the most influential parameters [8].
Lasers
A variety of lasers have shown success in MALDI-MS experiments, as summarised 
in Table 1.1. Nitrogen lasers are used most frequently due to their relatively low
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Figure 1.1: Energy absorption, ionisation and formation of molecular ion.
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U ltraviolet (UV) 266 nm, frequency quadrupled Nd-YAG [9] 
337 nm, N2 [6,7]
355 nm, frequency tripled Nd-YAG [10]
Infrared  (IR) 2.94 mm, Er-YAG [11]
10 fim, C 02 [12]
Tuneable free electron laser (FEL) [13] 
Optical parametric oscillator (OPO) [14]
Visible 532 nm, frequency doubled Nd-YAG [15]
Table 1.1: Lasers employed in MALDI-MS
cost and good reliability.
The use of infrared (IR) lasers may however have some advantages over the more 
widely adopted ultraviolet (UV) approach. Liquid matrices in IR MALDI may yield 
more reproducible spectra than in UV MALDI as solid crystalline samples prepared 
with UV matrices demonstrate a high degree of heterogeneity Also, it has been 
reported that IR MALDI is a softer ionisation technique (yields less metastable 
fragmentation) than UV MALDI [16]. A disadvantage of IR MALDI is that much 
more sample is ablated in IR MALDI MS. MALDI spectra are generated from mul­
tiple laser shots. Typically, UV MALDI experiments average 100 laser shots and it 
has been observed that that ions in IR MALDI MS can only be generated from the 
first two or three laser shots [17]. Several papers compare the use of UV and IR 
MALDI MS [18-21].
T he m atrix
The matrix performs two important functions: (1) it absorbs photon energy from 
the laser beam and transfers it into excitation energy, and (2) it serves as a solvent 
for the analyte, so that the intermolecular forces are reduced and aggregation of the 
analyte molecules is held to a minimum. Some desirable characteristics of a typical 
MALDI matrix are:
• high molar absorptivity at the laser wavelength employed;
• solubility in the same solvent as the analyte material;
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• unreactivity towards the analyte. (However, evidence suggests that proton 
transfer reactions of excited states of the matrix are involved in UV MALDI: 
see page 14);
• appropriate physical properties, such as lattice structure and heat of sublim­
ation;
• ability to promote ionisation;
• vacuum stability
The matrix should provide maximum ion intensity and signal reproducibility, and 
should minimise fragmentation and adduct formation. The matrix material must 
not give rise to ions with m /z  values that may coincide with those of the analyte 
ions. The ideal matrix produces strong symmetrical peaks showing a minimum of 
unimolecular decay (except when desired, as in post-source decay, PSD [22]).
Many different matrix materials and matrix mixtures have been used since the 
introduction of the MALDI technique. Unfortunately there is not enough informa­
tion to date to permit an a priori prediction of suitable matrices for experiments, 
largely due to the fact that the full MALDI ionisation and desorption processes are 
not completely understood. Thus vast numbers of potential candidates have been 
tested, and a general trial and error approach is still adopted in many scenarios. 
The majority of successful matrices are low molecular weight organic acids prepared 
in a suitable solvent.
The matrices and applications discussed in this section refer to UV (nitrogen) 
MALDI unless otherwise specified. Structures of commonly-used matrix compounds 
are shown in Figure 1.2.
a —cyano—4—hydroxycinnamic acid (a-CHCA) [23] has proved particularly use­
ful for peptide analysis. This is commonly prepared at a concentration of 5-25 mg*ml-1 
in methanol or acetonitrile, incorporating 0.1 % aqueous trifluroacetic acid (TFA). 
2,5—dihydroxybenzoic acid (DHB, also called gentisic acid) [24] has also been widely 
used for the analysis of peptides, either alone, or in conjunction with a co-matrix. 
A co-matrix is a compound that has no specific matrix activity, but when added 
to a matrix (as an additive), enhances the mass spectral quality, generally by redu­
cing the extent of analyte fragmentation. Fructose has been demonstrated as a good
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Figure 1.2: Chemical structures of some commonly-used MALDI matrices
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co-matrix with DHB [25]. Super-DHB (sDHB, a 9:1 mixture of DHB and 2-hydroxy- 
5-methoxybenzoic acid (HMB)) [26], as well as DHB mixed with 5-methoxy-salicylic 
acid [27] have also shown excellent results. These may be described as binary matrix 
systems because both components of the mixture exhibit matrix activity.
The standard matrix for the analysis of proteins is 3,5—dimethoxy—4—hydroxy- 
cinnamic acid (sinapinic acid [10]), most commonly prepared in 50:50 water:acetonitrile 
(0.1% TFA). This matrix typically requires more laser energy (25 /zJ) than a-CHCA 
and DHB (around 5 — 15 /zJ).
2—(4—hydroxyphenylazo)-benzoic acid (HABA) has been used for the analysis 
of large proteins and glycoproteins, however, it has been shown to enhance formation 
of alkali metal adducts (though this is not particulary important at high mass ranges 
[28].
3—hydroxy-picolinic acid (3—HPA) has been used for the analysis of small pro­
teins, but has demonstrated spot to spot variations and excessive adduct peaks [10].
Several authors have reported the use of binary matrix systems for protein ana­
lysis [27,29], For example, mixtures of matrices already mentioned as well as ferulic 
acid (4—hydroxy—3—methoxy-cinnamic acid) [30] and caffeic acid (3,4—dihydroxy- 
cinnamic acid).
The analysis of oligonucleotides has proved problematic, and the most useful 
matrix is probably 3—HPA [31]. This may be substituted with (10%) diammonium 
tartrate or citrate (in order to remove alkali metal ions). 2,4,5—trihydroxyacetophenone 
(THAP) with diammonium citrate or tartrate [32], 6—aza—2—thiothymine [33] and 
quinaldic acid [34] have demonstrated good results for detection of nucleic acids. It 
should be noted that nucleic acid analyis is usually conducted in the negative ion 
mode.
Carbohydrate analysis is usually performed using either DHB or sDHB [35].
MALDI has also been used for the analysis of complex synthetic polymers, with 
a major problem being the solubility of the analyte and matrix in the same system. 
Water-soluble polymers have been successfully analysed with both sinapinic acid 
and DHB. Less polar polymers have proved more complicated, and some fairly 
uncommon matrices such as 7—amino—4—carbostyril dissolved in tetrahydrofuran 
[36] have been described.
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Recently a new matrix, 2,5—dihydroxybenzoic acid butylamine (DHBB) has 
shown improved results compared with a-CHCA for the analysis of oligosacchar­
ides, glycoconjugates, polymers and gangliosides. However for peptide and protein 
analysis a-CHCA was found to be superior due to multiple alkali adducts observed 
with DHBB [37].
Ice [12], succinic acid [38], and glycerol [12] have all been identified as successful 
matrices for use with infrared MALDI.
M ethods of matrix preparation/ application
A variety of methods of matrix sample preparation have been developed. The most 
common method is the original dried-droplet method introduced by Hillenkamp and 
co-workers [24]. This method involves simple co-crystallisation of the matrix and 
analyte on a sample target. The surface of the droplet is the preferred site for 
crystallisaton: crystals form at the liquid/air interface and are carried into the rest 
of the solution by convection. A commonly observed problem with this technique 
is the aggregation of larger amounts of crystals around the edge of the dried spot. 
In addition, the overall sample surfaces obtained using the dried-droplet method 
are heterogeneous, with a crystal layer uneven both in size and number. Confocal 
fluorescence microscopy has been used to demonstrate that the analyte is not evenly 
distributed among or within the crystals, and that some matrix crystals contain no 
analyte at all [39]. Another limitation of the technique is segregation during crys­
tallisaton: as the matrix forms crystals, the salts and some analyte molecules are 
excluded. Whilst this limits overall ionisation of the analyte, it is of particular con­
sequence in situations where cationisation is preferred. The dried-droplet method 
often demonstrates both poor mass accuracy (particulatly on linear time-of-flight 
instruments) and poor spectral quality. Mass accuracy is the ability to measure 
or calibrate the instrument response against a known entity [40]. The measure­
ment indicates the deviation of the instrument response from a known monoisotopic 
calculated mass.
Vacuum drying [41] has been developed to overcome some of the limitations 
associated with the dried-droplet method. The analyte/matrix drop on the target 
is rapidly dried in a vacuum chamber before MALDI analysis. This reduces crystal 
size, and increases crystal homogeneity by reducing the segregation effect. The
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formation of smaller crystals offers the advantage of thinner samples and improved 
mass resolution and accuracy with certain instruments. (Mass resolution is the 
dimensionless ratio of the mass of the peak divided by its width. Usually, the 
peak width is taken as the full width at half maximum intensity. Resolution is a 
measure of the separating or resolving power of a mass spectromter, i.e. the ability 
to distinguish between two masses [40]).
A more uniform inclusion of the analyte into matrix crystals may be achieved by 
using the crushed-crystal technique [42]. Matrix-only solution is deposited onto the 
target and the resultant crystals are then crushed and spread by overlaying, pressing 
and twisting a glass slide upon them. Loose material is subsequently brushed away 
prior to the depostion of a mixture of analyte and matrix (prepared as in the dried- 
droplet method) onto the crushed crystals. In this method, crystallisation of the 
analyte and matrix onto the sample plate is facilitated by the nucleation sites of the 
crushed initial matrix layer. Crystal nucleation shifts from the liquid air interface to 
the surface of the substrate and microcrystals form within the solution. This results 
in a polycrystalline film of the matrix and analyte that is more uniform than in the 
dried-droplet method in terms of spot-to-spot reproducibility and ion production. 
This method has been claimed to be particularly useful in oligonuleotide and protein 
analysis [43].
An alternative method, fast-matrix-evaporation, was developed by Vorm et al. 
[44-46] with a view to improving mass accuracy and resolution. This involves applic­
ation of the matrix layer in a highly volatile solvent (acetone) to create a thin film 
of matrix. The analyte is subsequently deposited onto the preformed matrix crystal 
layer. Confocal fluorescence microscopy [39] has been used to demonstrate that the 
crystals produced are more homogenous than those produced by the dried-droplet 
method.
The principles of the crushed-crystal and fast-evaporation methods were com­
bined to develop the overlayer (also termed seed-layer and two-layer) method 
[39,45,47,48]. A layer of matrix crystals is created by fast evaporation, and onto this 
a mixture of the matrix and analyte is added (as in the crushed-crystal method). 
This has enhanced sensitivity and spot-to-spot reproducibility compared to fast 
evaporation, probably because of improved isolation of the analyte molecules on the 
crystal surfaces in the presence of extra matrix.
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The sandwich method was derived from the fast-evaporation and overlayer meth­
ods. A droplet of analyte solution is applied to a thin thin film of matrix created by 
fast evaporation, followed by the depostion of a second layer of matrix so that the 
analyte is effectively sandwiched between two layers of matrix. This method was 
introduced by Li et al. for the analysis of single mammalian cell lysates [49], but 
has not been widely adopted by the mass spectrometric community.
Spin coating has proved useful for the analysis large biomolecules [50]. A relat­
ively large volume (up to 10 ml) of matrix/analyte solution is deposited onto a plate, 
which is then spun at around 300 rpm to create a more homogeneous film than in 
the conventional dried-droplet method.
In cases where the analyte is insoluble, the pellet method may be useful [51]. A 
mixture of finely ground analyte and matrix is pressed together in a hydraulic press 
to give a combined pellet.
The use of matrix pre-coated targets and membranes has proved particularly 
useful when there is only a small amount of analyte available. A range of substrates 
including PVDF, nitrocellulose, cellulose, and nylon have all been tested. The use of 
such materials as a method of matrix support and also as tissue blotting substrates 
is reviewed more fully in Chapter 2.
Several research groups have investigated the use of liquid matrices as an al­
ternative approach to the desorption of solid matrix-analye deposits. The major 
advantage of these methods is that the analyte is likely to be more evenly distrib­
uted throughout the matrix, as a function of simple molecular diffusion. Liquid 
matrices can be divided into three categories:
1. Chemical liquid matrices [52,53]: the liquid matrix absorbs the laser energy 
(similarly to a solid matrix).
2. Suspension or particle-doped liquid matrices [7,54-56]: fine graphite or metal 
particles are suspended in a liquid that does not absorb the laser energy (for 
example glycerol). The fine particles absorb the energy and facilitate desorp­
tion while the liquid molecules provide the charge for ionisation.
3. Chemical-doped liquid matrices [57]: an organic material that is highly absorb­
ent at the laser wavelength employed is added to a liquid medium.
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Alternative methods such as electrospray and airspray matrix depostion have 
been developed and show particular promise in investigations where the method 
of matrix application must offer a degree of matrix crystal homogeneity across the 
sample that would allow the full surface area to be scanned, and have spot-to-spot 
reproducibility.
Electrospray as a method of MALDI sample preparation was introduced by 
Owen [58,59] and independently by Axelsson [60]. In this technique a small amount 
of matrix-analyte mixture, or matrix alone, is elecrosprayed from a high voltage- 
biased (3-5 kV) stainless steel (or glass) capillary onto a grounded metal plate, moun­
ted 0.5-3 cm away from the tip of the capillary. This method has superior crystal 
homogeneity, producing an even matrix layer across the sample surface. Quantitat­
ive analysis has been reported by Owen [58] with use of an internal standard.
The airspray method [61] uses a compressed airbrush device to spray matrix or 
a matrix/analyte mixture onto the sample plate. This is a very simple, inexpensive 
alernative to the electrospray method and has shown excellent reproducibility [61,62]
1.1.3 M ALDI ion formation
Despite the widespread use and application of MALDI over the last twenty years, the 
process of ion formation remains poorly understood. MALDI has proved to be an 
extremely difficult process to characterise, and it is clear that even in a single exper­
iment no one mechanism can explain all ions observed. It has also been calculated 
that while one laser pulse results in several thousands of ions, the overall iomneutral 
ratio in UV MALDI is only about 1 : 104. Thus we are trying to understand a 
mechanism that results in minority species. Several theories and mechanisms have 
been proposed, and are reviewed in an excellent article by Zenobi and Knochen- 
muss [8]. It is widely accepted that a variety of different pathways contribute to the 
ions observed in a MALDI spectrum, as summarised in Table 1.2.
MALDI ionisation mechanisms can be divided into primary and secondary ion­
isation steps [8]. Primary ion formation accounts for pathways in which neutral 
reactants are converted into charged products (gas phase ions) by action of the laser 
pulse on the sample. These conversions occur in the MALDI plume and usually 
result in the formation of matrix ions. Secondary steps are any subsequent ion- 
molecule reactions that convert the initial charged species into the ions that are
12
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P rim ary  ion form ation Desorption of preformed ions 
Multi-photon ionisation 
Energy pooling 
Excited-state proton transfer 
Disproportionation reactions 
Thermal ionisation
Secondary ion form ation Proton transfer 
Electron transfer 
Cationisation
Table 1.2: Possible pathways for MALDI ion formation (as reviewed by Zenobi and 
Knochenmuss [8])
observed at the detector. It is possible that primary ionisation may be partially 
or completely masked by secondary reactions [63]. While this complicates elucid­
ation of the primary ionisation steps, it explains the similarity of MALDI spectra 
recorded under different conditions, and may be useful in predicting MALDI mass 
spectra [64].
P rim ary  ion form ation
An attractive mechanism is that ions observed in the spectrum may already be 
present in the solid sample and are liberated with the laser pulse (desorption of 
pre-formed ions) [65].
The formation of the cation radical of the matrix by multi-photon ionisation was 
considered by many as a likely model of primary ion formation [66]:
M  Af+* +  e~
However, in theory the laser irradiances used in UV MALDI are too low to allow 
significant absorption of more than two photons by a matrix molecule. Since the 
ionisation energy of most matrices is estimated to be greater than the energy of two 
photons of a nitrogen laser, the two photon ionisation model cannot be assumed [67].
Nevertheless, two-photon excitation of a matrix molecule may still be an import­
ant step in the ionisation process. It has been observed that thermal energy from
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the MALDI plume may make up the difference between a two-photon excitation 
and the ionisation potential, thus a photothermal model has been proposed [68]. 
Furthermore, energy pooling is considered as a likely mechanism [69]. In this model 
two or more matrix molecules pool their internal energy together while in an excited 
state (M *M *) to yield one matrix radical cation:
2M ^  M 'M *  — > M  +  M** — *M  + M+- +  e~
Following photoionisation, excited state proton transfer (ESPT) is the most fre­
quently proposed MALDI ionisation model, dating back to the origin of MALDI [9]. 
The acidic properties of many aromatic derivatives are enhanced when molecules 
are laser excited; thus a single excited matrix molecule (M*) may transfer the labile 
proton to an analyte or matrix molecule in the ground state:
— > + A— * [M + H]- + [A + H]+
or
M  — >+M — ► [M +  H)~ +  [M +  H]+
This is an attractive pathway as it only requires one photon, and also because 
it rationalises the formation of pseudomolecular ions. However, none of the popular 
matrices is known to be particularly ESPT-active in solution or gas phase, and also 
known ESPT compounds have been demonstrated to be poor MALDI matrices [70].
Disproportionation reactions have been proposed to explain the simultaneous 
formation of positive and negative ions [71,72]. Proton transfer of two coupled and 
excited matrix molecules is thought to give rise to positive and negative species as 
follows:
2M M  + M** — ► [M -  H]~ +  [M + H]+
This reaction has been shown to be energetically possible with two nitrogen laser 
photons [71]. Despite this, there is still little evidence to support this mechanism [8].
Thermal ionisation has been demonstrated as a possible pathway of ion forma­
tion, and is particularly likely in scenarios employing particle suspension matrices [8]. 
In these cases, the laser energy is absorbed by particles suspended in a liquid that 
is transparent to the laser, and formation of ions from the excited particles is thus 
thought to occur via thermal routes.
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Secondary ion formation
In cases where primary ions are radical cations, gas phase proton transfer reactions 
have been shown to occur with both neutral matrix and neutral analyte molecules
[73].
Electron transfer has been shown to be a plausible pathway for MALDI analysis 
of compounds with low ionisation potential (IP) [74]. In this situation a matrix 
radical cation and an analyte molecule may react to produce an analyte radical 
cation:
M +' + A — >M + A+
Several studies of cationised molecules generated under MALDI conditions have 
shown that these ions often result from ion-molecule reactions in the gas phase. Thus 
the process of cationisation has been widely accepted as a pathway of secondary ion 
formation.
The fact that MALDI is generally characterised by the presence of only singly- 
charged molecules led to the development of the lucky survivor model [75]. This 
uniform model of the MALDI ionisation process proposes that multiply-charged 
clusters are desorbed, but are subsequently neutralised or have their charge reduced 
by proton transfers or electron captures with reactive matrix species. By this ra­
tionale, the only ions that will survive the process and reach the detector are those 
that are singularly charged.
Although all of these mechanisms are clearly important in MALDI, no definitive 
explanation of the process has been offered. A better understanding of MALDI ion­
isation could result in improved ion yields, control of fragmentation and ion charge 
states, permit access to new compounds by MALDI, provide a solid rationale for 
marix selection, and may also hi-light reasons for discrimination effects in quantit­
ative UV MALDI [8].
1.1.4 Desorption mechansisms
Several theories have been developed to explain the desorption of molecules in the 
MALDI process.
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The thermal spike model [76] proposes that the matrix molecules sublime from 
the surface as a result of local heating at low laser fluence, but above a certain laser 
intensity, a rapid increase in the desorption efficiency occurs. The ejection of intact 
molecules is attributed to poor vibrational couplng between the matrix and analyte 
which leads to a bottleneck in the energy transfer from the matrix to the vibrational 
mode of the analyte molecule.
The pressure-pulse theory [77] proposes that a pressure gradient is created nor­
mal to the surface, and that desorption of large molecules might be enhanced by 
momentum transfer from collisions with fast moving matrix molecules.
A more recent theory suggested by Hillenkamp et al. [78,79], the quasi-thermal 
model is the most widely accepted scenario of desorption in MALDI. The primary 
step involves a pressure driven decomposition of the co-crystallised analyte/matrix 
material into smaller particles consisting of both clusters and single molecules. These 
are subsequently thermally desorbed in a second step to create the MALDI plume. 
High density and collision rates within the plume create an explosive phase trans­
ition that results in molecular gas phase species of both the matrix and analyte by 
expansion cooling.
1.1.5 Time-of-flight mass spectrom etry
Time-of-flight (TOF) mass spectrometry was first successfully used as an ion ana­
lyser in the 1950’s [80]. The principle of mass analysis in a time-of-flight analyser is 
based on the principle that ions of different m /z  values have the same energy, but 
different velocities, after acceleration out of the ion source. Thus, the time required 
for each to traverse the flight tube is different: high mass ions take longer to reach 
the detector than low mass ions.
The kinetic energy given to an ion by the electric field is the product of the 
charge of the ion and the electrical field strength [81]. This is shown in Equation 1.
Equation 1: zeV  =  \m v 2
Where z =  number of charges
e =  charge of an electron 
m =  mass of ion 
v =  velocity of ion 
V =  electrical field strength
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If the length of the source region is s, then the drift time, £1 , through the source 
region is determined by Equation 2:
Equation 2: f  _  2s _  (2m )1/ 2s 1 V (Zev y / 2
If the length of the drift tube is 1, then the time-of-flight, t2, of an ion through 
the drift tube is determined by Equation 3:
Equation 3:
(:2 Z e V )1/ 2
The time-of-flight for an ion can be determined by combining Equations 2 and 3:
,1 /2Equation 4: t = (:2 Z e V y / 2
A schematic overview of MALDI-TOF-MS is illustrated in Figure 1.3.
Laser beam
zeV = 1/2 mv
h —
Sample desorbed as ions 
and neutrals
Detectoro a
Acceleration region
t, = 2s = (2m) s 
V (ZeV)m
Figure 1.3: MALDI-TOF-MS (linear time-of-flight)
Thus the time taken for an ion to reach the detector is proportional to the square 
root of its m/ z  value. The larger the mass of a singly charged ion, the longer it takes 
to traverse the field free region.
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The pulsed laser used for MALDI makes it an ideal technique for coupling with 
TOF mass spectrometry since there is a previously defined time of ion generation. 
Mass to charge ratios are determined by measuring the time that ions take to move 
through the drift tube between the source and the detector.
Today’s linear TOF MS instruments are capable of attaining a resolution of 1 
part per 1000. A major limitation in achieving high resolution is the consequence 
of the spread in time, space and kinetic energy of the initial ion packet. The time 
difference in formation of two ions of the same mass caused, for instance, by the 
length of a laser pulse, will remain the same during the flight to the detector. Ions 
that are not formed at the same location, due to the spread of the sample on the 
target or width of the ion beam, will be accelerated to different kinetic energies. 
Also, ions can be generated with different initial kinetic energy.
Reflectron TOF
This spread in kinetic energy can be partially compensated by using a device called 
a reflectron (Figure 1.4). Ions of higher energy will penetrate deeper into an elec­
trostatic repeller field (ion mirror) and will be turned around and arrive at the 
detector at the same time as ions of lower initial energy that penetrate the field less. 
In a linear TOF, neutral and charged fragments generated through fragmentation 
of ions in the drift region cannot be distinguished from the original ion, because 
their velocity remains the same. Metastable ions generated prior to reflection have 
the same velocity as their precursor ion, but a reduced energy and hence can be 
distinguished when spectra acquired in linear and reflectron mode are compared, 
due to their time difference. Reflectron TOF instruments are capable of a resolving 
power of over 1:10,000.
Delayed extraction
Peak broadening can also be reduced by delayed ion extraction out of the ion 
source [82,83]. With delayed extraction (DE), the extraction voltage pulse is applied 
between 100 and 500 ns following the laser pulse. During this delay, ions are allowed 
to spread in the source and higher energy ions will move further away than lower 
energy ions with the same mass. The extraction voltage is applied as a potential 
gradient over the ion source. This compensates for the distribution of initial kinetic
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Laser
Reflectron 
(ion mirror)ions
Detector
MALDI Target
Figure 1.4: Reflectron TOF mass spectrometer.
energies, so that ions with identical m/z values will arrive at the same time at the 
detector.
Time-of-flight analysers have some special advantages. In contrast to sector 
instruments and quadropoles, all ions accelerated out of the ion source of the TOF 
instrument will reach the detector, giving it a relatively high sensitivity. Of course, 
the ions must be pulsed into the analyser, and so, some dead time exists when ions 
are not being analysed. Also, the mass range of TOF analysers is virtually unlimited 
and any practical upper limit is dictated by the ionisation process and by detector 
efficiency. The combinations of time-of-flight mass spectrometry with MALD, PD 
and ES have all been used extensively in biochemical research.
L atest instrum ent developments
A number of new instruments for MALDI-MS have been introduced over the last 
five years. These offer advantages such as enhanced sensitivity, improved mass 
resolution and accuracy, and the ability to perform tandem MS experiments. Thus 
the field of MALDI-MS continues to develop at an ever-increasing rate. These
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novel instruments include a MALDI ion source coupled to a hybrid quadrupole-TOF 
(QTOF) [84]; tandem MALDI TOF-TOF [85]; and Fourier-transform ion cyclotron 
resonance (FT-ICR) MS [86,87].
The QTOF has already found widespread use in biomolecular analysis. Such 
instruments employ orthogonal ion acceleration (reviewed by Guilaus et al [88]) 
which has a number of advantages over the more common axial-injection geometry. 
The hybrid mass analyser configuration permits compound identification either by 
analysis of the intact molecule or by spectral analysis of product ions produced 
by collisionally-induced dissociation of individual precursor ions in a collision cell. 
Both kinds of spectra can be acquired from a single sample in the same experiment. 
The use of collision-induced dissociation to yield sequence information circumvents 
the low product ion yields and problematic interpretation of product ion spectra 
acquired by the postsource decay technique. Collisional damping is used to cool 
the ions produced by MALDI before they enter the quadrupole. The time-of-flight 
measurement is thus decoupled from the MALDI process and provides high mass 
accuracy for both precursor and product ions, high resolution, simple selection of 
precursor ions and precise tuning of collision energies. MALDI-QTOF-MS with 
orthogonal ion injection has been evaluated for in situ analysis and imaging on skin 
in Chapters 3-6.
Finally, a range of separation techniques have been successfully interfaced with 
MALDI to improve the sensitivity further, e.g., scanning IEF gel separation coupled 
to MALDI-TOF mass spectrometry [89]; replacement of IEF with reversed phase 
(RP)-HPLC [90]; and nonporous RP-HPLC [91].
This ever-expanding range of new mass analysis and sample interface configur­
ations is opening access to a range of new compounds for MALDI analysis, and is 
increasing the spectral quality of existing procedures.
1.2 Imaging mass spectrom etry
The use of mass spectrometry (MS) to obtain spatially resolved information com­
menced 30 years ago with the advent of secondary ion mass spectrometry (SIMS).
In SIMS, the surface of the sample is subjected to bombardment by high energy 
ions — this leads to the ejection (or sputtering) of both neutral and charged ( + /—)
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species from the surface. The ejected species may include atoms, clusters of atoms 
and molecular fragments. In traditional SIMS, it is only the positive ions that are 
analysed. Since the technique uses a beam of atomic ions (i.e., charged particles) 
as the probe, it is a relatively easy matter to focus the incident beam and then to 
scan it across the surface. Thus the detector response for a selected mass at each 
raster spot becomes a pixel in the image. SIMS is particularly appropriate for the 
determination of the inorganic fraction and the elemental composition of the sample 
surface, whereas non-specific ions are usually generated from the organic fraction.
Secondary ion mass spectrometric imaging has been widely used and developed 
by both the chemical and biomedical communities. The technique has been applied 
to the analysis of biological samples in a range of applications, e.g., to monitor phar­
maceuticals at the cellular and subcellular level; to study ion transport in organisms 
by isotopic labelling; to map the distribution of ions in hard tissue such as bone and 
teeth and to study chromosomes [92]. In addition, there have been recent efforts to 
apply SIMS to organic compounds and metabolites of low mass (500 amu) in single 
cells [93].
For the study of organic solid compounds, laser desorption mass spectrometry 
(LDMS) is a promising technique. The use of lasers in imaging MS has several 
advantages over the use of ion-beams alone, for example high sensitivity, select­
ive ionisation, and quantification. This technique is similar to SIMS and permits 
investigation of solid samples directly—without the need for extensive sample pre­
paration/separation prior to analysis. UV laser spot sizes can be focused to under 
5 pm  and thus the technique is ideally suited to spatially-resolved analyses. The use 
of laser desorption mass spectrometry to obtain spatial information is often referred 
to as laser microprobe mass spectrometry (LMMS). This technique became widely 
available with the introduction of commercial instruments [94]. Several reviews 
discuss applications, fundamentals and limitations of LD and LMMS [5,94-97].
A major limitation of this technique is the accessible mass range, as ionisation 
of intact biomolecules over around 1000 amu was impossible. This was overcome 
with the introduction of matrix-assisted laser desorption ionisation MS (MALDI- 
MS) [6, 7,9]. A low concentration of analyte is embedded in a matrix consisting 
of species that highly absorb the applied laser light. The development of MALDI
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exponentially increased the mass limits of laser desorption. The technique was 
reviewed in detail above (page 3).
Recently, imaging using MALDI has become a subject of interest and is demon­
strating great potential. Practical aspects of both MALDI and SIMS imaging are 
discussed in an excellent article by Todd et al. [98]. A review of imaging mass 
spectrometry covering applications of SIMS, LD and the introduction of MALDI 
imaging has been published by Pachowlski and Winograd [92].
1.2.1 Imaging M ALDI MS
A common initial step in MALDI imaging involves the application of a thin layer of 
matrix to the sample. The chemistry of the sample can then be imaged by holding 
the laser, moving the sample and acquiring mass spectra from each point. Three- 
dimensional images may be obtained by plotting the spatial dimensions of x  and y 
versus absolute ion intensity, which gives a semi-quantitative indication of analyte 
concentration at a given location.
MALDI has been used for the imaging of both biological samples [99-113] and 
thin layer chromatography (TLC) plates [114-118], with the method of matrix ap­
plication to such samples requiring that the spatial distribution of the analyte in the 
sample be maintained. Conventional MALDI sample preparation is known to de­
pend upon formation of a homogeneous liquid phase mixture of matrix and analyte 
before crystallisation. However, for spatially resolved analyses, it is essential that 
redistribution or migration of the analyte from its original location is avoided. Thus 
in imaging MALDI there should be no laterally-extended liquid phase mixing of the 
matrix and analyte. A number of methods of matrix application have been developed 
and assessed to meet this requirement, including indirect matrix deposition [115], 
brushing the sample with a supersaturated matrix solution [116], spreading a loaded 
matrix drop [103], electrospraying [101,116], airspraying [100,118,119], and robotic 
deposition of small (picolitre) volumes of matrix [113,120].
Imaging thin-layer chromatography (TLC) plates
The imaging of TLC plates by MALDI-MS was introduced by Gusev et al. [114], who 
were able to detect nanogram quantities of bradykinin, angiotensin and enkaphalin 
derivatives. The analyte molecules were brought to the surface of the TLC plate by
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solvent extraction, and matrix material was dropped onto the plate with a syringe 
or pipette. The degree of analyte spreading was found to be around 1.5 mm. In 
addition, the surface heterogeneity of the sample resulted in signal intensities being 
averaged for five successive laser spots, so that the effective spatial resolution was 
estimated at 1 mm.
Further methods were developed for imaging compounds in the molecular weight 
region of 400 — 1100 Da, for example bradykinin, angiotensin, rhodamine B and 
guinea green B [115]. Both direct and indirect methods of matrix deposition onto 
TLC plates were evaluated in these experiments.
The direct method involved gently spraying a matrix solution onto TLC plates 
with a glass reagent sprayer. However, this approach induced analyte spreading and 
so was considered unsuccessful. The indirect matrix deposition technique entailed 
initial crystallisation of the matrix solution on a stainless steel plate. The matrix 
was then transferred onto the TLC plate by pressing the steel plate matrix side 
down into the TLC plate. This method successfully restricted analyte spreading.
Images were obtained for all analytes at nanogram concentrations. Efforts were 
made to improve the spatial resolution by modification of the laser beam lens ar­
rangement. However, focusing the beam to achieve a laser spot of under 30 fim 
resulted in signal degradation and poor signal reproducibility. This is a known lim­
itation. Furthermore, matrix heterogeneity was estimated at 10 — 20 fim  and so use 
of a laser spot size of 30 fim resulted in an ultimate resolution of around 50 fim.
Mowthorpe and colleagues [116] investigated the effectiveness of different matrix 
deposition methods onto TLC sample surfaces, extending the work of Gusev et 
al [114,115]. They presented a method for analysing pharmaceutical compounds of 
~  400 — 500 Da separated by TLC with use of a linear time-of-flight instrument.
A method for brushing a supersaturated matrix solution onto a TLC plate was 
developed. The investigation concluded that matrix deposition by electrospray (us­
ing a purpose built device) was superior to the other methods, and indicated that 
this method should be used where spatial resolution of the analyte is desired. (Elec­
trospray as a method of matrix application is discussed on page 12, and investigated 
in Chapters 2-4.)
By modification of a commercial MALDI-TOF mass spectrometer and software 
they succeeded in obtaining chromatographic data from replicate spots of tetracyc­
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line at the 1 mg level, showing successful acquisition of chromatographic data from 
a TLC plate by MALDI-MS. A nitrogen laser was employed offering a spot size of 
~  200 /im. In further work, methods for the quantitative determination of pirox- 
icam by TLC MALDI were tested and developed. This work is discussed more fully 
in Chapter 5 of this thesis. A novel method of predeveloping TLC plates in an 
internal standard prior to drug separation and MALDI analysis was presented, in 
which linearity was observed over the range 400-800 ng of drug [118].
It has been shown that signal intensities may be improved by blotting the TLC 
plate onto a membrane by heat transfer [117]. Extraction solvent is applied to the 
chromatographic spots, and the analytes are then transferred to a membrane by 
pressing the plate onto the membrane with a hot iron. In this work matrix solu­
tion was applied by pipetting, and thus the problematic issues of analyte spreading 
resulted in a poor spatial resolution.
Imaging biological samples
Caprioli and co-workers (1997) developed MALDI imaging techniques to identify 
and profile peptides and proteins in biological tissue [101]. They presented successful 
localisation of hormone peptides in a tissue section taken from rat pituitary, and 
succeeded in mapping insulin within a section of rat pancreas. In addition, human 
buccal mucosa (cheek) cells were dried, sprayed with MALDI matrix, and then 
imaged. A protein involved in the prevention of tooth decay was identified. Methods 
of direct tissue analysis and indirect analysis (blotting onto a layer of C18 beads or 
a cellulose membrane) were compared. Analysis of C18 blots was found to be the 
superior method. Optimum results were achieved by electrospraying the matrix 
onto the C18 blots: this minimised analyte spreading and allowed mapping and 
localisation of specific compounds within tissue sections.
In a subsequent study, Caprioli investigated the use of a carbon-filled polyethyl­
ene membrane as a blotting substrate, selected because of its electrical conductivity 
and protein adhesion properties [102] . Analysis of such membranes yielded unique 
protein profiles [102]. The former facilitates matrix application by electrospray and 
the latter enables effective purification of proteins from intact tissue. A further 
study using improved instrumentation achieved faster image acquisition [103], lend­
ing itself to automation and use as a routine high throughput method.
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The use of membranes for matrix support has been investigated for a variety of 
substrates e.g., nylon [121], poly(vinylidine difluoride) [122], nitrocellulose [123] and 
polyethylene [124]. The use of these membranes to enhance the mass spectrometric 
analysis of proteins has been reviewed by Vestling et al. [125]. The use of membranes 
as tissue blotting substrates, and as a method of achieving enhanced mass spectral 
profiles is investigated and reviewed in Chapters 2 and 4.
Disease s ta te  profiling MALDI peptide and protein imaging has paved the way 
for the development of techniques for disease state profiling, which are now described.
Stoeckli and co-workers investigated the use of MALDI imaging as a method 
for identifying and mapping amyloid beta (A/3) peptides in transgenic mice brains 
[104,105]. The formation of plaques containing high levels of Aft is thought to be 
a central process in Alzheimer’s disease. 50 /zl of matrix was applied directly to the 
tissue surface. Crystallisation was performed at 4°C: this slow drying method 
was selected in order to increase signal intensity by reducing salt contamination. 
Unfortunately, although signal intensity was enhanced, the method typically yielded 
large crystals of ~  200 fim. In addition, by filming the drying process, migration of 
individual matrix crystals by up to 400 /zm was observed, with obvious implications 
for analyte spreading. Despite limitations of the spatial resolution due to the matrix 
application and crystallisation, the mass images correlated well to optical images of 
the plaques indicating the potential of the technique.
Another major neurological disorder, Parkinson’s disease, is currently being in­
vestigated by imaging MALDI-MS [106,107]. Imaging analysis of experimental mod­
els of Parkinson’s disease in mouse brain demonstrated a range of region-specific 
protein images in affected vs. control tissues. Matrix deposition by spotting small 
matrix volumes (as described later in this section) reduced protein migration within 
the tissue samples.
The identification of tumour-specific proteins has been achieved by the ana­
lysis of tissue blotted membranes [108] and by direct tissue analysis [109]. Healthy 
and cancerous tissue from mouse colon was blotted onto a polyethylene membrane, 
which was subsequently coated in matrix material by elecrospray. Tumour-specific 
biomarkers were identified by comparison of the mass spectral profiles obtained from 
the blots of healthy and diseased tissue [108]. The alternative approach of direct
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tissue analysis for tumour typing human brain tissue has recently been presented. 
Unique tumour associated protein profiles were obtained, and examination of the 
mass spectral profiles permitted classification of tumour samples by histological 
grade [109].
The studies described thus far have involved analysis of single, two-dimensional 
sections of tissue. Recently, a three-dimensional model of myelin basic protein in 
mouse brain tissue by MALDI-MS was presented [110]. Optical images of successive 
sections of mouse brain were compiled to give a three-dimensional model of the brain 
tissue. Approximately 1 in 20 of the sections obtained were subjected to imaging 
MALDI-MS. Resultant mass images were incorporated into the model by computer- 
aided design, and mass spectrometric images were incorporated into MRI images of 
the same tissue, demonstrating good anatomical homology.
Single-cell analysis MALDI-TOF can also be used to study single cells and is 
becoming a popular method of cellular peptide profiling. Peptides in single neurons 
from invertebrate ganglia and atrial glands were imaged by MALDI-MS by Sweedler 
et al. [111]. Invertebrates possess relatively large central nervous system neurons 
(15 — 500/zm) compared to mammalian tissue, and thus successful imaging of pep­
tides within individual neurons in such systems is conceivable. Intact tissue sections 
were coated with matrix by electrospray. The authors describe that both matrix de­
position and tissue freezing and sectioning protocols influence the spatial resolution 
in terms of peptide migration and signal intensity. Images depicting the distribution 
of a neuropeptide are displayed at a laser spot size of 100 /zm. The image demon­
strates areas of both analyte spreading and signal suppression. This highlights that 
while the instrumentation employed offered a spatial resoltion of 30 /zm, the ultimate 
resolution was impaired by sample preparation.
Peptide profiling in cells has also been accomplished with the use of laser capture 
microdissection (LCM). In LCM, a thermoplastic membrane placed directly on a 
tissue section melts and adheres selectively to cells of interest after irradiation with 
a focused infared laser pulse. The thermoplastic film is then coated with matrix and 
analysed by MALDI-MS. Caprioli and co-workers describe coating the membrane 
using picolitre volumes of matrix deposited via a finely-pulled glass capillary [112]. 
The reduced volume of solvent applied in this method has been shown to minimise
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analyte spreading and, with the advent of specifically-designed robots [113,120], the 
technique is likely to have widespread use for imaging applications. Such robots 
are capable of spotting matrix in volumes low enough to achieve minimal analyte 
spreading. Furthermore, analyte migration is confined within the picolitre spot, and 
is likely to be comparable for all spots. Samples are spotted on specialised targets, 
and an ASCII file is generated containing the xy  co-ordinates of all spots. Thus 
mass spectral data can be acquired from the tissue according to the precise location 
of the deposited matrix spots.
Analysis of pharm aceutical com pounds In addition to the successful detec­
tion and mapping of peptides and proteins in tissue and single cells, in situ ana­
lysis [99] and imaging [100] of pharmaceutical compounds in tissue has also been 
demonstrated.
In situ MALDI analysis of drugs was introduced by Troendle and colleagues [99]. 
Matrix was applied to the tissue surface by pipetting and electrospraying. In these 
experiments, a MALDI quadropole ion trap was employed to detect the anti-cancer 
drug paclitaxel in a human ovarian tumour. In other studies, the anti-psychotic 
drug spiperone has been detected in spiked sections of rat liver tissue [99].
The determination of two pharmaceutical compounds in rat brain tumour tissue 
was presented by Reyzer et al. [100]. Tissue sections were coated in sinapinic acid 
by airspray deposition. It was found that MALDI-TOF technology was unable to 
differentiate between the drug compound, matrix clusters, and endogenous tissue 
molecules in the majority of samples. In order to overcome this, MALDI-Qq-TOF 
using selected reaction monitoring was evaluated. Unambiguous determination of 
the drug by dissociation of the protonated molecule to its predominant fragment was 
achieved. Thus the spatial location of the drug molecule in brain tumour tissue was 
shown as a map of the fragment ion by tandem MS. Ultimate spatial resolution in 
these experiments is not discussed, but is likely to be in the region of 50 /zm—given 
the instrument employed (in the absence of excessive analyte spreading).
O ther biological applications MALDI imaging has also been used to analyse 
plant tissues [119]. Successful localisation of a range of amino acids and primary
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metabolites has been demonstrated by blotting potato tuber and leaf samples onto 
matrix coated membranes. This work is included in Appendix A of this thesis.
MALDI imaging has also been used as a method of assessing the homogeneity of 
matrix application methods. Electrospray was shown to be far superior to pipetted 
drops in terms of layer uniformity [126].
R ecent developm ents Whilst MALDI imaging experiments have yielded better 
quality spectra, and can detect a superior mass and compound range compared 
with LDMS and SIMS, the lateral resolution is significantly less good than with 
laser microprobe or ion beam approaches. The quoted diameter of the laser spot 
size in most reports of MALDI imaging is between 50 — 200 fim, which may limit 
the usefulness of the technique for some applications. In view of this, efforts are 
being made to develop a microprobe MALDI approach: scanning microprobe MALDI 
(SMALDI) [127]. Sub-micron focusing of the laser beam is achieved by prefocusing 
outside the vacuum and final focusing directly above the sample. This permits 
a nitrogen laser to be focussed to approx 0.6 pm. Although this offers a 100-fold 
improvement in spatial resolution over the majority of MALDI imaging experiments, 
certain issues need to be addressed. First, smaller spot sizes have been associated 
with poor signal intensities [27] and, second, methods of matrix application that do 
not induce analyte spreading have only been reported for resolutions of 50 /im, and 
are yet to be demonstrated for the sub-micron range.
It is clear from the rapidly-emerging MALDI imaging literature that successful 
homogeneous coverage and formation of matrix crystals on the sample is key to the 
success of the technique. It has been demonstrated that there is no clear protocol 
for achieving the best results. Choice of matrix material and application method 
vary with respect to both the analyte (e.g., protein vs. drug), and the sample itself 
(e.g., intact tissue, cells, TLC plates, and membranes). Thus the various different 
approaches have shown success and failure in different applications. A recent article 
outlines optimal strategies for the direct analysis of proteins in tissue [113], and 
discusses aspects such as tissue handling & storage, as well as matrix application. 
However it is impossible as yet to make an a priori prediction of a successful protocol 
for new applications. Thus the majority of imaging experiments must start with
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the trial, error, and evaluation of documented methods such as direct analysis vs. 
blotting, choice of matrix, and method of matrix application.
The detection and imaging of pharmaceutical compounds in tissue [99,100], to­
gether with the imaging of drugs on TLC plates [114-118] and of proteins in tis­
sue [101-113] by MALDI-MS shows that imaging with MALDI-MS has promise as 
a routine method for mapping drugs in tissues. This has widespread application in 
pharmaceutical and medical research.
The work described in this thesis concerns the development of optimal strategies 
for the analysis, imaging, and quantification of drugs in skin by MALDI-TOF-MS.
1.3 Dermal absorption
1.3.1 The structure of skin
The skin is a metabolically-active organ with vital functions such as thermoregu­
lation, protection, metabolism, excretion, immunity and sensation. It consists of 
two distinct layers—the epidermis and the dermis—each with a distinct function. 
The dermis is attached to an underlying hypodermis, (subcutaneous tissue layer), 
consisting of adipose tissue and areolar connective tissue (Figure 1.5 [128]).
The stratified epidermis is the outermost layer of the skin (100 — 150 /im thick) 
and is subdivided into five layers or strata (Figure 1.6): the stratum basale, the 
stratum spinosum, the stratum granulosum, the stratum lucidum, and the stratum 
corneum in which a keratinocyte (the principal cell type found in the epidermis) 
gradually migrates to the surface and is sloughed off in a process called desquam­
ation. Keratinocytes comprise about 95% of the epidermis. The stratum basale is 
a single layer of columnar keratinocytes, attached to the basement membrane by 
hemidesmosomes—junctions that anchor the cell to a non-cellular substrate. After 
a mitotic division, newly formed cells will undergo a progressive maturation called 
keratinisation as they migrate to the surface. The stratum basale also contains 
melanocytes, Langerhans cells, and Merkel cells. (Figure 1.6 [129]).
The stratum spinosum consists of 8-10 layers of keratinocytes which accumulate 
many desmosomes (junctions that attach a cell to its neighbour) on their outer 
surface providing the characteristic ‘prickles’ of this stratum, which is often called 
the prickle-cell layer. Langerhans cells and melanocytes may also be present.
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Figure 1.5: The integumentary system consists of skin, associated appendages, 
muscles and nerves (from [128]).
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Figure 1.6: Layers of the epidermis (from [129]).
The stratum granulosum comprises around five layers of flattened keratinocytes. 
These cells accumulate dense basophilic keratohyaline granules, containing lipids, 
which along with the desmosomal connections, help to form a waterproof barrier 
that functions to prevent fluid loss from the body.
The stratum lucidum consists of about five layers of clear, flat, dead cells. This 
layer is normally only present in the thick skin of the palm and soles.
As a cell accumulates keratinohyaline granules, it is thought that rupture of 
lysosomal membranes release lysosomal enzymes that eventually cause cell death. 
The dead and dying cells filled with mature keratin form the stratum corneum. 
The deeper cells of the stratum corneum retain their desmosomal junctions, but 
as they are pushed to the surface by newly forming cells, the dead cells gradually 
desquamate.
The dermis assumes the important functions of thermoregulation and supports 
the vascular network to supply the avascular epidermis with nutrients. The dermis 
is typically subdivided into two zones, a papillary dermis and a reticular layer. The 
principal cell of the dermis is the fibroblast. Fibroblasts secrete collagen and elastin
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that result in the support and elasticity of the skin. Also present are immune cells 
that are involved in defence against foreign bodies passing through the epidermis.
The papillary dermis contains vascular networks that have two important func­
tions. The first being to support the avascular epidermis with vital nutrients and 
secondly to provide a network for thermoregulation. The papillary dermis also con­
tains the free sensory nerve endings and structures called Meissners corpuscles in 
highly sensitive areas.
The reticular layer of the dermis consists of dense irregular connective tissue. 
This layer is responsible for the overall strength and elasticity of the skin, as well 
as housing other important epithelial derived appendages such as sebaceous glands 
and hair follicles.
1.3.2 The skin barrier
The barrier function of mammalian skin is principally attributed to the stratum 
corneum [130]. Barrier properties are based on the specific content and compos­
ition of the stratum corneum lipids [131] and in particular on the structural ar­
rangement of the intercellular lipid matrix and the lipid envelope surrounding the 
cells [132] .The lipids form bilayers surrounding the corneocytes, producing a brick 
and mortar model (proposed by Elias in 1983 [133-135]) with corneocytes as the 
bricks and the intercellular lipids forming the mortar. The intercellular lipids are 
primarily ceramides, cholesterol, cholesteryl esters, fatty acids, and a small frac­
tion of cholesterol sulphate [136]. The protein enriched corneocyte bricks impart a 
high degree of tortuosity to water or any other molecule that traverses the stratum 
corneum, while the hydrophobic lipid mortar provides a water tight barrier prop­
erty to the already tortuous route of permeation [137]. Gene gun studies have 
revealed that the corneocytes impart physical protection, in the form of impact 
resistance [138]. Extensive research has been performed to attempt to determine 
the composition and arrangement of the lipid mortar, and a detailed discussion is 
considered beyond the scope of this thesis. Current theories suggest that in fact 
the stratum corneum is not strictly a brick wall type barrier but instead a complex 
biopolymer with barrier and membrane properties [139].
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1.3.3 Percutaneous absorption
A percutaneously-delivered therapeutic agent, whether directed at the systemic cir­
culation or the local tissues, must traverse the stratum corneum. Despite an insuf­
ficient knowledge of the precise mechanism of skin penetration it is clear that both 
the physiochemical and structural properties of the penetrating molecules and the 
internal structure and composition of the skin membrane are involved in the process. 
The vitality of the skin determines the metabolism, distribution, and excretion of 
the compounds in the skin and body [140].
Absorption across the stratum corneum is a passive process of diffusion, with the 
stratum corneum behaving as a semi-permeable membrane. In principle, there are 
three routes of diffusion: intercellular diffusion through the lipid matrix; transcel- 
lular diffusion through the corneocytes; and pilosebaceous diffusion along the sweat 
pores and follicles that pierce the stratum corneum.
The route of pilosebaceous diffusion is considered to be insignificant because 
the orifices only account for 0.1% of the total skin surface area and because diffu­
sion through sweat pores is against an aqueous flow [141]. Comparison of diffusion 
across skin and across a pore-free membrane showed little difference, suggesting that 
diffusion occurs without these aqueous channels.
Although recent mathematical modelling approaches suggest that permeation 
through the corneocytes should not be ignored [142], the majority of evidence sug­
gests that the primary route of a drug through the skin is via the intercellular lipid 
matrices [143].
The thesis routes of permeation are illustrated in Figure 1.7 [144].
A variety of factors influence the absorption of compounds into the skin layers 
and these are summarised in Table 1.3.
1.3.4 M ethods for the analysis of percutaneous absorption  
and quantification of drugs in skin
In  vivo  vs. in  vitro  methods
Percutaneous absorption studies are essential to the understanding of the dermatox- 
icity and pharmacological activity of substances that may come into contact with
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Figure 1.7: Permeation routes through the stratum corneum: (i) via the lipid matrix 
between the corneocytes (intercellular route) and (ii) across the corneocytes and the 
intercellular lipid matrix (transcellular route) [144].
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Test com pound Molecular weight
Water/lipid partition coefficient
ionisation
Vehicle Solubility /  polarity
Volatility
Concentration
Distribution in stratum corneum 
Penetration enhancer 
pH
Skin Species 
Age, sex, race 
Anatomical site 
Temperature
Hydration of stratum corneum 
Damage to stratum corneum 
Metabolism
A pplication Skin area dose (e.g. film thickness, concentration) 
Total skin area in contact with vehicle 
Duration of exposure
Table 1.3: Factors affecting percutaneous absorption
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the skin, e.g., an environmental hazard or drug intended for therapeutic use. Hu­
man in vivo studies are the most relevant and are obviously the preferred approach 
for obtaining data pertaining to man. However, human volunteer studies are often 
difficult to justify ethically, particularly if the dermal application has toxic or irrit­
ant properties, or if the methods involved areT invasive or painful to the subject. 
Therefore, in vitro techniques have also been used, and have good agreement with 
in vivo experiments [145-147]. Hence in vitro techniques are popular, especially in 
preliminary drug studies and method development.
In  vivo  assessm ent
It should be noted that some of these techniques may also be adopted in in vitro 
method but are included here because they can be performed in a safe, relatively 
non-invasive manner on living subjects.
R adioactiv ity  in excreta  Percutaneous absorption in vivo may be determ­
ined indirectly by measuring radioactivity in excreta or sometimes plasma after 
topical application of the radioactively-labelled compound. This approach is par­
ticularly useful when plasma levels of topically applied compounds are below assay 
detection level [148]. This method obviously offers no information about the loca­
tion or quantity of drug in the skin layers but is used as a general measure of drug 
uptake through the skin.
Spectroscopic m ethods Attenuated total reflectance-Fourier transform in­
frared (ATR-FTIR) spectroscopy has been used to monitor the in vivo transport 
kinetics of drugs and other permeants within the stratum corneum [149]. IR spec­
troscopy records the molecular vibrations of an absorbing species, and consequently 
can either identify an unknown or track a known chemical entity. It is essential that 
the compound to be monitored possesses a uniquely identifiable IR absorbance dis­
tinct from those of the stratum corneum components. The IR absorbance is directly 
proportional to the amount of compound at the sample location. Profiles of the 
drug in skin can be compiled by repeated analysis of an area following sequential 
tape stripping and the data fitted to a Fick diffusion model [150]. This assumes 
that if the stratum corneum is the rate limiting step in dermal absorption, then
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quantification of the drug within this layer must provide an estimate of the rate and 
extent of delivery to the underlying tissues. FTIR spectroscopy has also been used 
for biophysical examination of the skin barrier function [151].
Remittance spectroscopy involves the detection of backscattered light from the 
interior of the stratum corneum. Since the presence of additional light absorbing 
compounds in the skin will reduce backscattering, it is possible to quantify the 
compounds within the skin. This has been demonstrated to be highly sensitive and 
reproducible for analysis of compounds in skin [152].
Fluorescence spectroscopy has been successfully used for the quantification of 
drugs in skin, using a self fluorescent marker [153]. As in remittance this depends 
upon the analysis of remitted light, with measuring depth being dependent on beam 
wavelength. The light is detected after passing through a second monochromator, 
and so only a specific emission wavelength is detected [154].
Photothermal spectroscopy is based upon the projection of a modulated (chopped) 
monochromatic UV beam upon the skin followed by measurement of the subsequent 
periodic heating caused by light absorbance. The presence of a UV absorbing drug 
in the tissue will increase the oscillating surface temperature, resulting in pressure 
oscillations in the skin surface that can be detected with a microphone [155]. This 
technique is limited to the analysis of the drug in the stratum corneum [156].
Surface recovery This approach is based on loss of a material on the skin 
surface as it penetrates into the tissue. It is assumed that the difference in applied 
dose and residual dose is the amount of drug absorbed. A related technique, surface 
disappearance monitors the disappearance of 14C from the skin surface as a 14C- 
labelled compound is absorbed into the skin [157].
A utoradiography Autoradiography is a photographic technique used to de­
tect the localisation of radioactive materials in specimens. Autoradiography for the 
examination of skin samples has been used at the tissue, cellular and sub-cellular 
levels [158]. The technique may be performed on small areas, or the whole body. 
Whole body auto-radiography provides an overall picture of the dermal absorption 
followed by the involvement of other body tissues [148]. Autoradiography is most
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useful when used in conjunction with skin sectioning or stratum corneum tape strip­
ping [157]. Semi-quantitative results may be obtained with the use imaging software. 
The autoradiograph is superimposed upon a histological image of the tissue and the 
computer system is used to quantify the drugs in all areas it is observed [154].
Tape stripp ing  The tape-stripping technique is being increasingly used to 
measure a drug’s concentration profile across the stratum corneum. The stratum 
corneum is progressively removed by serial adhesive tape-stripping (Figure 1.8 [159]), 
and the determination of (a) the drug amount in each tape and (b) the thickness 
of stratum corneum removed by each tape-strip, enable the diffusion capacity and 
solubility of the permeant within the stratum corneum to be calculated using Fick’s 
second law of diffusion [150]. This predicts concentration of the drug (C x) as a 
function of position (x) within the stratum corneum. The concentration of drug in 
the outermost layer of the stratum corneum (Cx =  0) divided by its concentration 
in the applied vehicle (Cv) gives the partition coefficient (k). Fitting experimental 
concentration profiles to the equation provides both k and D/L2.
Donor
Epidermis
a)
Tape Stratum
corneum
Epidermis
b)
Figure 1.8: Schematic representation of the method of tape stripping for determin­
ation of the amount of drug penetrated into the skin. After application of the for­
mulation at the donor site (a) and removal of the formulation, the stratum corneum 
is progressively removed by tape stripping (b) [159].
A major advantage of this technique is that ‘unlabelled’ compounds can be eval­
uated because the tape strippings contain adequate concentrations for non-labelled 
assay method. The two major disadvantages of the technique are: (a) unless suffi­
cient data is available in the literature about the thickness of each skin layer at the
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selected site, preliminary experiments are needed in order to assess this parameter 
and (b) the stratum corneum can not be removed entirely by stripping. Gener­
ally, about one third of the layer will remain attached as ‘islets to the epidermal 
surface [146]. As a result of this the corneocytes collected on one tape strip may 
be derived from different depths. In addition any tape strip will remove different 
amount of stratum corneum at different depths and sites of the skin. This makes it 
necessary to estimate the body mass removed with each strip e.g., by weighing the 
pieces of sellotape before and after stripping. The experimental errors associated 
with these limitations may be large.
I n  vitro  assessm ent
Skin source The most suitable source of skin is obviously human skin. How­
ever, availability is usually limited and ethical approval may be hard to obtain, and 
therefore animal tissue is often used. The most relevant animal model for human 
skin studies is the pig. Material is readily available from abattoirs and its histo­
logical and biochemical properties [160] have been shown to be similar to human 
skin. In addition, the permeability of drugs through pig skin is well documented 
as being similar to that in human skin [145,161,162]. Porcine ear is considered the 
best choice for permeation studies and has been shown to give comparable results to 
human skin [162-164]. While the act of freezing skin may affect its metabolic activ­
ity, permeation into the skin is a passive diffusion process, and it has been shown 
that freezing has little [164] or no [165] effect on skin permeability. It is therefore 
acceptable to use frozen tissue samples for in vitro measurement of drugs within 
skin.
Diffusion cell The classic diffusion cell consists of donor and receptor com­
partments separated by the skin sample. The permeation rate of the drug from 
the donor chamber through the skin and into the receptor is determined by meas­
uring the amount of drug permeated over time e.g., with high-performance liquid 
chromatography (HPLC) as the analytical method.
Tape stripp ing  In vivo studies can be hard to justify ethically and extremely 
expensive. In view of this in vitro tape stripping can be viewed as an alternative
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option, and is particularly useful in initial studies of compounds traversing the 
stratum corneum [166]. (For methodological details see page 38).
Skin ex traction  m easurem ents A biopsy of treated tissue is homogenised 
and the drug extracted in a suitable solvent. A sensitive analytical technique such 
as GLC, HPLC or scintillation counting is used to quantify the drug. This has the 
inherent disadvantage that destruction of the tissue structure in the drug extraction 
process rules out any information on the localisation of the drug being obtained [156].
Fluorescence microscopy Fluorescent or fluorescent-labelled substances can 
be localised in the skin strata with a fluorescent microscope. Some of the earliest 
fluorescent microscopy studies showed evidence that the shunt pathways of per­
meation through the pilosebaceous units are of relevance; wells of the applied com­
pounds were demonstrated within the hair follicles [157].
In summary, a variety of techniques may be employed for the determination of 
drugs in skin. None of the methods discussed is capable of displaying quantitative 
information of the spatial location of an unlabelled drug in tissue.
Work presented in this thesis concerns the development of methods for the ana­
lysis of drugs in skin by imaging MALDI-MS. Direct tissue analysis is compared 
with the indirect analysis of a variety of tissue imprinted membranes. Methods 
of matrix application are evaluated with a view to creating a homogeneous mat­
rix layer, without causing analyte spreading. Quantitative analysis of the drug by 
MALDI-TOF-MS is investigated. Finally, the methods developed are compared to 
corneum tape stripping/HPLC analysis.
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The Preparation of Tissue 
Samples for the D eterm ination of  
Pharm aceutical Compounds by 
M ALDI-TOF-M S
2.1 Introduction
The successful determination [99] and imaging [100] of pharmaceutical compounds 
and proteins [101-113] in tissue by MALDI-TOF-MS has been reported. In this 
chapter, methods for the analysis of drugs in porcine ear epidermal tissue by MALDI- 
TOF-MS are evaluated. Initial investigations were conducted with three test com­
pounds to explore the feasibility of the technique as a method of profiling drugs 
in skin. Following the selection of a suitable test analyte, the methods of direct 
tissue analysis and the indirect analysis of tissue-imprinted membranes were com­
pared and evaluated. Reyzer et al. [100] report successful localisation of a drug 
by direct analysis of matrix-coated brain tissue by MALDI-Qq-TOF-MS. The use 
of tissue blotting methods has been widely adopted for protein isolation and ana­
lysis [167]. Membranes have been used in mass spectrometry experiments as blotting 
substrates for the analysis of tissues by MALDI-MS, thereby as a means of spatially 
fixing proteins from tissues [102], and also as a method of matrix support and protein 
purification [125]. The indirect analysis of tissue-imprinted membranes for studying 
biological systems has shown promising results. Caprioli’s group reported improved 
localisation of peptides and proteins when blotting onto C18 beads adherent to a 
MALDI target [101], or onto cellulose [101] or carbon conductive [102] membranes.
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The use of poly(vinyl difluoride) (PVDF) and nitrocelluose membranes to improve 
ion intensities in protein analysis is well documented [122,123].
In the work described here, the utility of blotting drug treated skin samples 
onto substrates for MALDI-TOF-MS analysis was investigated. To enable a full 
comparison between blotting and direct tissue analysis, two different approaches to 
tissue treatment were adopted. For a technique to be useful in localising and profiling 
drugs in epidermal tissue, it must be able to show the correct spatial distribution 
of the analyte. Problems with analyte spreading by matrix application methods 
are well recognised [100-103,113], and to assess the extent of this phenomenon in 
these experiments a method of confining the tissue area studied was devised. By 
fixing a plastic ring (with an internal diameter of 5 mm) onto the epidermal surface, 
and applying drug within the ring, it was anticipated that the drug should only be 
observed on the surface within this area.
2.2 Experimental
2.2.1 M aterials
Ketoconazole (((±)—1—acetyl—4—[p—[ [(2R,4S)—2—(2,4—dichlorophenyl)—2— 
(imidazol—1—ylmethyl)—1,3—dioxolan—4—yljmethoxy] phenyl] piperazine)), aciclovir 
(previously known as acyclovir, 2—amino—9— [(2—hydroxyethoxy) methyl]—1,9— 
dihydro—6H—purin—6—one), and piroxicam (N-l(pyridyl)—4—hydroxy—2—methyl— 
2H—1,2— benzothiazine—3—carboxamide 1,1—dioxide), Sigma-Aldrich (Dorset, UK) 
were evaluated as potential test analytes. The structures of these compounds are 
shown in Figure 2.1.
The following MALDI matrices were investigated for in situ analysis of these 
compounds: a —cyano—4—hydroxycinnamic acid (a-CHCA), 2,5—dihydroxbenzoic 
acid (DHB), 3,4—dihydroxycinnamic acid (DHC), 2—aceto—2—hydroxybutyrate 
(AHB). All matrices and trifluoroacetic acid (AR grade) were purchased from Sigma- 
Aldrich (Dorset, UK). Methanol was HPLC grade, purchased from Fisher Sci­
entific (Loughborough, UK). Nitrocellulose (0.2 fim pore size) membranes, C18 solid 
phase extraction discs (C18 Envidiscs), and PVDF (Immobilon P) transfer mem­
branes (0.45/mi pore size) were purchased from Supelco/Sigma-Aldrich (Dorset, 
UK). Polyethylene-filled carbon conductive membranes (including their cellulose
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Acyclovir FW: 225.21
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Piroxicam FW: 331.35
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Figure 2.1: Structures and formula weights of the pharmaceutical analytes
43
2.2 Experimental
membrane spacers) were obtained from Goodfellow (Huntingdon, UK). Double-sided 
sticky tape was obtained commercially (Sellotape). Fresh porcine ears were obtained 
from Doncaster abbatoir.
2.2.2 Instrum entation
The electrospray matrix deposition device developed at Sheffield Hallam Univer­
sity [110] was employed in all experiments. This comprises an in-house modified 
commercial robotic x — y — 2:-axis motion system (Figure 2.2, PROBOT, BAI, Ger­
many). Modifications to the instrument were undertaken in order to use the ap­
paratus as an electrospray deposition device. The alterations were as follows: a 
PTFE tube was used to transfer matrix solution from a 100 //I syringe to a Supelco 
coupling. The electrospray needle consisted of a 94 mm length of stainless steel ca­
pillary (0.5 mm OD, 0.11 mm ID, ASH Instruments, U.K.) and the seal to the PTFE 
tube was made within the Supelco coupling. The electrospray needle was threaded 
through a stainless steel Swagelock tee coupling (1/16 in OD) and through a piece 
of stainless steel tubing (38 mm length, 1/16 in OD, 0.75 mm ID, Jones Chromato­
graphy, U.K.). A gas line was attached to the tee to provide nitrogen (2bar) coaxial 
to the spray to assist in gas nebulisation, if required.
The syringe pump (Harvard microliter syringe pump) set at a flow rate of 
0.6 ml-hr-1 delivered the matrix solution to the tip of the stainless steel capillary. To 
obtain a fine spray of the matrix solution, ca. 2 kV was applied to the tee coupling 
using a high voltage supply. The metal plate (7x15 cm) was earthed and placed 
2 mm from the end of the electrospray needle. The plate was then moved across in 
front of the spray at a rate of 25mm-s-1.
A modified LaserTOF 1500 (SAI, Manchester, UK) was employed in these invest­
igations. This is a linear time-of-flight mass spectrometer, fitted with a 337 nm nitro­
gen laser and delayed ion extraction. Modified MALDI targets previously designed 
for the analysis of TLC plates [116] were used. These targets have a 64 x 2 x 0.2 mm 
recess, into which a section of tissue or membrane was mounted with double-sided 
tape. Previous instrument modifications to the sample probe and software updates 
allowed free movement along the vertical (z) axis, and the construction of summed 
ion chromatograms. All samples were analysed in the positive ion mode.
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Stainless steel tubing High voltage supply
Figure 2.2: Electrospray deposition device employed in these investigations
Scanning electron microscopy was performed using a Phillips XL40 Scanning 
electron microscope, fitted with a tungsten wire filament. The working distance 
(from the bottom of the column to the sample surface) was 10 mm. An electron gun 
potential of 15 kV was employed in all experiments.
2.2.3 M ethods
Porcine epidermal tissue was treated with 50 /A 2 mg*ml_1 analyte solutions (pre­
pared in methanol) by pipetting onto the tissue surface. Tissue was incubated at 
37 °C for one hour. Following ‘snap-freezing’ in liquid nitrogen-cooled isopentane, 
the tissue was sectioned by microtoming in a cryostat. Surface sections of approx­
imately 30 x 2 x 0.2 mm were mounted onto modified stainless steel MALDI targets 
using double-sided tape. The mounted tissue samples were left to dry under vacuum 
overnight. The matrix was then applied to the sample using the electrospray depos­
ition device. Matrices were sprayed at concentrations between 10 and 25mg-ml_1 
at a flow rate of 0.6mMir-1.
Following matrix deposition by electrospray, samples were dried under vacuum 
for one hour prior to analysis by MALDI-TOF-MS. Mass spectra were acquired
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every 0.25 mm along the MALDI target.
Once a suitable test analyte and matrix had been selected, two different ap­
proaches for treatment were attempted in order to assess the potential of MALDI- 
TOF-MS for dermal permeation depth profiling: (1) tissue spiking; and (2) confined 
tissue spiking (spiking within a plastic ring). Direct analysis of a tissue section was 
compared with analysis of tissue imprints obtained by blotting onto a variety of 
substrates. Analyte solution (as described above) was pipetted either directly onto 
the surface, or in the centre of a plastic ring fixed to the tissue surface (confined 
tissue spiking) of a 30 x 30 x 5 mm piece of porcine epidermal tissue.
The treated tissue was incubated at 37 °C for 1 hour (and in confined tissue 
spiking experiments the ring removed), then rinsed in deionised water.
For direct analysis the sample was then frozen and a 15 /zm surface section of 
tissue was obtained by microtoming. The resultant tissue slice was sectioned with a 
surgical scalpel within the frozen conditions of the cryostat to yield a strip of tissue 
2 mm wide, which was then stuck onto the modified stainless steel TLC-MALDI 
target with double-sided tape.
For indirect analysis the tissue was blotted onto either PVDF, nitrocellulose, 
cellulose or carbon conducting membranes, or onto C18 beads directly adherent 
to the modified MALDI target. Sections of the membrane were prepared in the 
same dimensions as the tissue sections and mounted accordingly. All samples were 
then coated with matrix (as described above) and dried prior to MALDI analysis. 
Mass spectra were acquired every 0.25 mm along the MALDI target as previously 
described.
2.3 Results and discussion
Initial experiments were undertaken to assess the suitability of various matrices for 
the analysis of the potential test compounds.
In general, optimum results with MALDI-TOF-MS are achieved when a solvent is 
used in which both analyte and matrix axe soluble. Matrix assessment was therefore 
based on solubility in methanol, and on the behaviour of a pre-mixed matrix/analyte 
solution during MALDI-TOF-MS analysis on a conventional 25 spot stainless steel 
target. Assessment was made according to the following criteria:
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• the absence of interfering peaks in the spectral region of interest;
•  the reproducibility of analyte signal intensity from laser spot to spot over the 
target;
• high analyte signal intensity for the pharmaceutical analyte.
Poor spectral results were obtained for all analytes using AHB and DHC matrices. 
These matrices were therefore not investigated further.
a-CHCA provided the best spectral results, analyte signal intensity and reprodu­
cibility for the detection of piroxicam and ketoconazole, while DHB was considered 
the optimum matrix for analysis of aciclovir. These matrices were therfore used in 
subsequent experiments, described below.
2.3.1 Evaluation of the suitability o f different analytes 
Aciclovir
The potassium adduct of a-CHCA (m /z  228) appeared to interfere with detection 
of the protonated molecule of aciclovir (m /z  226), and the best spectral results were 
observed using DHB as the matrix for analysis of this compound (Figure 2.3).
DHB could not be successfully electrosprayed at concentrations over 10 mg-ml-1 
as at concentrations above this, matrix crystals appeared to block the capillary 
needle of the electrospray device, resulting in inefficient matrix coverage of the 
sample. However, a-CHCA could be successfully electrosprayed at concentrations up 
to 25 mg-ml-1. In general, higher analyte intensities were observed using 25 mg-ml-1 
a-CHCA compared to 10 mg-ml-1 DHB. a-CHCA was therefore chosen as the pre­
ferred matrix for further development of this method, and—in view of matrix- 
associated interference in the spatial region of interest when using a-CHCA—aciclovir 
was rejected as a poor choice of test compound for in situ MALDI-TOF-MS analysis 
with a linear TOF instrument.
Piroxicam
While mass spectra were obtained demonstrating the presence of piroxicam in the 
tissue section (Figure 2.4), results were not reproducible. This may have been due 
to poor ionisation of the drug in the tissue, and/or insufficient formation of matrix
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Figure 2.3: MALDI mass spectrum of aciclovir showing the protonated drug 
molecule [M+H]+ at m /z  225, and the sodium and potassium drug adducts at 
m /z  247 and 263 respectively. DHB-associated peaks, [Matrix+H]+ at m /z  154; 
[Matrix-f-Na]+ at m /z  176; and [Matrix+K]+ at m /z  192 are also seen.
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crystals on the tissue surface. In the majority of spectra obtained, no compounds— 
including the matrix—were detected in the region where the tissue was mounted. 
Summed ion chromatograms for the range m/ z  330-334 were inconclusive, and diffi­
cult to interpret (Figure 2.5): The majority of chromatograms indicated that pirox­
icam was not ionised in the tissue.
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Figure 2.4: MALDI mass spectrum of piroxicam-treated tissue showing the pro- 
tonated analyte ion [M+H]+ at m/ z  332. Expected matrix peaks at m / z  191: 
[Matrix+H]+; m / z  212: [Matrix+Na]+; and m / z  228: [Matrix+K]+ are also ob­
served. The matrix dimer ion is present at m / z  380. Drug-treated tissue was 
mounted from 3551 mm, and coated in a-CHCA by electrospray deposition.
Insufficient matrix coverage of the tissue samples resulted in chromatograms that 
initially implied the presence of piroxicam outside the region in which tissue was 
mounted. This may have been because, when there is little or no ionisation in the 
target region, noise either side may be mistaken for a significant signal. However, 
as well as this effect indicating the possible presence (in the chromatograms) of 
the compound outside the tissue area, spectra were acquired that demonstrated a 
compound at m / z  332 up to 1.5 cm either side of where the tissue was mounted.
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Figure 2.5: Summed ion chromatogram for the range m /z  330-334 demonstrating 
that compounds were detected from 15-28 mm and 32-48 mm. Treated tissue was 
mounted between 15-48 mm and coated in a-CHCA by electrospray deposition.
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It was first considered that matrix application by electrospray was causing the 
analyte to be washed out of the tissue onto the target at either side. Though this 
may account for the detection of piroxicam a couple of millimetres either side of the 
mounted tissue section, electrospray matrix deposition is unlikely to cause such a 
high degree of analyte spreading.
Double-sided tape was used to mount the tissue sections onto the MALDI tar­
gets: a length of tape exceeding that of the tissue section ensured that either end 
of the section was fully stuck onto the target prior to MALDI analysis. The chro­
matograms and spectra clearly depicting a peak at m/ z  332/333 either side of the 
tissue could therefore be considered to confirm detection of compounds present in 
the tape (Figures 2.5 and 2.6).
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Figure 2.6: MALDI mass spectrum acquired at a position on the target where 
no tissue was present. A peak at m / z  332 can be seen with an ion intensity of 
approximately 120. Matrix associated peaks are observed at m/ z  212: [M+Na]+; 
m / z  228: [M+K]+. The matrix dimer is present at m / z  379. Treated tissue was 
mounted onto a MALDI target and coated in a-CHCA by electrospray deposition.
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Further experiments were performed to determine whether or not a compound 
with a molecular weight of 332 or 333 was present in the double-sided tape.
Tape was dissolved in THF and analysed by MALDI-TOF-MS following co­
crystallisation with a-CHCA on a conventional 25 spot target. In a separate exper­
iment tape was mounted onto a modified TLC target and a-CHCA was applied by 
electrospray.
Both experiments yielded spectra showing the presence of a peak at m /z  333, 
indicating that detection of a compound of molecular weight 332 either side of the 
mounted tissue sections could be as a direct result of analysing the tape itself.
Analysis of mounted, untreated tissue sections also yielded a peak at m /z  333. 
This indicated that either the tissue was absorbing compounds from the tape, or 
that the tissue itself contains a compound with a molecular weight of 332, observed 
at m /z  333. It was not possible to analyse sections of tissue on the modified TLC 
targets without the tape, and so tissue was homogenised, mixed with matrix and 
applied to a conventional 25 spot target. Spectra obtained showed the presence of 
a peak at m /z  333 (Figure 2.7). This suggested that a compound with molecular 
weight 332 was present in both tape and tissue, or was perhaps an instrument 
contaminant.
In order to ensure that peak m /z  333 was not associated with a-CHCA, some 
experiments were repeated using DHB as the matrix. In some cases with a-CHCA a 
peak occurs at m /z  334. This may be attributed to the matrix dimer ion undergoing 
a loss of the carboxylic acid group.
Results obtained for homogenised tissue, dissolved tape, mounted tape and 
mounted tissue using DHB as the matrix all clearly showed a peak with m /z  333. 
These results demonstrate that piroxicam is an unsuitable test compound for use 
by this method using this instrument.
Ketoconazole
Results obtained for the analysis of ketoconazole in tissue presented more promising 
results. Mass spectra were produced demonstrating detection of the protonated 
analyte in the tissue (Figure 2.8). No interfering compounds appeared to be present 
in either the tissue or the tape—no other peaks were observed in the region of m /z  
530-535.
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Figure 2.7: MALDI mass spectrum of untreated tissue, showing a peak at m / z  333. 
Tissue was coated in a-CHCA by electrospray deposition.
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Figure 2.8: MALDI mass spectra for (a) untreated tissue, and (b) ketoconazole- 
treated tissue. Spectrum (a) clearly shows an absence of possibly-interfering peaks, 
while (b) clearly shows successful detection of the protonated analyte. Tissue was 
coated in a-CHCA by electrospray deposition.
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However, results were not reproducible, and chromatograms were inconclusive 
(Figure 2.9), and again in the majority of cases no ions were detected within the 
tissue. This may have been attributed to poor matrix deposition by the electrospray 
device, or may have been associated with the sample itself. Varying the drying time 
of the tissue prior to both electrospray and MALDI analysis appeared to make no 
difference.
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Figure 2.9: Summed ion chromatogram for the mass range m /z  531-533. No com­
pounds in this range were detected between 32-42 mm. Treated tissue was mounted 
from 32-44 mm and coated in a-CHCA by electrospray.
These results suggest that the direct analysis of these test compounds (aciclovir, 
piroxicam and ketoconazole) in skin by MALDI-TOF-MS conducted on a linear 
TOF instrument is inconsistent and unreliable.
2.3.2 Comparison of direct tissue analysis vs. tissue blot­
ting for the determination of ketoconazole in skin by 
M ALDI-TOF-M S.
Direct analysis of drug treated tissue
As previously described, problems were encountered with direct analysis of tissue. 
The protonated analyte molecule could be detected, but not at every increment
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along the target. In the majority of experiments, no ions were detected—indicating 
insufficient matrix crystal formation and sample coverage, or an inability to ionise 
compounds in (or on) the tissue.
C18 beads
Analysis of ‘tissue-imprinted’ C18 beads was also considered unsuccessful. Firstly it 
was extremely difficult to obtain an even layer of C18 beads on the MALDI target. 
Secondly it was observed that during the blotting procedure, the tissue surface 
became covered in the C18 beads, suggesting that they had in fact been removed 
from the target, and had become stuck to the tissue, rather than that a successful 
tissue imprint had been made upon ‘anchored’ beads. Thirdly it was observed that 
the electrospray procedure of matrix deposition displaced the ‘loose’ C18 covering. 
(This would obviously result in an inability to acquire useful information about the 
relative spatial distribution of the analyte). Some spectra depicting detection of 
the analyte were collected (Figure 2.10), but in the majority of experiments ion 
intensities were low, and in fact the analyte was detected at a location where it was 
not expected.
C18 Envidiscs
C18 Envidiscs could not be successfully analysed by this technique as it was dis­
covered that these solid phase extraction discs were too thick to be mounted within 
the MALDI target recess. Because of this no mass spectrometry experiments were 
performed as it was thought that the extraction grid of the time-of-flight mass spec­
trometer would be damaged. In addition, preliminary blotting experiments revealed 
that this was unlikely to be a suitable blotting substrate: the blotting procedure 
resulted in the apparently ‘loose’ C18 covering ending up on the tissue surface, sug­
gesting that an insufficient tissue imprint would have been made upon the substrate. 
Finally it was observed that following matrix deposition the membrane surface ap­
peared to be ‘cracked’, presumably this occurred following drying/evaporation of 
the sprayed methanol. This is likely to have resulted in an un-even distribution of 
matrix crystals on the sample surface.
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Figure 2.10: MALDI mass spectrum of a ketoconazole-treated tissue imprint on 
C18 beads. The analyte is detected at m / z  531 with a relative ion intensity of 
approximately 240. Matrix-associated peaks are observed at m / z  190: [Matrix+H]+; 
m / z  212: [Matrix+Na]+; and m / z  379 [Matrix-f Matrix]+. The sample was coated 
in a-CHCA by electrospray deposition.
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N itrocellulose m em branes
Excellent mass spectra were acquired (Figure 2.11), demonstrating high ion intens­
ities for the matrix ions and protonated analyte molecule.
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Figure 2.11: MALDI mass spectrum of a ketoconazole-treated tissue imprint on a 
nitrocellulose membrane. The analyte is detected at m / z  530 with a relative ion 
intensity of approximately 1600. Matrix-associated peaks are observed at m / z  190: 
[Matrix+H]+; m/ z  211: [Matrix-f-Na]+; m / z  226.8: [Matrix+K]+; and m / z  379 
[Matrix-f-Matrix]+. The sample was coated in a-CHCA by electrospray deposition.
Some promising summed ion chromatograms were constructed (Figure 2.12), 
illustrating that in the confined tissue treatment experiments, the analyte was pre­
dominantly observed within the diameter of the plastic treatment ring. However, it 
can be seen that it was also present in other areas, where perhaps no treated tissue 
was even blotted.
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Figure 2.12: Summed ion chromatogram for the range m/ z  531-533. Greatest ion 
intensities were observed between 41-43 mm. Tissue was treated with ketoconazole 
and blotted onto a nitrocellulose membrane coated with o-CHCA by electrospray. 
The original treatment area corresponded to between 38 and 43 mm.
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However, this did not prove to be reproducible: in the majority of experiments 
the chromatograms did not demonstrate the expected distribution of the analyte, 
and at some points on the target, no ions were detected (as in the direct tissue 
analysis experiments). This is may be due to the nature of the membrane. The 
surfaces of the membranes were ‘waxy’ and because of this the matrix did not dry 
as a uniform layer, but instead formed ‘beads’. As a result it could be seen that there 
were areas on the membrane where there were abundant crystals, and others where 
there were few or no crystals. This may account for the misleading chromatograms, 
and also for the spectra obtained that showed no ions (presumably because no matrix 
was present at these locations). So despite some good results, this was also found 
to be an unsuitable substrate for this application.
Polyvinyl difluoride (Immobilon P PVDF) membranes
Mass spectra showing relatively high analyte ion intensities were obtained (Fig­
ure 2.13). Some mass chromatograms were constructed demonstrating that the 
relative intensity of the analyte was greatest within the diameter of the plastic ring 
(confined tissue treatment experiments) (Figure 2.14).
However, in other experiments similar problems to those encountered in dir­
ect tissue analysis and whilst using nitrocellulose membranes were observed. Once 
again there appeared to be areas where no ionisation was achieved, and as with 
the nitrocellulose membranes this is thought to be attributed to the membrane it­
self. This substrate also possesses a ‘waxy’ surface which resulted in insufficient and 
non-homogeneous matrix coverage. Given that an even matrix layer is essential to 
the success of this technique, this limitation led to the conclusion that these were 
inappropriate substrates.
Cellulose membranes
Cellulose membranes proved to be suitable blotting substrates for this application. 
Mass spectra obtained exhibited good analyte intensities, and summed ion chro­
matograms from both the confined tissue treatment experiments and the standard 
treatment experiments identified the analyte only within the areas it was expected. 
In the confined tissue treatment experiments, the analyte was observed only within 
the diameter of the treatment ring (Figure 2.15), and in standard tissue treatment
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Figure 2.13: MALDI mass spectrum of a ketoconazole-treated tissue imprint on a 
PVDF membrane. The analyte is detected at m / 2  530 with a relative ion intensity 
of 1000. Matrix-associated peaks are observed at m / z  211: [Matrix+Na]+; m / z  
227: [Matrix+K]+; and m/ z  379: [Matrix+Matrix]+. The sample was coated in 
a-CHCA by electrospray deposition.
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Figure 2.14: Summed ion chromatogram for the range ra/z 530-533. Tissue was 
mounted from 21-42 mm. Ketoconazole was pipetted onto the surface of the tissue 
within the diameter of a plastic ring corresponding to 24-28 mm and subsequently 
blotted onto a PVDF membrane and coated with a-CHCA by electrospray.
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experiments the analyte was detected across a larger area of the tissue surface (Fig­
ure 2.16), indicating that it had diffused through the tissue.
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Figure 2.15: Summed ion chromatogram (from m /z  531-533) and mass spectra from 
a confined tissue treatment tissue blotting experiment, on a cellulose membrane. The 
diameter of the plastic ring corresponded to 30-35 mm. The protonated analyte 
molecule is detected between 30.5 and 35 mm. The sample was coated in a-CHCA 
by electrospray deposition.
These experiments showed good reproducibility, and no problems were incurred 
during matrix application. Mass spectra showing matrix ions and (when expected) 
the analyte were acquired at every position on the target. This was not achieved 
using the other substrates.
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Figure 2.16: Summed ion chromatogram (from m /z 531-533 from a standard tissue 
spiking experiment. Treated tissue was blotted onto a cellulose membrane, and 
coated with o-CHCA by electrospray. The original treatment location corresponds 
to 32 mm.
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Polyethylene-filled carbon conductive m em brane
Mass spectra were acquired demonstrating successful determination of the proton- 
ated molecule of ketoconazole (Figure 2.17). Matrix ions were detected at all loca­
tions across the membrane, which was not achieved with any other substrate except 
cellulose. Unfortunately mass chromatograms obtained showed presence of the ana­
lyte at locations it was not expected, indicating evidence of analyte spreading, pre­
sumably by matrix application. The mass chromatogram presented in Figure 2.18 
demonstrates that while analyte intensities were greatest at the original treatment 
location, the analyte was also evident at areas on the membrane outside the ex­
pected region corresponding to the confined treatment area. The results obtained 
indicate that if analyte spreading could be avoided, carbon conductive membranes 
may prove to be useful tissue blotting substrates for imaging MALDI-MS.
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Figure 2.17: MALDI mass spectrum of a ketoconazole-treated tissue imprint on a 
carbon membrane. The analyte is detected at m/ z  532 with a relative ion intens­
ity of 170. The most abundant matrix-associated peak was observed at m / z  212: 
[Matrix+Na]+. The sample was coated in a-CHCA by electrospray deposition.
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Figure 2.18: Summed ion chromatogram (from m /z  531-533) from a confined tissue 
treatment tissue blotting experiment. The tissue was treated with ketoconazole and 
blotted onto a carbon membrane. The membrane was coated with a-CHCA by 
electrospray. The original treatment area corresponded to 34-39 mm.
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2.3.3 Assessm ent of matrix coverage
It is suggested here that there are two major factors that influence whether or not 
blotting onto a substrate is likely to be successful for the analysis of drugs in tissue 
by MALDI-TOF-MS: first, the efficiency of the blotting procedure itself, and the 
quality of the tissue imprint achieved and second, the ability to coat the sample 
with an even layer of matrix.
The matrix coverage is thought to have been at least partially responsible for the 
poor results observed with direct tissue analysis, and with analysis of C18 beads, 
nitrocellulose and PVDF membranes. As previously described, analysis of C18 beads 
was also problematic because of the feasibility of the actual blotting procedure, and 
the C18 Envidiscs were rejected as they were too thick.
Some spectra obtained from the PVDF and nitrocellulose experiments indicate 
that these were ideal blotting substrates, but the fact that these spectra were not 
acquired at all points along the target, and the chromatograms were often non- 
conclusive indicated that poor matrix coverage was achieved. Conversely results 
obtained from the carbon conductive membranes indicate that a relatively homo­
geneous matrix layer was deposited on the substrate, but that application of the 
matrix appeared to induce analyte spreading. Mass spectra and chromatograms 
obtained from analysis of tissue-imprinted cellulose membranes indicated that a suf­
ficient and homogeneous layer of matrix was created upon the substrate, and that 
this did not induce analyte spreading.
In order to evaluate whether or not matrix coverage was truly the reason for 
success or failure of these experiments, matrix-covered membranes were examined 
by scanning electron microscopy. Images at a range of magnifications 200-6000 x 
were obtained for the C18 Envidiscs, PVDF, nitrocellulose, and carbon conductive 
membranes. Images at 500x (Figures 2.19, 2.20, 2.21, 2.23 and 2.22) and 3000 x 
(Figures 2.24, 2.25, 2.26, 2.28 and 2.27) magnifications are presented for these five 
membranes. The most abundant and superior matrix crystals were observed on the 
carbon conductive (Figure 2.23 and 2.28 and cellulose membranes (Figure 2.22 and 
2.27. The C18 Envidisc surface morphology was very different to the other substrates 
and, as could be seen by eye, the surface appeared to be ‘cracked’. Matrix crystals 
observed were sparse (Figure 2.19) and 2.24). The nitrocellulose (Figure 2.21) and
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2.26)and PVDF membranes (Figure 2.20 and 2.25) appeared to be very similar. In 
both cases, areas of small and abundant crystals were observed, and there were also 
areas where no matrix crystals were seen. The SEM images indicate that the matrix 
coverage was the predominant factor in the quality of mass spectra and summed ion 
intensities acquired.
Figure 2.19: SEM images of Envidisc membrane coated with 15mg-ml 1 a-CHCA 
by electrospray deposition. Image acquired at 500 x magnification.
The presence or absence of a homogeneous matrix layer on the substrates may be 
attributed to a number of different factors. The poor matrix coverage observed with 
the PVDF and nitrocellulose membranes is believed to be due to the substrate’s 
waxy surface nature. This resulted in the matrix drying in ‘beads’ or droplets, 
and not as a uniform layer. The success of the cellulose membranes may also be 
attributed to the polarity of the sample surface, and the drying ‘pattern’ of the 
matrix. The membranes were similar to a piece of filter paper, and appeared highly
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Figure 2.20: SEM images of pvdf membrane coated with 15mg-ml 1 a-CHCA by 
electrospray deposition. Image acquired at 500 x magnification.
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Figure 2.21: SEM images of nitrocellulose membrane coated with 15mg-ml 1 a- 
CHCA by electrospray deposition. Image acquired at 500 x magnification.
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Figure 2.22: SEM images of cellulose membrane coated with 15 mg-ml 1 a-CHCA 
by electrospray deposition. Image acquired at 500 x magnification.
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Figure 2.23: SEM images of carbon membrane coated with 15mg-ml 1 a-CHCA by 
electrospray deposition. Image acquired at 500 x magnification.
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Figure 2.24: SEM images of Envidisc membrane coated with 15mg-ml 1 a-CHCA 
by electrospray deposition. Image acquired at 3000 x magnification.
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Figure 2.25: SEM images of pvdf membrane coated with 15mg-ml 1 a-CHCA by 
electrospray deposition. Image acquired at 3000 x magnification.
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Figure 2.26: SEM images of nitrocellulose membrane coated with 15mg-ml 1 a- 
CHCA by electrospray deposition. Image acquired at 3000 x magnification.
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Figure 2.27: SEM images of cellulose membrane coated with 15mg-ml 1 a-CHCA 
by electrospray deposition. Image acquired at 3000 x magnification.
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Figure 2.28: SEM images of carbon membrane coated with 15mg-ml 1 a-CHCA by 
electrospray deposition. Image acquired at 3000 x magnification.
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absorbent. This may be the reason for the superior matrix layer observed using this 
membrane.
Another possible factor that may dictate whether or not matrix deposition by 
electrospray results in an even layer upon the membranes could be the conductive 
nature of the substrate. The principle of electrospray is that there is an applied 
potential between the end of the capillary needle and the grounded metal plate (upon 
which the sample is placed). If the sample is conductive (e.g., the carbon membrane) 
it will effectively become analogous to the sample plate, and the applied potential 
between needle and plate is maintained. If however the sample is non-conductive, 
this is not achieved and may perhaps result in charging, larger droplet formation, or 
a total cessation of matrix spraying. It is proposed here that a combination of the 
electrical conductivity and polar nature of the blotting substrates dictates whether 
or not a membrane is likely to be appropriate for use in this application, in terms 
of the ability to achieve a uniform layer of matrix upon the sample.
2.4 Conclusions
Preliminary investigations to select a test compound found both aciclovir and pirox- 
icam to be unsuitable, because of the presence of interfering peaks in the spectral re­
gion of interest from the matrix (aciclovir), or compounds present in either the tissue 
or tape (piroxicam). Similar problems were encountered by Reyzer et al. [100], who 
were unable to differentiate between a pharmaceutical analyte and matrix clusters 
or endogenous biomolecules using conventional MALDI-TOF-MS technology. They 
overcame this by use of selected ion monitoring using MALDI-Qq-TOF-MS. This 
was not possible using the linear TOF instrument employed in this chapter. As 
a similar hybrid q-TOF instrument was used for the work described in the sub­
sequent chapters of this thesis, and because (a) unambiguous determination of the 
protonated molecule of ketoconazole was achieved by MALDI-TOF-MS, and (b) a 
topical formulation of the drug is commercially available, ketoconazole was chosen 
for all subsequent work. However it should be noted that problems encountered with 
aciclovir and piroxicam could well be overcome by analysis with a hybrid qTOF in­
strument, partly because of its superior mass accuracy and resolution, and because
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if interference continues, tandem mass spectrometry could be employed to map the 
analyte.
In some of the spectra presented in this chapter, there appears to be an apparent 
‘shift’ in the expected masses for analyte and matrix ions e.g., ketoconazole was 
detected at m /z  530 and not at m /z  531. This is thought to be partially due to 
the poor mass accuracy and resolution of the linear TOF analyser. In addition, it 
is likely that none of the tissue samples or substrates were entirely ‘even’. This will 
have resulted in erroneous mass values as mass analysis is based on flight times, 
and if the flight distances are different, the masses will appear distorted. This may 
be entirely overcome with the use of an orthogonal ion source, as discussed and 
evaluated in Chapter 3.
Uneven sample surfaces also lead to changes in the efficiency of the electrospray 
deposition: at different points along the surface the capillary needle will be at dif­
ferent distances from the sample surface. Thus the formation of crystals across the 
sample is likely to be different at different points. This has obvious implications in 
imaging experiments, where matrix layer homogeneity is key to the success of the 
technique.
As previously discussed, direct analysis of tissues was not reproducible and spec­
tra and chromatograms show that this may have been attributed to poor matrix 
formation and coverage. Recent reports [100,113,168] demonstrate that crystal 
formation directly on a tissue sample is more readily achieved using sinapinic acid. 
This matrix has been found to be far more tolerant of salt content, which is likely 
to be the major factor in poor crystallisation of a-CHCA on tissue samples. Zhao 
et al. [168] compared the crystallisation of a-CHCA and sinapinc acid on tissue 
samples, and found sinapinic acid to be the matrix of choice for such investigations. 
However it was also commented that this matrix is far more suitable for protein 
analysis than for determination of small molecules, such as pharmaceutical com­
pounds. The use of sinapinic acid for the direct examination of skin samples by 
MALDI-TOF-MS is investigated in Chapter 4.
Analysis of C18 Envidiscs was not possible due to the thickness of the substrates. 
Analysis of C18 beads was considered to be inferior to direct analysis of tissue 
sections, and provided the poorest results of all the tested substrates. This differs 
from the findings of Caprioli et al. [102], who reported success with this technique
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and concluded that it was superior to direct tissue analysis and analysis of cellulose- 
imprinted membranes. However, their work concerned determination of peptides 
and proteins, and not drugs.
Mass spectra were acquired demonstrating that both the PVDF and nitrocellu­
lose membranes were in fact good blotting substrates, though not for this applica­
tion. Impressive ion intensities were observed, but due to the problems encountered 
with uniform matrix deposition, they failed to provide useful information about 
the spatial distribution of the analyte. This is of course key to the success of this 
technique. Both of these substrates have proved to be extremely useful in stand­
ard protein analysis, presumably where the degree of matrix homogeneity over a 
relatively large area is not essential.
Impressive spectral results were obtained using the polyethylene-filled carbon 
conductive membranes. This concurs with the findings of Caprioli’s group that this 
substrate produced “unique protein profiles” [103]. For the analysis of ketoconazole, 
however, matrix application onto such membranes induced analyte spreading. This 
membrane was selected for peptide analysis by Caprioli et al. because of its elec­
trostatic and protein adhesion properties. In their experiments, the peptide and 
protein analytes are likely to have been anchored to the substrate, and so matrix 
application by electrospray did not result in a loss of the expected spatial distri­
bution. Unfortunately, the membrane appeared to have no binding specificity for 
ketoconazole. Results presented in this chapter demonstrate good spectral results, 
and SEM images indicate good formation and coverage of matrix crystals, but chro­
matograms show a lack of spatial information. This is believed to be due to analyte 
spreading by matrix application.
Cellulose membranes were found to be the best blotting substrate for the ana­
lysis of drugs in skin by MALDI-TOF-MS. This also differs from Caprioli’s findings 
that this substrate was inferior to both analysis of tissue-imprinted C18 beads and 
direct tissue analysis [102]. This is unsuprising, however, as proteins and drugs are 
likely to behave differently. For the analysis of ketoconazole, spectra and chromato­
grams were obtained demonstrating the expected distribution of the analyte. Mass 
spectra reveal good analyte intensities and detection of the analyte only in areas it 
was expected. SEM images reveal excellent matrix crystal formation and coverage. 
Electrospray matrix deposition onto this substrate did not appear to induce analyte
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spreading. It is proposed that the absorbant nature of this substrate resulted in 
the membrane being fully impregnated with matrix following the electrospraying 
procedure. Thus the matrix material was not left to run freely across the membrane 
surfaces until it dried, as was observed with the nitrocellulose, PVDF and carbon 
membranes. This is thought to have reduced analyte spreading.
The SEM images collated indicate that matrix coverage was the predominant 
factor in whether or not a substrate lent itself to this application. Mass spectrometric 
imaging is used in Chapter 4 to investigate matrix application for direct tissue 
analysis, and the use of cellulose and carbon membranes for the analysis of drugs in 
skin. No other substrates were investigated further.
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Chapter 3
Imaging Tissue Imprints by 
M ALDI-Q-TOF-M S
3.1 Introduction
The tissue blotting experiments showed that analysis of tissue imprints on cellu­
lose membranes by MALDI-TOF-MS was capable of both detecting, and spatially 
resolving the test analyte, ketoconazole, in epidermal tissue. While these results 
were extremely promising, the instrument capabilities did not permit analysis of 
a larger area of membrane, or of obtaining information that could be considered 
‘biologically useful’ in terms of drug mapping. Recent work by Caprioli and co­
workers [100,102,103,113] has demonstrated that imaging of proteins, peptides and 
drugs in tissue could be achieved using a quadrupole time-of-flight instrument.
Such a hybrid instrument offers the capabilities of obtaining mass spectra from a 
range of x  and y co-ordinates over a larger rectangular area, by moving the sample 
plate under the laser.
Furthermore, the hybrid instrumentation offers superior mass accuracy, resolu­
tion and sensitivity compared with conventional TOF analysis. Additional advant­
ages are offered by an orthogonal ion source arrangement. It was observed in the 
data presented in Chapter 2 that mass values were distorted. This was partially at­
tributed to the inherent mass accuracy, limitations of the linear mass analyser, and 
also to the sample topography of the tissue and membrane sections. As described in 
Chapter 2, irregularities of the sample surface may have resulted in erroneous mass 
determination.
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This is a common problem with conventional linear MALDI-TOF arrangements, 
which are based on what is referred to as an ‘axial’ design. This axial geometry 
necessitates that the MALDI source is coupled by a direct flight path to the TOF 
mass analyser. In doing this, any variations associated with the ionisation of the 
sample and/or the sample surface are carried out to the detector. Deviations in 
sample topography which shift the relative position of the plate to the detector 
result in an effective shift of flight time, which in turn will be manifested as a mass 
shift. Despite the use of delayed extraction in the work described in Chapter 2, peak 
broadening was still evident. This is partly due to the wide energy distribution of 
the initial ion packet. Another limitation of axial systems is the fact that a large 
number of ions are produced per pulse and all must be measured because the detector 
is in-line with the target. Thus analog detection must be used. This requires careful 
matching of the detector gain to the laser fluence to avoid saturating the analog- 
to-digital converter on intense peaks, and to avoid detector shadowing problems 
produced by intense low-mass signals.
In an orthogonal arrangement, the MALDI source is decoupled from the TOF, 
which eliminates any effects associated with ionisation or sample topography. The 
relative position of the pulser to the detector is always constant, regardless of sample 
surface irregularities. This provides higher mass accuracy and stability, and better 
resolution over a wider mass range. Figure 3.1 illustrates the advantages of an 
orthogonal arrangement compared to the previously used axial geometry for surface 
analysis by MALDI-TOF-MS.
A hybrid quadrupole time-of-flight instrument fitted with an orthogonal MALDI 
ion source (Qstar pulsar i, Applied Biosystems, Foster City, US) and beta-test ion 
imaging software (MDS Sciex, Ontario, Canada) was employed in the work presented 
in this chapter. Whole membranes were analysed and ion images were created using 
the test software. The aim of this phase of work was firstly to determine whether or 
not images could be obtained by use of this instrument and software, and secondly to 
evaluate improvements in mass resolution and accuracy as compared to conventional 
MALDI-TOF-MS on a linear instrument. Parameters such as matrix coverage that 
had proved essential to success of earlier experiments were also investigated. The 
laser spot size of this instrument was also evaluated.
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Axial MALDI geometry
detec tor
Irregularities in sample surface (Ax) result in mass 
accuracy shiftAx
Orthogonal MALDI system P u l s e r
Irregularities in sample surface (Ax) do NOT 
result in mass accuracy shift
Ax It
Detector
Figure 3.1: Use of an orthogonal MALDI ion source eliminates mass shifts that arise 
from irregular sample surfaces. ^
3.2 Experimental
3.2 Experimental
3.2.1 M aterials
Trifluoroacetic acid (AR grade) and ct-CHCA were purchased from Sigma-Aldrich 
(Dorset, UK). Methanol was HPLC grade, purchased from Fisher Scientific (Lough­
borough, UK). Cellulose membrane spacers (as previously) were obtained from 
Goodfellow (Huntingdon, UK). Porcine ears were obtained from Doncaster abbatoir. 
Nizoral shampoo (2% ketoconazole) was obtained commercially.
3.2.2 Instrum entation
The electrospray deposition device developed at Sheffield Hallam University (as 
previously described in Chapter 2) was employed in these experiments. Mass spec- 
trometric analysis was performed on an Applied Biosystems Qstar pulsar i hybrid 
quadropole time of flight mass spectrometer, fitted with an orthogonal MALDI 
source and beta test ion imaging software. A schematic of the Qstar pulsar i is 
shown in Figure 3.2
3.2.3 M ethods
Porcine ear epidermal tissue was covered with 50 /d Nizoral shampoo (2% keto­
conazole) and incubated at 37 °C for one hour. The tissue surface was rinsed in 
deionsised water to ensure removal of excess drug formulation on the skin surface. 
The tissue was then blotted onto a cellulose membrane. The membrane was fixed 
onto an aluminium backed TLC plate and coated in a-CHCA (15mg-ml-1) by elec­
trospray deposition. The sample was then mounted within the square recess of a 
specialised MALDI membrane target. Standard MALDI analysis and imaging of 
the membrane was performed on the Q-Star in the positive ion mode.
3.3 Results and discussion
3.3.1 M ALDI-Q-TOF analysis o f aciclovir and piroxicam
It was concluded in Chapter 2 that limitations in mass accuracy and resolution asso­
ciated with the linear TOF instrument resulted in the unsuccessful determination of
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Figure 3.2: Schematic diagram of the hybrid quadrupole-time of flight mass spec­
trometer (Qstar pulsar i), fitted with an orthogonal MALDI ion source, as used 
in these investigations. Reprinted with kind permission from the oMALDI Server 
Users Manual, MDS Sciex, 2003.
86
02
3.3 Results and discussion
acyclovir and piroxicam by MALDI-MS. Interfering peaks were observed in the spec­
tral region of interest from the matrix (acyclovir) and endogenous/tape/instrument 
species (piroxicam). It was postulated that the superior mass resolution and accur­
acy of the hybrid QTOF instrument, together with the orthogonal ion source ar­
rangement might permit successful MALDI-MS determination of these drugs. The 
following experiments were conducted in order to assess the suitability of this tech­
nology for the analysis of these drugs.
Double sided tape was mounted in the recess of a specialised MALDI target. 
1 [A of an equal volumetric mixture of 1 mg-ml-1 drug and 25mg mg-ml-1 a-CHCA 
was spotted onto the tape. MALDI-Q-TOF analysis was performed on an Applied 
Biosystems Qstar Pulsar i in the positive ion mode.
Figures 3.3 and 3.4 demonstrate that the protonated molecule of acyclovir is 
clearly resolved from the potassium adduct of a-CHCA. This was not observed on 
the Linear TOF instrument, as presented in Chapter 2.
Figure 3.5 shows a cluster of peaks around m /z  332. Enlarging the spectral 
region of interest (Figure 3.6) reveals that the protonated molecule of piroxicam 
(m/z  332.13) is distinguishable from potentially interfering compounds detected at 
m /z  332.40, 333.14, and 334.13. All of these compounds are likely to have caused 
ambiguous determination of the drug molecule using a linear TOF instrument.
It is concluded from these experiments that both acyclovir and piroxicam can 
be successfully detected by MALDI-Q-TOF analysis. Spectra presented demon­
strate the resolution of the protonated drug molecules from previously interfering 
compounds.
These drugs are not discussed further in this thesis as all subsequent imaging 
method development was conducted with a topical formulation of ketoconazole 
(Nizoral shampoo). However, these experiments show the potential of MALDI- 
MS for the in situ analysis of acyclovir and piroxicam, and again illustrate the 
advantages of the hybrid mass analyser.
Mass determination of ketoconazole by MALDI-Q-TOF MS
It was observed in spectra presented in Chapter 2 that ketoconazole was detected 
between m /z  530-533. There are three possible theories for these discrepancies in the
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Figure 3.3: MALDI mass spectrum of acyclovir acquired using the Qstar Pulsar i. a- 
CHCA was employed as the matrix material. The protonated drug molecule (m/z  
226) and the potassium adduct matrix ion (m/z  228) are clearly resolved as two 
separate peaks. Matrix-associated peaks are also observed at m / z  172 ([Matrix- 
H20+HJ+), m / z  190 ([Matrix-|-H]+), and m/ z  228 ([Matrix+K]+).
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Figure 3.4: MALDI mass spectrum of acyclovir acquired using the Qstar Pulsar i  
a-CHCA was employed as the matrix material. The spectral region of interest (m/z  
225-230) from Figure 3.3 is enlarged to reveal good resolution of drug and matrix 
peaks. The protonated drug molecule (m/z  226) and the potassium adduct matrix 
ion (m/z  228) are clearly resolved as two separate peaks.
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Figure 3.5: MALDI mass spectrum of piroxicam acquired using the Qstar Pulsar i  
o-CHCA was employed as the matrix material. A cluster of peaks with similar m/ z  
values is evident around the protonated drug molecule (m / z  332). Matrix-associated 
peaks are observed at m / z  172 ([Matrix— m / z  190 ([Matrix+H]+), m/ z  
212 ([Matrix+Na]+) and m/ z  228 ([Matrix+K]+).
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Figure 3.6: MALDI mass spectrum of piroxicam acquired using the Qstar Pulsar i  
a-CHCA was employed as the matrix material. Enlarging the cluster of peaks 
around m / z  332 shown in Figure 3.5 reveals that the protonated drug molecule is 
successfully resolved from other possibly interfering peaks. This illustrates the bene­
fits of the hybrid mass analysis instrument compared to the linear TOF instrument 
employed in Chapter 2.
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mass value: (1) Surface charging was observed; (2) Sample topography resulted in 
erroneous mass values; (3) Poor instrument mass accuracy or instrument calibration.
It was predicted that use of an orthogonal MALDI ion source would result in sur­
face charging and sample irregularities having little effect on mass determination, 
and that QTOF analysis would offer exponential improvements in mass accuracy 
as compared to analysis with a linear TOF. Thus the mass determination of keto­
conazole by oMALDI-Q-TOF MS was evaluated.
The m jz  value of the protonated molecule of ketoconazole (m/z  531.1566) at 
20 points across a 130 minute imaging run (analysis of a tissue imprinted cellulose 
membrane) were recorded, as presented in Figure 3.7 . An average error of 1.6 mmu 
was obtained, and mass values ranged from m /z  531.1529 to m / z  531.1616, demon­
strating the superior mass accuracy of the hybrid instrumentation. It is clear that 
mass accuracy is maintained across the sample surface, thus sample topography has 
little effect on mass values in an orthogonal MALDI arrangement. In addition the 
random scatter of mass values indicates that mass measurements are not affected 
by surface sample charging with this instrument configuration.
These results illustrate the suitability of this instrument for imaging experiments 
(where a molecule is mapped across a relatively large and irregular area), and show 
the superior mass accuracy of the instrument as compared to the linear TOF instru­
ment employed in Chapter 2.
MALDI-Q-TOF analysis of membranes
Mass spectra were acquired from a variety of positions on the membrane. Areas 
corresponding to regions outside the treated tissue imprint showed an absence of 
interfering peaks in the mass region of interest (Figure 3.8). Mass spectra acquired 
within the region of the tissue imprint showed detection of the analyte with good ion 
intensities (Figure 3.9). ‘Background’ spectra (obtained from a co-ordinate where 
no drug was present; Figure 3.8) were subtracted from the sample spectra (obtained 
from a co-ordinate where treated tissue was blotted), (Figure 3.9) and the resulting 
spectra created (Figure 3.10) could be considered to show drug associated peaks in 
better detail.
Spectra collected on the Qstar demonstrated significant improvements in terms 
of both mass resolution and mass accuracy, as expected. It was also noted that the
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Figure 3.7: Mass measurement of the protonated molecule of ketoconazole at m / z  
531.1566 across a 130 minute imaging run. Treated tissue was blotted onto a cellulose 
membrane. An average error of 1.6 mmu was obtained, demonstrating the superior 
mass accuracy of the hybrid instrumentation. It is clear that mass accuracy is 
maintained across the sample surface, thus sample topography has little effect on 
mass values in an orthogonal MALDI arrangement. In addition the random scatter 
of mass values indicates that mass measurements are not affected by surface sample 
charging, as is often noted with axial geometry.
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Figure 3.8: MALDI mass spectrum acquired at a position on the membrane where 
no drug was blotted. No possibly interfering peaks were observed in the region m / z  
530-535.
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Figure 3.9: MALDI mass spectrum acquired at a position on the membrane where 
drug treated tissue was blotted. Ketoconazole was detected at m / z  531.19.
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Figure 3.10: The background spectra can be subtracted from the sample spectra to 
emphasise the presence of the drug.
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mass values for detected ions did not fluctuate across the sample surface, illustrating 
the advantage of the orthogonal arrangement. Improvements in mass resolution are 
best illustrated by comparison of the isotopic pattern of the protonated ketoconazole 
molecule as measured by the Linear TOF and the hybrid qTOF (Qstar) instruments, 
as shown in Figure 3.11.
Imaging the membrane
These preliminary imaging studies were conducted using novel beta test ion imaging 
software, supplied by MDS Sciex. This software had not been commercially released 
at the time of this work. The imaging facility is incorporated into the main data 
acquisition software (oMALDI server), which allows plate positioning and full design 
of data acquisition methods based on conventional experimental paprameters, such 
as ion mode, mass range, and laser power etc. oMALDI is designed as a Windows- 
based platform in order to permit theoretically simple integration of data and spectra 
into widely-used Microsoft applications. The imaging software permits selection of 
a rectangular region of interest on the specialised recessed targets, construction of 
a data acquisition pattern, mass spectral data collection from each location within 
the defined area, and finally construction of ion images.
The area on the target where the membrane was mounted was imaged by moving 
the sample stage under the nitrogen laser in the x  and y dimensions (optimum 
results were achieved by firing the laser for 2 seconds at every location, at 25% laser 
threshold power (14//J)). Mass spectra were acquired at sequential increments over 
a ‘snake like’ pattern over the entire two-dimensional area. This created a data set 
of several thousand mass spectra. Software capabilities enabled ion images to be 
created by selecting peak mass ranges (e.g., m /z  531-533 for the isotopic envelope 
of the protonated drug molecule). The distribution, and relative ion intensities were 
displayed as two dimensional pixel images, with the colour of each pixel representing 
the intensity of ions at that location, thereby creating an xyz  plot of location vs. 
intensity of the selected ion/ions.
Unfortunately, it proved impossible to manipulate directly the processed images 
with this version of the software. Although images were successfully generated, 
they could only be saved as a file type (.wifi) that was unreadable by other software 
applications. Furthemore, the graphical capabilities of the software did not permit
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Figure 3.11: Mass spectra demonstrating the chlorine isotope pattern of keto­
conazole acquired with (a) an SAI LinearTOF 1500, and (b) an Applied Biosystems 
Qstar pulsar*. This highlights the superior mass resolution of the Q-TOF mass 
spectrometer.
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manipulation of the image. Thus in order to manipulate and present the images, 
they had to be generated by alternative software.
The mass spectrometric data acquired during an imaging run yields a total ion 
chromatogram (TIC) file of all ions detected at all locations. Information about 
relative ions intensities for selected mass ranges can be extracted from this ‘master’ 
data file, generating a table of ion intensity for the selected ion/ions at each spot 
acquired, i.e., a list of spot numbers and corresponding ion intensities. Calculation 
of the xy  co-ordinate (relative position on the sample plate or membrane) of every 
‘spot number’ would therefore enable images to be created in alternative graphics 
software.
Knowledge of the image search pattern, e.g., a ’’snake” rastering pattern, the 
start and end points as xy  co-ordinates, and the increment size (vertical and hori­
zontal spacing) can be obtained from the original data file.
An algorithm was therefore developed to convert spot number to an xy  co­
ordinate in the original area of interest, based the parameters described above. The 
mathematical reasoning is as follows:
Knowledge of the start and end co-ordinates of the imaging run gives information 
of the minimum and maximum x  and y values, this enables calculation of the image 
area (Figure 3.12).
In all cases in this thesis the image search pattern (pattern of data acquisuition) 
was set as demonstrated in Figure 3.13. In this illustration z denotes the increment 
size (the degree of vertical and horizontal spacing between spots). This parameter 
is set by the user, and is thus known for all images.
Understanding of the image area (Figure 3.12) and increment size (Figure 3.13) 
permits simple calculation of both the number of spots in a row (Xdiff), and the 
number of rows in the area ( ydi f f ) -
Xd i f f  = (xmax -  xmin)/z  =number of spots in a row.
Vdi f f  =  (Umax — y m i n ) / z  =number of rows in the image area.
The algorithm then calculates the xy  co-ordinates for spots in the grid area 
in a mathematical loop until the co-ordinates of every spot have been generated 
(Algorithm 1).
An online resource was created (http://www.pugwash-uk.co.uk/spotcalc.php) to 
perform this calculation.
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Figure 3.12: The start and end co-ordinates of an imaging run provide detail about 
the minimum and maximum x  and y values of the area, thus defining the image 
area.
start
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*■ x
Figure 3.13: The image data acquisition search pattern, as defined within the ima­
ging software application.
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Algorithm 1: An algorithm to compute the xy co-ordinates of spots in the image 
area
g i v e n !  Xffiax-, X m i m  V m ax i  Vm in  •> %
X d i f f  * { X m a x  •Emi n) / %
V d i f f  * ( Umax l / m i n ) / %
V  * Vm ax
for i *— 0;z < Xdiff',i +  +  do 
if (im od2)= =  0 th en
X  < X m i n
else 
x * xmax 
end if
for j  <- 0 ; j  < xdiff',j +  +  do 
p rin t x , y
if (i m od 2)== 0 then
X  <r— X  +  Z
else 
x <— x  — z 
end if 
end for 
y *— y — z 
end for
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These xy values, plotted against the ion intensity (z) (extracted from the original 
.wiff file) for each spot number, may then be used to generate an image. The images 
presented here have been produced using a charting and graphing software package 
for Apple Macintosh, Delta Graph 4.5.
An imaging run was performed over the entire membrane (drug treated tissue 
imprint) area. The laser was fired for 2 seconds at 25% threshold power at each 
location. Data was collected for the mass range 0-1000 amu, in the positive ion mode. 
Horizontal and vertical spacing between spots (increment size, z) was set at 0.75 mm 
The area imaged had the following dimensions: xmin= 7.545 mm, xmax= 48.795 mm, 
ymin= 9.337 mm, ymax= 37.087 mm. Mass spectrometric data was thereby acquired 
at 2128 positions. The ions corresponding to the protonated drug molecule (m/z  
531) and sodium adduct of the matrix (m/z  212) were extracted from the data file.
Spot numbers for all ions were converted to an xy co-ordinate using the algorithm 
to produce the following mass spectrometric images (Figures 3.14, 3.15 and 3.16) .
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Figure 3.14: MALDI-TOF-MS image of the protonated molecule of ketoconazole on 
a tissue imprinted cellulose membrane.
It can be seen from these images that drug was detected at nearly all positions
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Figure 3.15: MALDI-TOF-MS image of the sodium adduct of a-CHCA coating the 
membrane.
on the membrane. There appears to be a ‘cross’ in the centre of the tissue where 
either no drug is present, or no drug is detected (Figure 3.14). Examination of 
coverage of the sodium adduct of o-CHCA reveals the same pattern (Figure 3.15). 
This indicates that the regions where no drug is detected is probably due to the 
absence of sufficient matrix crystals, limiting successful ionisation. This once again 
highlights the importance of a homogeneous matrix layer in imaging MALDI-MS. 
The pattern observed where neither the matrix or sample is detected is thought 
to have been attributed to the electrospraying procedure. After completion of 60 
‘rows’, the spraying was stopped and the syringe refilled with matrix. It is thought 
that the areas where no drug, and no matrix were observed reflect a mis-calculation 
of the restart location of the spraying, resulting in a row being missed.
Figure 3.16 demonstrates how the images may be manipulated to show different 
information by altering the scale range of the axis. It effectively becomes a trade­
off between qualitative and quantitiative information. This is because the range of 
intensities is so large (0 — 2000), and so it is difficult to compare all intensities on 
the same scale.
The superiority of electrospray, compared to pipetting matrix solution onto a
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Figure 3.16: The effect of altering the z (ion intensity) scale on image presentation. 
All four images were created from the same data file: by altering the scale of ion 
intensity (z axis), very different images are produced.
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membrane surface is demonstrated in Figure 3.17. In this experiment, two deposits 
of ketoconazole mixed with a-CHCA were applied to the membrane in the areas 
highlighted. The protonated ketoconazole molecule is only observed in a fraction 
of the expected area. This is thought to be attributed to the absence of a uniform 
layer of matrix. Spot samples are generally associated with achieving poor matrix 
homogeneity, and poor inclusion of the analyte molecule within the matrix crystals. 
Thus for this application matrix deposition by electrospray has clear advantages.
Airspray matrix deposition has been used previously for coating TLC plates at 
Sheffield Hallam University, and is considerably simpler and quicker than electros­
praying matrix material onto samples. It is therefore evaluated in the next chapter.
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The circles outline the area on the plate to which the 
drug/matrix mixture was applied. Drug was expected to be 
seen throughout this area.
Relative ion 
intensity 
ketoconazole 
(m/z 531.44)
Figure 3.17: Imaging a spot sample: an indication of the superiority of matrix 
deposition by electrospray.
Another important experimental parameter in imaging investigations is the laser 
spot size. In order to estimate the dimensions of the Qstar pulsar i N2 laser spot size, 
an ‘imaging run’ was performed on heat sensitive paper. As before the laser was fired
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for 2 seconds at 25% threshold energy (in order to mimic real imaging conditions). 
The heat sensitive paper was then viewed with a confocal microscope (Zeiss 510 
CSLM, equipped with an argon laser), and a phase-contrast image was obtained. 
The laser spot size dimensions were measured using the confocal microscopy imaging 
software, and calculated as 150 x 200 /im (Figure 3.18). The spot size is elliptical, 
as would be expected.
Figure 3.18: Confocal microscopy image of the MALDI laser spot size obtained by 
analysis of heat-sensitive paper.
3.4 Conclusions
Superior mass spectra in terms of mass accuracy and resolution, as compared to 
those acquired with the linear TOF, were obtained. Spectra demonstrate excellent 
resolution of the isotopic peaks of the protonated analyte, highlighting its superiority 
to the instrument employed in Chapter 2. Use of the orthogonal ion source proved 
successful in maintaining mass accuracy across an uneven sample surface. This is 
essential in imaging applications. The ability to analyse larger areas has proved 
particulary useful, and beta test software provided permitted construction of ion 
images. Unfortunately, software limitations resulted in the need to construct an 
algorithm to enable construction of data images in an alternative software package, 
so that they may be presented in reports such as this. The algorithm created
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has permitted images to be prepared in external graphical software. Images were 
created depicting the presence of the drug on/in the skin surface, by analysis of 
tissue imprinted, matrix-coated membranes.
Ion images depicting matrix coverage were created by selection of data pertaining 
to the presence of the sodium adduct of a-CHCA. This highlights that while in 
general the electrospray procedure resulted in a relatively homogeneous matrix layer, 
errors such as missed rows have profound effects on the relative display of the analyte 
location. Matrix coverage was once again found to be the predominant factor in 
successful detection of the drug, and while it appeared that problems had occurred 
during the spraying procedure, it was shown to produce a superior layer to simple 
pipetting. Images reveal superior crystal formation and more efficient incorporation 
of the analyte into crystals, as compared with spotted samples. This is concurrent 
with the findings of Garden et al. [126], who reported similar results by MALDI 
imaging.
The images presented in this chapter confirm the findings of Chapter 2, where cel­
lulose membranes were found to be suitable blotting substrates for imaging MALDI- 
MS. This can be seen by both the successful imprint of drug onto the membrane, 
and secondly the presence of matrix crystals at nearly all locations.
Further manipulation of the images with the graphical software showed both 
a semi-quantitative and qualitative presentation of the acquired data. Changing 
the detail of the intensity range significantly altered the images produced. Thus 
it is important that a scale that offers both detection of the ions, as well as some 
semi-quantitative information is selected. It should be noted that incorporation 
of an internal standard or some form of data normalisation is necessary for true 
quantification of the drug in skin. This is investigated in Chapter 5 of this thesis.
The laser spot size was found to have elliptical dimensions of 150 x 200 fini. This 
may in the future be a limiting factor, but with the current methods is not thought 
to be a major problem, especially when relatively large increment sizes are used. 
It does however imply that increment sizes should not be reduced beyond 200 //m, 
as this would result in overlapping spots, and ambiguous data. The majority of 
MALDI imaging literature reports use of similar spot size dimensions. The advent 
of lasers with smaller spot sizes was discussed in the Introduction (Chapter 1).
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In conclusion, these initial imaging experiments demonstrated great promise for 
the application of imaging MALDI-MS as a method of profiling and quantifying 
drugs in epidermal tissue.
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Chapter 4
Optim isation of m ethods o f m atrix  
application for analysis of treated  
tissue
4.1 Introduction
The success of an imaging experiment is highly dependent upon the formation of 
a homogeneous crystal layer upon the sample. Matrix application must not give 
rise to analyte spreading which will result in an incorrect impression of the spatial 
location of compounds of interest. Experiments presented in Chapter 2 indicated 
that both carbon and cellulose membranes could be successfully coated in matrix 
by electrospray deposition.
It is essential that matrix application is optimised so that a successful image 
depicting the true distribution of the drug may be acquired. In this chapter the 
considerably simpler approach of airspraying (as previously demonstrated for TLC- 
MALDI analysis [116] was compared to electrospray deposition for the coating of 
carbon and cellulose membranes.
The novel technique of precoating membranes prior to the tissue blotting process 
was also investigated.
Direct tissue analysis was revisited in this programme of work, given that the 
Qstar targets permitted analysis of an entire tissue section.
Ion imaging software updates (MDS Sciex, October 2003) permitted images ac­
quired to be edited with the software provided (image rotation, selection of plot 
style) and saved as graphic files in .bmp format. These graphics were subsequently
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imported into Adobe Photoshop to enhance the definition of the axis and label in­
formation and to convert to portable document format (.pdf) for incorporation into 
this thesis. The algorithm and graphical methods of data presentation employed in 
Chapter 3 were therefore not required, and all images presented in this chapter were 
created within the ion imaging software.
4.2 Experimental
4.2.1 M aterials
Trifluoroacetic acid (AR grade). ct-CHCA and sinapinic acid were purchased from 
Sigma-Aldrich (Dorset, UK). Methanol was HPLC grade, purchased from Fisher 
Scientific (Loughborough, UK). Polyethylene filled carbon conductive membranes 
and their cellulose membrane spacers (as previously) were obtained from Goodfellow 
(Huntingdon, UK). Porcine ears were obtained from Doncaster abattoir. Nizoral 
shampoo (2% ketoconazole) was obtained commercially.
4.2.2 Instrum entation
The electrospray deposition device developed at Sheffield Hallam University was 
employed in these investigations and is described in Chapter 2. Matrix application 
was alternatively conducted using a suction feed airspray device (Badger 150 Suc­
tion Feed air brush: The Air Brush Company, Lancing, West Sussex, UK). Mass 
spectrometric analyses were performed on an Applied Biosystems Qstar pulsar i hy­
brid quadropole time of flight mass spectrometer, fitted with an orthogonal MALDI 
source and ion imaging software, as discussed in Chapter 3.
4.2.3 M ethods
Comparison of electrospray and airspray matrix deposition on carbon 
and cellulose membranes
2 x 2 cm pieces of carbon and cellulose membranes were coated in 15mg-ml-1 or 
25mg-ml-1 a-CHCA by electrospray (as described in Chapter 2) and airspray de­
position respectively. All matrix solutions were prepared in methanol containing 
0.1% trifluoroacetic acid. The airspray method involved the application of matrix
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(25mg*ml_1) to the membrane using 5 cycles of the air brush, where one cycle com­
prises five passes of the air brush over the sample, giving an estimated total matrix 
usage of approximately 375 mg per sample. The membranes were dried under a heat 
lamp for 5 minutes between each cycle.
Treatment
A ‘confined treatment area’ was created on the tissue surface by protecting the skin 
around the application site with adhesive tape sealed with barrier cream to give 
a ‘triangular’ treatment area. The tissue was treated with 500 fil Nizoral shampoo 
(2% ketoconazole) inside the area of the former and incubated for one hour at 37 0 C. 
These experiments were used to assess the success of the matrix application methods 
in retaining spatially relevant information.
After incubation the tissue surface was rinsed with deionised water to remove 
any excess formulation.
Membrane preparation and tissue blotting
The epidermal surface of the treated tissue was blotted (pressed) onto either cellulose 
or carbon membranes and subsequently coated in a-CHCA (25 mg-ml-1) by airspray 
deposition (as above).
In separate experiments, membranes were coated in matrix prior to the tissue 
blotting procedure.
All membranes were mounted in the square recess of a specialised MALDI target 
(VoyagerDE, MDS Sciex, Canada) prior to mass spectral analysis.
Direct tissue analysis
Porcine epidermal tissue was snap frozen in liquid nitrogen cooled isopentane and 
sectioned by microtoming to achieve 15 fim surface sections. The sections were thaw- 
mounted in the recess of a specialised MALDI target and dried prior to coating with 
a-CHCA or sinapinic acid by airspray deposition.
Standard MALDI analysis and imaging of the membranes and tissue sections 
was performed on the Q-Star in the positive ion mode. In all images presented in 
this chapter, the increment size (degree of horizontal and vertical spacing) was set at
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0.25 mm. The laser was fired for 2 seconds, with an energy of 14 fiJ and a repetition 
rate of 20 Hz at all spots.
4.3 Results and discussion
Airspray and electrospray methods were evaluated with respect to the formation 
of an abundant and homogeneous matrix layer upon cellulose and carbon mem­
branes. MALDI imaging was used to determine the extent of matrix coverage on 
both membranes by both methods.
4.3.1 Electrospray matrix deposition
Images of the sodium adduct of a-CHCA (Figures 4.1 and 4.2) reveal that similar 
patterns of matrix coverage are observed on both carbon and cellulose membranes. 
While in general the crystal coverage is dense, there are areas on both substrates 
where no matrix material is detected. This is thought to be attributed to capillary 
needle blockages resulting in a loss of spraying. This is consistent with the findings 
presented in Chapter 2. Higher matrix ion intensities are observed with the carbon 
membrane than with cellulose: this may be explained by the electrical conductivity 
of the substrate. The electrospraying procedure is optimised by an applied potential 
being maintained between the end of the capillary needle and the grounded sample 
stage; carbon membranes are therefore ideal for coating by electrospray. Several 
groups report matrix application by electrospray, and successful coating of carbon 
membranes with a-CHCA by electrospray for MALDI imaging of tissue blots for 
protein analysis has been carried out by Caprioli et al. [102,103].
4.3.2 Airspray deposition
Images of the sodium adduct of a-CHCA deposited by airspray deposition onto a 
carbon membrane (Figure 4.3) demonstrate complete coverage. It is clear however 
that there are variations in the matrix intensities observed. This matrix layer in­
homogeneity may be problematic in an imaging experiment. However, providing 
that data collated is purely qualitative, and that at all areas on the membrane 
there is sufficient matrix for analyte ionisation, the extent of matrix coverage may 
overcome limitations of uniformity, and this may therefore be a suitable approach.
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Figure 4.1: MALDI image of the sodium adduct of a-CHCA. Carbon membrane 
was coated in 15mg-ml_1 a-CHCA by electrospray deposition. Image demonstrates 
areas of dense matrix coverage, but also areas where the electrospray procedure 
failed.
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Figure 4.2: MALDI image of the sodium adduct of a-CHCA. Cellulose membrane 
was coated in 15mg-ml_1 a-CHCA by electrospray deposition. Image demonstrates 
areas of dense matrix coverage, but also areas where the electrospray procedure 
failed.
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Figure 4.3: MALDI image of the sodium adduct of a-CHCA. Carbon membrane was 
coated in 25mg-ml_1 a-CHCA by airspray deposition. Image demonstrates good 
area coverage of the membrane, but indicates that the matrix layer is inhomogen- 
eous.
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Figure 4.4 shows an image of the sodium adduct of a-CHCA on a cellulose 
membrane. As observed with the carbon substrate, the entire membrane area is 
coated with matrix material. The matrix coating appears more uniform than with 
the carbon membrane, which may be due to the absorbent nature of the material. 
As discussed in Chapter 2, the absorbent quality results in matrix being drawn into 
the membrane, rather than running freely over a hydrophobic surface until it dries. 
Areas of relative matrix abundance in Figure 4.3 may therefore represent areas where 
the matrix ‘pooled’ prior to solvent evaporation.
Intensity Height (mm)
I .
6.850 19.400 32.860
Width (rnrn)
Figure 4.4: MALDI image of the sodium adduct of a-CHCA. Cellulose membrane 
was coated in 25mg-ml_1 a-CHCA by airspray deposition. Image demonstrates a 
relatively homogeneous matrix coverage.
These results indicate that matrix application by airspray deposition offers a 
more uniform and ‘reliable’ matrix coverage than electrospray.
Over the last year, several reports of airspray deposition as a method of coat­
ing tissue samples in imaging MALDI-MS experiments have been published [100, 
113,168]. The technique offers enormous advantages of speed, and simplicity, as 
compared to electrospray.
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In Chapter 2, analyte spreading by matrix application was observed on all sub­
strates except cellulose. It is essential that matrix application does not result in 
analyte migration, as this would give rise to an incorrect display of the analyte’s 
spatial location. Thus a method of pre-coating membranes in matrix material prior 
to the blotting procedure was investigated. This strategy would negate the possib­
ility of matrix deposition causing the analyte to be ‘washed’ to new areas. For this 
to be a viable approach, successful inclusion of the blotted analyte into predried 
matrix crystals must be observed, and the expected distribution of the analyte must 
also be evident.
The following phase of work was conducted in order to assess the suitability of 
carbon and cellulose membranes as tissue blotting substrates in imaging MALDI- 
MS. Membranes were coated in matrix material by airspray deposition, either before 
or after the blotting procedure. The methods were assessed by the degree of matrix 
layer homogeneity on the substrates, as well as the distribution and successful de­
tection of the analyte molecule. Tissue treatment was performed within a triangular 
former, and thus the successful method was predicted to demonstrate a triangular 
distribution of the protonated molecule of ketoconazole.
Analysis of tissue-imprinted carbon membranes: matrix applied after the  
blotting procedure
The image presented in Figure 4.5 shows the distribution of the isotopic envelope of 
the protonated drug molecule. It is evident that a high degree of analyte spreading 
occurred. Similar findings were presented in Chapter 2, where electrospray depos­
ition resulted in analyte spreading on carbon membranes. The airspray method uses 
a considerably higher volume of matrix—and therefore solvent—than electrospray, 
and thus this is likely to result in extensive analyte migration. There appears to 
be an area in the centre of the image where no drug is observed. This is in fact 
the area where drug was expected. The image of the distribution of the sodium 
adduct matrix ion (presented in Figure 4.6) illustrates that matrix coverage shows 
a similar pattern. It is proposed that shampoo formulation blotted in this area has 
resulted in inferior matrix crystal formation. There is clearly an area of no crystals 
or ion suppression in the area where drug was expected. These results show that
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the method of coating carbon membranes in matrix after the blotting procedure is 
unsuitable for this application.
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Figure 4.5: MALDI Image of the distribution of the isotopic envelope of the pro­
tonated molecule [M-f-H]+ (m/z  531-533) of ketoconazole. Tissue was treated with 
Nizoral within a triangular former. The skin was blotted onto a carbon membrane, 
and subsequently coated in a-CHCA by airspray deposition. The image demon­
strates an unsuccessful triangular imprint, indicating analyte spreading by matrix 
application. Ketoconazole is detected across the majority of the membrane area.
Analyte spreading on a carbon membrane does not concur with the findings of 
Caprioli et al. [103]. However, as discussed in Chapter 2, they describe an analysis of 
proteins, which are likely to be bound to such a substrate by electrostatic attraction.
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Figure 4.6: MALDI Image of the sodium adduct matrix ion [Matrix+Na]+ (m/z
211.5-212.5). Tissue was treated with Nizoral within a triangular former. The 
skin was blotted onto a carbon membrane, and subsequently coated in o-CHCA by 
airspray deposition. Image demonstrates relatively dense and homogeneous matrix 
coverage, but reveals a triangular area of matrix suppression.
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Analysis of tissue-imprinted cellulose membranes: matrix applied after 
the blotting procedure
It can be seen from the image representing the distribution of the isotopic envelope of 
the protonated molecule of ketoconazole (Figure 4.7) that the analyte was detected 
across the majority of the membrane surface. This high degree of analyte spreading 
was not expected. It was postulated in Chapter 2 that the absorbent nature of 
the cellulose substrate reduced effects of analyte spreading. However, as discussed 
above the airspray method uses a much larger volume of solvent, and this is thought 
to have attributed to the analyte distribution observed. In addition, experiments 
presented in this chapter entailed analysis of a much larger membrane area than 
investigated in Chapter 2. It is likely that results presented in Chapter 2 did not 
fully demonstrate the extent of lateral migration, which can only be appreciated by 
imaging a larger square, as presented here.
The image of the distribution of the sodium adduct matrix ion (Figure 4.8) shows 
that matrix coverage in this experiment was surprisingly poor compared to all other 
airspray experiments. Given that there was clear analyte spreading, the method 
of airspraying matrix onto a tissue imprinted cellulose membrane was rejected as 
being unsuitable for this application. The poor matrix coverage is thought to be an 
anomaly, given the success of airspray deposition in all other experiments.
Analysis of tissue imprinted carbon membranes: matrix applied prior to  
the blotting procedure
The image presented in Figure 4.9 shows the distribution of the isotopic envelope 
of the protonated molecule of ketoconazole. An outline of the expected triangular 
distribution of the drug was observed. However the imprint appeared to be incom­
plete. It was observed during sample preparation of these membranes that there 
were loose or residual matrix crystals on the membrane following the airspraying 
procedure. This is thought to be due to the un-absorbent nature of the substrate. 
Thus it was observed that the tissue became covered in matrix within the triangular 
treatment area (due to wet formulation) after the blotting procedure. This resulted 
in an insufficient tissue imprint being made upon the membrane. This is similar to 
problems incurred in Chapter 2 while blotting tissue onto C18 beads.
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Figure 4.7: MALDI Image of the distribution of the isotopic envelope of the pro­
tonated molecule [M+H]+ (m/z  531-533) of ketoconazole. Tissue was treated with 
Nizoral within a triangular former. The skin was blotted onto a cellulose membrane, 
and subsequently coated in a-CHCA by airspray deposition. Image demonstrates an 
unsuccessful triangular imprint, indicating analyte spreading by matrix application. 
Ketoconazole is detected across the majority of the membrane area
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Figure 4.8: MALDI image of the sodium adduct matrix ion [Matrix+Na]+ (m/z
211.5-212.5). Tissue was treated with Nizoral within a triangular former. The skin 
was blotted onto a cellulose membrane, and subsequently coated in a-CHCA by 
airspray deposition. Image demonstrates poor matrix homogeneity as compared 
with the other airspray experiments.
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While there appears to be no analyte spreading, the method was not found to 
be suitable given the poor quality of tissue imprint.
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Figure 4.9: MALDI Image of the distribution of the isotopic envelope of the pro­
tonated molecule [M+H]+ (m/z  531-533) of ketoconazole. Tissue was treated with 
Nizoral within a triangular former. The skin was blotted onto a carbon membrane, 
precoated in a-CHCA by airspray deposition. Image demonstrates an incomplete 
triangular imprint.
The image of the distribution of the matrix (Figure 4.10) does not show a trian­
gular area of missing matrix material. The matrix coverage appears to be relatively 
abundant and homogeneous. Despite some matrix material being removed by the 
blotting process there is still an impressive matrix layer. The experiment was re­
peated using 3 instead of 5 cycles of airspray deposition. No drug was detected and 
matrix appeared sparse.
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Figure 4.10: MALDI Image of the sodium adduct matrix ion [Matrix+Na]+ (m / z
211.5-212.5). Tissue was treated with Nizoral within a triangular former. The skin 
was blotted onto a carbon membrane, precoated in a-CHCA by airspray deposition. 
Image demonstrates relatively abundant and homogeneous matrix coverage.
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Analysis of tissue imprinted cellulose membranes: matrix applied prior 
to the blotting procedure
This method was found to be superior to all other methods investigated. A dense 
and uniform triangle of ketoconazole can be seen from the image of the distribution 
of the isotopic envelope of the protonated drug molecule (Figure 4.11). This trian­
gular distribution shows that successful tissue imprints may be made upon matrix 
coated cellulose membranes. There were no problems encountered during the sample 
preparation. The membranes were found to become fully impregnated with matrix 
material, and the absence of excess surface matrix material enabled the creation 
of an impressive tissue imprint. Matrix application prior to the blotting process 
prevented matrix associated analyte migration.
Figure 4.12 shows a relatively dense and even matrix coverage. However, as was 
observed with carbon membranes, there appears to be an area of matrix suppression 
in the presence of excess drug. The determination of ketoconazole throughout the 
triangular area implies that matrix crystals were formed, and so the absence of mat­
rix ions detected in this region is thought to be attributed to the matrix suppression 
effect.
4.3.3 Direct tissue analysis
Poor results were obtained for direct tissue analysis in Chapter 2. Given that entire 
tissue sections could be mounted in the recess of Qstar targets, direct tissue analysis 
was re-evaluated in this phase of work. It was felt that analysis of a larger area 
might offer more promising results. However, as presented in Figures 4.13 and 4.14, 
similarly disappointing results were obtained. No drug was detected in the area 
where the tissue sample was mounted (Figure 4.13). Figure 4.14 reveals that this is 
likely to have been because no matrix material was detected on the tissue surface. 
Both the drug and matrix compounds were detected around the edge of the skin 
section, indicating analyte spreading. It is thought that the high salt content of skin 
is likely to have prevented the formation of viable matrix crystals.
Recent reports have shown that sinapinic acid, which is generally used for the 
analysis of high molecular weight proteins, may be useful as a matrix material for 
direct tissue analysis [100,113,168]. Sinapinic acid has a much higher salt tolerance
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Figure 4.11: MALDI Image of the distribution of the isotopic envelope of the pro­
tonated molecule [M+H]+ (m/z  531-533) of ketoconazole. Tissue was treated with 
Nizoral within a triangular former. The skin was blotted onto a cellulose membrane, 
precoated in <a-CHCA by airspray deposition. A triangular distribution of the drug 
is observed. Image demonstrates retention of spatial information when the blotting 
technique is employed.
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Figure 4.12: MALDI Image of the sodium adduct matrix ion [Matrix+Na]+ (m/z
211.5-212.5). Tissue was treated with Nizoral within a triangular former. The skin 
was blotted onto a cellulose membrane, precoated in a-CHCA by airspray deposition. 
Image demonstrates a triangular area of matrix suppression.
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Figure 4.13: Image of the distribution of the isotopic envelope of the protonated mo­
lecule [M+H]+ (m/z  531-533) of ketoconazole. Porcine epidermal tissue was treated 
with 500 fi\ Nizoral shampoo. A 15 /im surface section was obtained by microtoming 
and coated in 25 mg*ml' 1 a -CHCA by airspray deposition (while mounted on the 
MALDI target). Image demonstrates unsuccessful ionisation of drug within the area 
where tissue was mounted, and analyte spreading from the tissue onto the target.
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Figure 4.14: MALDI Image of the sodium adduct matrix ion [Matrix+Na]+ (m/z
211.5-212.5). Porcine epidermal tissue was treated with 500/A Nizoral shampoo. 
A 15 //m surface section was obtained by microtoming and coated in 25mg-ml-1 
cc-CHCA by airspray deposition (while mounted on the MALDI target). Image 
demonstrates unsuccessful coverage or ionisation of matrix material within the area 
where tissue was mounted. Matrix is only detected outside the tissue region.
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than o-CHCA, and so may form matrix crystals on the skin surface. Thus the 
experiment was repeated employing sinapinic acid as the matrix.
Unfortunately while spectra were acquired outside the area of drug treated skin 
showing successful determination of ketoconazole (Figure 4.15), no compounds, in­
cluding the matrix were detected on or in the skin section. It is probable that matrix 
compounds behave differently on different tissue groups; while this matrix has been 
usefully employed in the in analysis of brain tissue [113,168], it was not found to be 
suitable for the examination of skin.
+TOF MS: 180 MCA scans from Sample 2 (sinapinictissue) of sinapinicketo.wiff 
a=3.56505062976160490e-004, t0=5.32919478115945820e+001
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Figure 4.15: MALDI mass spectrum of ketoconazole acquired with sinapinic acid
as the matrix material. The protonated drug molecule is detected at m / z  531. The 
protonated matrix molecule is detected at m / z  224.
Results from this chapter are in accordance with the findings presented in Chapter 2; 
the direct analysis of drug treated skin is inferior to the analysis of tissue imprinted
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membranes.
4.4 Conclusions
Images of the sodium matrix adduct ion on carbon and cellulose membranes (Fig­
ures 4.1-4.4) indicate that airspray deposition is most reliable method. While there 
were areas on both cellulose and carbon membranes of abundant matrix material 
in electrospray experiments, the coverage over the entire membrane area is not as 
homogeneous as achieved by airspraying.
Regions in the images acquired from both substrates show areas where the elec­
trospraying procedure failed (Figures 4.1 and 4.2). Ion images reveal that greater 
ion intensities were observed upon the carbon substrate (Figure 4.1), highlighting 
the advantages of a conductive sample for electrospray deposition. Conversely in­
tensities may have been higher as all matrix material dries upon the surface, as 
opposed to being drawn into the absorbent cellulose membrane.
The technique of coating the membranes in matrix by airspray deposition (Fig­
ures 4.3 and 4.4) was found to give rise to complete coverage of both substrates. 
The layer achieved upon the cellulose membranes demonstrated a lower matrix ion 
intensity, but a more uniform coverage as compared to analysis of the carbon sub­
strate. These results may also be attributed to the absorbent nature of cellulose.
In addition, as described in Chapter 2, concentrations above 15mg-ml-1 could 
not be sprayed using the electrospray device as this appeared to block the capil­
lary needle, resulting in a loss of spraying. Samples were successfully coated with 
25 mg-ml-1 by airspray, resulting in a superior matrix layer.
Sample preparation times are another important factor. Electrospray deposition 
over a 2 x 2 cm area took around 3 hours, as compared to airspraying, which took 
approximately 15 minutes. Shorter preparation times are thus a major advantage 
of the airspray method. In addition airspraying requires considerably simpler and 
cheaper ‘instrumentation’, as compared to the robotic electrospray device.
Given the superior uniform coverage, and faster preparation times, airspraying 
was considered the optimum method of matrix deposition.
Airspraying matrix onto both substrates after the blotting procedure (Figures 4.5 
and 4.7) was found to cause extensive analyte spreading. This is because keto-
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conazole is highly soluble in methanol. The procedure involves use of a relatively 
large volume of solvent and thus analyte on both substrates was washed to new loc­
ations. In the carbon membrane experiments insufficient matrix crystal formation 
was observed in areas of excess formulation, resulting in poor detection of both the 
drug and matrix material (Figure 4.5 and 4.6).
The technique of pre-coating carbon membranes with matrix prior to the blot­
ting procedure was found to be unsuccessful. Excess matrix crystals were found 
to become stuck to the tissue surface during the blotting procedure resulting in an 
incomplete tissue imprint (Figure 4.9).
The approach of blotting treated tissue onto a cellulose membrane pre-coated 
in matrix material was found to be the optimum strategy. An impressive image 
demonstrating the triangular distribution of ketoconazole is presented in Figure 4.11. 
Matrix ions were suppressed in the presence of excess formulation (Figure 4.12), but 
ketoconazole was detected at all expected locations.
Direct tissue analysis was found to be unsuccessful with both a-CHCA and 
sinapinic acid. This is thought to have been attributed to poor matrix crystal 
formation upon the tissue surface.
Results presented in this chapter reveal that the novel method of blotting drug 
treated skin onto matrix coated cellulose membranes may be useful in permeation 
depth profiling of pharmaceutical compounds in skin.
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Chapter 5
Analysis of a Vertical Imprint of 
Drug-treated Tissue w ith respect 
to  the Quantification of 
K etoconazole at Different Tissue 
D epths
5.1 Introduction
In Chapter 4 the method of blotting treated tissue onto cellulose membranes pre­
coated in ct-CHCA by airspray deposition was found to be successful in maintaining 
the expected analyte distribution. Therefore, given that the method does not show 
analyte spreading by matrix application, studying the relative location of the drug on 
a membrane surface may demonstrate potential as a method of permeation profiling.
The aim of work presented in this chapter was to estimate the extent of drug 
permeation by analysis of a cross sectional imprint of treated tissue. Histological 
examination of porcine ear epidermal tissue should enable the calculated depth 
profile to be related to the tissue structure.
To date there have been no reports of quantitative MALDI-MS images.
The main factor complicating the use of MALDI for quantitative analysis is 
the inhomogeneous distribution of matrix and analyte molecules in the crystalline 
sample [126], This results in poor shot to shot and spot to spot reproducibility. 
The need for matrix homogeneity across a sample surface in imaging experiments 
has been discussed in Chapters 1-4, and is essential if imaging MALDI is to be a
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quantitative assessment. A range of techniques have been described to improve the 
homogeneity of matrix crystals [7,39,41-43,45-50,52-56,58-62,120], as discussed in 
sections 1.1.2 and 1.2.1 of the Introduction (Chapter 1). Investigations in Chapter 4 
reveal that airspray deposition is the most suitable technique for this application.
As with many other mass spectrometric techniques, incorporation of an internal 
standard has resulted in successful quantification by standard MALDI-TOF. In such 
experiments the internal standard selected should possess high molecular identity 
with the analyte, and thus have similar crystallisation behaviour.
Internal standards have been used to quantify antibiotics [169], bile acids in 
urine [170], drugs from blood samples [171], [172], chlormequat [173], substrates 
or products from cultivations [174], enzyme kinetics [165,175-177], peptides [178], 
neurotensin in brain tissue [167] and, alpha- and beta-myosin proteins in atrial 
tissue [179] by MALDI-TOF-MS.
While the use of internal standards in conventional MALDI analysis has proved 
successful, imaging experiments present a complicated issue: How should the in­
ternal standard be incorporated into the experiment?
Several strategies have been considered for quantitative TLC-MALDI analysis 
of drugs [118]:
1. Application of the internal standard to the TLC plate by electrospray before 
matrix deposition;
2. Application of internal standard to TLC plate after matrix deposition;
3. Spraying the matrix and internal standard concurrently as a mixture;
4. Pre-developing the TLC plate in internal standard prior to the TLC separation 
(matrix deposited as the final stage).
The technique of pre-developing the TLC plate in the internal standard was 
found to be the optimum method.
This is not predicted to be as useful for the indirect analysis of tissue imprints on 
membranes: While the membrane could be precoated in internal standard prior to 
matrix application, this is likely to favour the inclusion of the internal standard into
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the matrix crystals as the solvents dry, over the inclusion of the analyte molecules 
that are blotted onto the preformed crystals. This is less than ideal.
There have been reports of MALDI quantification without the inclusion of an 
additional compound serving as an internal standard. Such methods may be useful 
in imaging experiments. Successful calibrations for the quantitative determination 
of lysophospholipids using the signal: noise ratio for analyte peaks was reported by 
Petkoviac et al [180]. While this may help to reduce variations in analyte respnse 
due to laser fluence, it does not address issues of matrix heterogeneity which are 
likely to result in erroneous determinations in imaging experiments.
Dally et al [181] reported quantification of underivatised free amino acids in 
mammalian cell culture media on spot targets by MALDI-TOF-MS. They present 
calibrations for 12 amino acids, using an airspray sample deposition method to 
improve spot homogeneity. The matrix (a-CHCA) served as an internal standard.
Using the matrix as an internal standard in an imaging experiment is an attract­
ive possibility. Firstly there is no need to incorporate an additional and problematic 
stage in the sample preparation, and secondly, measuring the response of analyte: 
matrix at each location is likely to normalise any discrepancies in matrix coverage 
that might otherwise result in erroneous analyte intensities.
Thus in this phase off work the quantitative determination of ketoconazole at 
different tissue depths, using the matrix as an internal standard, is to be investigated
5.2 Experimental
5.2.1 Materials
Trifluoroacetic acid (AR grade) and a —cyano—4—hydroxy cinnamic acid—cn-CHCA) 
were purchased from Sigma-Aldrich (Dorset, UK). Methanol was HPLC grade, pur­
chased from Fisher Scientific (Loughborough, UK). Nizoral shampoo (20mg-g_1 
ketoconazole (((±)—1—acetyl—4—[p—[ [(2R,4S)—2—(2,4—dichlorophenyl)—2— 
(imidazol—1—ylmethyl)—1,3—dioxolan—4—yljmethoxy] phenyl] piperazine)), man­
ufactured by Janssen Cilag, Buckinghamshire, UK, and cellulose membranes were 
obtained commercially. Porcine ears were obtained from Doncaster abbatoir.
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5.2.2 Instrumentation
All mass spectrometric analysis was performed using an Applied Biosystems (Foster 
City, USA) hybrid quadrupole time-of-flight instrument (QStax) fitted with an or­
thogonal MALDI ion source and beta test imaging software supplied by MDS Sciex 
(Ontario, Canada). The nitrogen laser used has an elliptical spot size of 100x 150 /zm 
and an available power range of 0 — 58.4 /zJ.
Confocal microscopy was performed on a Zeiss 510 CSLM, equipped with an 
argon laser. Phase contrast images were acquired with a x20 objective lens.
Sample preparation for optical microscopy
Samples for optical micrcoscopy were prepared by microtoming to an approxim­
ately 15 /zm thick section. They were subsequently mounted onto a poly lysine- 
coated microscope slide (BDH, Poole, UK) and stained using a conventional Harris 
haematoxylin and eosin (H&E ) staining protocol.
Tissue treatment and membrane preparation
Cellulose membranes were coated in a-CHCA matrix material by airspray depos­
ition, as described and presented in Chapter 4.
A 2 x 2 cm piece of porcine epidermal tissue was treated with 500 /zl Nizoral sham­
poo, and incubated at 370 C for 1 hr. Following incubation any excess formulation 
present on the skin surface was washed away. Tissue samples were subsequently 
bisected and a cross sectional imprint was created on the matrix coated cellulose 
membrane.
Imaging the membrane
The area on the target where the membrane was mounted was selected within the 
software and then imaged as follows: the target was moved in x  and y dimensions 
at set increments of 0.2 mm while firing the laser for 2 seconds at each location, at 
a laser repetition rate of 20 Hz.
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5.3 Results and discussion
Figure 5.1 shows an image generated of ketoconazole distribution in a ‘vertical’ 
skin section following blotting of the bisected tissue cross-section onto a precoated 
cellulose membrane. The apparent localisation of the drug in the uppermost layers 
of the skin is clearly observable.
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Figure 5.1: MALDI Image of the distribution of the isotopic envelope of the proton­
ated molecule [M-f-H]+ (m/z  531-533) of ketoconazole in a vertical section of porcine 
epidermal tissue. Treated tissue was bisected and a cross section was blotted onto 
cellulose membrane, precoated in a-CHCA by airspray deposition. The image shows 
a ‘vertical’ distribution of the protonated drug molecule.
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In order to clearly see the apparent depth of penetration the image shown in 
Figure 5.1 can be rotated via 90° using the supplied software. This is shown in 
Figure 5.2. This form of presentation allows a semi-quantitative assessment of the 
data.
5.3.1 Quantification of drugs in skin
The use of matrix peaks as an ‘internal standard’, for the normalisation of keto­
conazole signals has been investigated. This procedure was used in order to com­
pensate for variations in matrix coverage. Examination of spectra and images ob­
tained from analysis of (pre-coated) tissue imprinted cellulose membranes reveals 
that the most abundant and consistent matrix peak observed is the sodium adduct 
of a-CHCA (m/z  212) (Figures 5.3 and 5.4).
An initial calibration graph for the concentration range 0.25-1.75 mg-ml-1 keto­
conazole was prepared by plotting the ratio of m / z  531-533:212 against drug con­
centration (Figure 5.5). The calibration represents the mean value of 20 samples 
and their associated error. All analyses were performed using an automated search 
pattern to acquire data from within the sample spots.
The ratio of drug to matrix observed on tissue imprinted membranes is con­
sistently under 0.5, indicating that a more effective calibration range would be 0- 
0.4 mg-ml-1. The calibration was repeated for this range to ensure a more accurate 
interpretation of results (Figure 5.6). Good linearity (r2 =  0.9686) and precision 
(average standard deviation =  0.055 (n =  20)) were achieved.
The straight line equation from Figure 5.6 was then used to calculate the concen­
tration of ketoconazole in a vertical profile as follows: the data set used to construct 
the 3D images was was displayed in two dimensions and magnified in the software 
in order to observe individual pixels. Each pixel in the image corresponds to a 
spectrum acquired in the imaging run. Thus the intensities of the protonated ana­
lyte and sodium matrix adduct peaks were extracted from spectra acquired in a 
sequential, vertical fashion—as illustrated in Figure 5.7. The ratio of the peaks was 
calculated and the straight line equation from the calibration was used to calculate 
the concentration of drug at each location.
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Figure 5.2: MALDI Image of the distribution of the isotopic envelope of the proton­
ated molecule [M+H]+ (m/ z  531-533) of ketoconazole in a vertical section of porcine 
epidermal tissue. In this case the treated tissue was bisected and a cross section was 
blotted onto cellulose membrane, precoated in a-CHCA by airspray deposition. The 
image shows a ‘vertical’ distribution of the protonated drug molecule. This is the 
same data as shown in Figure 5.1 and has been rotated through 90°, giving a clear 
picture of the apparent change in drug concentration with depth.
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Figure 5.3: MALDI mass spectrum of ketoconazole treated tissue imprint on a 
cellulose membrane, precoated in a-CHCA by airspray deposition. The sodium 
matrix adduct ion is the most abundant matrix associated peak
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Figure 5.4: MALDI images of o-CHCA on cellulose membrane: (a) the protonated 
molecule (m/z  190), (b) the sodium adduct (m/z  212), (c) the potassium adduct 
(m/z  228), and (d) the matrix dimer (m/z  379).
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Figure 5.5: Calibration plot for the determination ketoconazole 0.25-1.75 mg con­
structed using the intensity of the Na adduct of o-CHCA ion at m / z  212 as an 
‘internal standard’ (y = 1.0699a; +  0.3566, r 2 = 0.9224.)
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Figure 5.6: Calibration plot for the determination ketoconazole 0-0.4 mg-ml-1 con­
structed using the intensity of the Na adduct of a-CHCA ion at m / z  212 as an 
‘internal standard’ (y =  2.7441a:, r 2 =  0.9686)
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Figure 5.7: A 2D representation of the data presented in Figure 5.1 was enlarged 
within the software to reveal pixels. Each pixel within the image corresponds to an 
individual mass spectrum. The ratio of drug to matrix in these spectra was used to 
calculate the concentration of drug at each location by rearranging the straight line 
equation obtained from the calibration plot shown in Figure 5.6.
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Knowledge of the degree of vertical spacing between spectra enables the data to 
be presented as a profile of drug concentration against increasing depth as shown in 
Figure 5.8. The drug is detected up to 0.8 mm into the skin.
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Figure 5.8: A quantitative profile of ketoconazole in porcine skin constructed from 
examination of selected spectra acquired during an imaging run.
In order to relate the profile to skin structure, conventional haemotoxylin and 
eosin staining was performed on a cross section of porcine epidermal tissue. The 
section was imaged by confocal microscopy and the histological image obtained is 
demonstrated in Figure 5.9. The original MALDI image (Figure 5.1) was enlarged 
to reveal individual pixels (each representing a 0.2 mm2 area) and this was super­
imposed upon the histological image, as shown in Figure 5.10. This demonstrates 
drug permeation up to and including the dermal skin layer. No drug is detected in 
the underlying connective tissue. All labelled concentrations are equivalent to the 
concentration of ketoconazole in solution. Thus further work will be necessary to cal­
culate a true concentration in skin. This may be possible by preparing calibrations 
of different drug concentrations on cellulose membranes, calibrations of different
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drug concentrations applied to the skin surface and blotted onto a membrane, and 
hence determining the blotting efficiency itself.
Figure 5.9: Confocal microscope image of a cross section of porcine skin. The sample 
was prepared by conventional haemotoxylin and eosin staining methods.
There may be concern over the possibility of smudging during the blotting pro­
cedure resulting in a loss in quality of spatial information. It is therefore essential to 
optimise methods for this blotting procedure, so that they are normalised or auto­
mated to ensure reproducibility. However the data shown here appear to confirm 
that at the current spatial resolution of 100 /un, smudging is not significant.
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Figure 5.10: The mass spectrometric image is superimposed upon a histological im­
age to reveal that the drug is absorbed into the dermal skin layer. All concentrations 
are equivalent to concentration in solution.
5.4 Conclusions
This programme of work has demonstrated that imaging MALDI-MS is a potentially 
powerful tool for studying pharmaceutical compounds in biological systems.
To date there has been limited exploration of the use of imaging MALDI in 
biomedical applications. Ion beam approaches such as SIMS have been used in sim­
ilar applications, but suffer limitations such as mass range and sensitivity. Caprioli 
and co-workers have introduced the use of MALDI imaging for studying peptides, 
proteins, and drugs in tissues. The author is unaware of any other research that 
employs imaging MS in percutaneous depth profiling. The work presented in this 
chapter illustrates the possibilities of this technique in such an application.
The use of lasers in imaging MS has several advantages as compared to using 
ion-beams alone, such as high sensitivity, selective ionisation, and quantification. 
However, while MALDI imaging experiments have yielded better quality spectra 
and can detect a higher mass range than SIMS, the lateral resolution needs to be 
greatly improved.
Successful detection and imaging of drug compounds on and under the skin 
surface has been achieved by the indirect analysis of tissue imprinted cellulose mem­
147
5.4 Conclusions
branes by MALDI-TOF-MS. The methods developed have yielded high quality spec­
tra and images of the drug molecule. The method of precoating celluose membranes 
in matrix by airspray deposition gives rise to a relatively abundant and homogen­
eous layer of matrix crystals as compared to other methods investigated. Treatment 
through a triangular former (presented in chapter 4) shows that the method is 
capable of maintaining the spatial distribution of the analyte. Images have been 
generated showing the dermal uptake of the drug molecule in skin, and show the 
expected trend of diminishing drug concentration with increasing depth.
Calibration graphs for the determination of ketoconazole have been prepared 
using the sodium matrix adduct as an internal standard. A relatively good degree 
of linearity and precision have been achieved. The linear relationship obtained has 
permitted calculation of the concentration of ketoconazole at different skin depths 
by examination of individual spectra acquired during an imaging run. Histological 
images reveal that this corresponds to drug permeation up to and including the 
dermal skin layer.
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Chapter 6
M ethods for the Quantification of 
Drug in Tissue by Imaging 
M ALDI-TOF-M S and a 
Comparison with HPLC Corneum  
Tape Stripping
6.1 Introduction
The optimum method for the analysis of ketoconazole in porcine epidermal tissue 
by MALDI-TOF-MS was found to be the ‘indirect analysis’ of tissue imprints on 
cellulose membranes, precoated in ct-CHCA by airspray deposition. This method 
was found to retain the expected distribution of the analyte molecule (as presented 
in Chapter 4 of this thesis). This approach was then employed for the analysis of a 
cross sectional tissue imprint, which permitted construction of a semi-quantitative 
profile of ketoconazole in skin (as presented in Chapter 5 of this thesis).
The percutaneous absorption of ketoconazole into porcine epidermal tissue should 
be assessed by an alternative method in order to validate the profile obtained by 
imaging MALDI-MS. Autoradiography would permit a comparison of images but 
is only semi-quantitative. In addition, labelled ketoconazole was not available, and 
thus this technique was not explored.
A widely used and well-documented technique for the determination of the per­
meation depth of drugs in skin is stratum corneum tape stripping, with analysis by 
high performance liquid chromatography (HPLC) [166]. In addition to permeation
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profiling, tape stripping has also been used for the study of biophysical proper­
ties [162], and the examination of skin constituents [182]. The technique is simple 
to perform and is reviewed on page 38.
In this chapter, a method for the analysis of ketoconazole in skin by tape strip- 
ping/HPLC is presented. The analysis of ketoconazole at different skin depths by 
this method was then compared to tape stripping with analysis by tissue blotting 
and MALDI-MS.
6.2 Experimental
6.2.1 M aterials
Ketoconazole, econazole, triethylamine, tetramethyl ammonium hydroxide, diisop­
ropylamine, and tetrahydroxybenzophenone were all purchased from Sigma-Aldrich 
(Dorset, UK). All solvents were HPLC grade and obtained from Fisher Scientific 
(Loughborough, UK). Porcine ears were obtained from Doncaster abbatoir. Sello- 
tape and Nizoral shampoo were obtained commercially.
6.2.2 Instrum entation
The chromatographic (HPLC) system comprised a Waters 600MS System controller, 
a Perkin Elmer ISS200 advanced LC sample processor, a Waters 490E programmable 
multiwavelength detector and a DP700 CE instruments integrator. The column 
employed in this work was a Supelcosil LC-18 (Supelco) 15 cm x 2*1 mm with a 5 finl 
pore size.
All mass spectrometric analyses were performed on a Qstar pulsar i (Applied 
Biosystems, Foster City, USA) fitted with an orthogonal MALDI ion source and 
beta test ion imaging software (MDS Sciex, Ontario, Canada).
6.2.3 M ethods
Optimisation of HPLC determination of ketoconazole in tape strippings
Methods were developed to determine concentrations of ketoconazole and an in­
ternal standard, without interference from either Sellotape components or matter
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extracted from tissue. Ketoconazole was detected by UV detection at 232 nm. Ini­
tial HPLC conditions comprising a mobile phase of 60:40 acetonitrile and 0-02M 
disodium hydrogen orthophosphate buffer, pH 4-0, containing 0-2% diisopropylam­
ine and a flow rate of 0-15ml-min-1 [183] were considered unsuccessful. All matter 
extracted from tape was eluted between 8 and 12 minutes, with the drug eluted at 
10 minutes. Introduction of a gradient method could not overcome this.
The instrument was refitted with stainless steel tubing and a mobile phase com­
prising acetonitrile, 1.59 mM tetramethyl ammonium hydroxide (TMAH) buffer, pH 
7-8 and tetrahydrofuran (THF) was investigated [184]. Under these conditions, the 
drug was successfully separated from all other components, and the optimum mobile 
phase was determined as containing 55% acetonitrile, 14-3% THF and 31-7% TMAH 
buffer, set at a flow rate of 0-15ml-min_1. Under these conditions, ketoconazole was 
eluted at around 9*6 minutes.
In order to permit the quantitative determination of ketoconazole by HPLC, 
compounds were investigated for use as internal standards. The structural ana­
logue, fluconazole, was the first choice of internal standard. Unfortunately this was 
not commercially available as an analytical reagent. An alternative azole anti-fungal 
agent, econazole, was subsequently evaluated. Despite showing good absorbance at 
232 nm, econazole could not be detected by this method. Tetrahydroxybenzophen- 
one was finally selected as the internal standard to be used in these experiments. 
Under the aforementioned conditions it was eluted at 4-6 minutes.
Topical treatments
A ‘confined treatment area’ of 2 x 2 cm was created on all tissue types by protecting 
the skin around the application site with adhesive tape (to ensure that the stripped 
area corresponded rigorously to the treated area).
Fresh porcine epidermal tissue was treated with 50 fil Nizoral shampoo (2% keto­
conazole) and transferred to an incubator (37° C) for one hour. Following incuba­
tion, the excess formulation was blotted away, and the tissue surface was rinsed in 
deionised water, and allowed to dry for 30 minutes.
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Tape stripping
The stratum corneum of the confined treatment area was sequentially stripped up to 
20 times with a commercially available adhesive tape (Sellotape), which was pressed 
to the skin by rubbing it back and forth with a spatula.
Ketoconazole was extracted from the tape strips over 16 hours in 2 ml of an 80:20 
mixture of acetonitrile and aqueous 0*72 mM TEA buffer, pH 2-5 [184] (containing 
100/ig*ml_1 tetrahydroxybenzophenone as an internal standard). The solution was 
then passed through an Acrodisc syringe filter and transferred to HPLC vials for 
quantification.
HPLC analysis
The mobile phase was isocratic and comprised a volumetric mixture of 55% acet­
onitrile, 14-3% THF and 31-7% 1.59 mM tetramethyl ammonium hydroxide buffer, 
pH 7-8. The flow rate was set at 0-15ml-min-1. Sample volumes of 5/d of ‘tape 
extract’ solution were injected into the system. UV detection was performed at 
232 nm.
Drug concentrations were determined from calibration plots generated with keto­
conazole dissolved in the same mixture used for extraction.
Tissue blotting and corneum tape stripping
In separate experiments, tissue was treated with 500 /d Nizoral (2% ketoconazole) 
within a 2 x 2 cm treatment area, and incubated at 370 C for one hour. The tissue 
surface was subsequently blotted onto a 2.2 x 2.2 cm cellulose membrane that had 
been precoated in 25mg-ml-1 a-CHCA (prepared in methanol (0-1% trifluoroacetic 
acid)) by airspray deposition.
The stratum corneum of the confined treatment area was then sequentially 
stripped as described above (page 152). The blotting procedure was repeated after 
every five tape strips.
MALDI-MS analysis of membranes
All membranes were analysed by MALDI-TOF-MS with the Qstar pulsar % in pos­
itive ion mode. Mass spectra were acquired every 0-5 mm by firing the laser for
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two seconds at each location at an energy of 14 fiJ and a repetition rate of 20 Hz. 
Relevant data was then extracted from the TIC file.
6.3 Results and discussion
6.3.1 Determ ination and quantification of ketoconazole in 
tape strip samples by HPLC
Examination of the chromatograms obtained by analysis of extracts from tapes used 
to strip treated and untreated tissue (presented in Figures 6.1 and 6.2 respectively) 
did not reveal any interfering peaks when compared to chromatograms obtained by 
analysis of ketoconazole standards (Figure 6.3). The chromatograms show that no 
interfering compounds were extracted from the tissue (analysis of a tape strip from 
untreated tissue shows no peak at 9*6 minutes (Figure 6.2), compared to analysis of a 
ketoconazole standard (Figure 6.3), and a tape strip from treated tissue (Figure 6.1), 
which both clearly show presence of a peak at 9*6 minutes. The experiments also 
demonstrate that the drug was successfully separated from Selloptape components 
in the chromatographic system. Chromatograms obtained from analysis of tape 
strip samples from treated (Figure 6.1) and untreated (Figure 6.2) tissue did not 
give rise to any possibly-interfering peaks in the chromatographic region of interest, 
when compared to analysis of a drug standard (Figure 6.3). The internal standard, 
tetrahydroxybenzophenone, was detected at around 4-6 minutes in all experiments. 
Ketoconazole was detected at around 9-6 minutes.
A calibration plot for the quantitative determination of ketoconazole (in concen­
trations from 0—lOO/xg-ml"1) by HPLC was prepared, as presented in Figure 6.4. 
This permitted calculation of the concentration of ketoconazole obtained from tape 
strippings.
The recovery of ketoconazole from tape was determined by coating tape samples 
with 50 fil of a 10mgmg-ml-1 ketoconazole solution preprared in 60:40 acetoni- 
trile:TEA buffer (corresponding to 500 fig per piece of tape used) and submitting 
them to the extraction protocol described on page 152 . The concentration of keto­
conazole ( /zg*ml_1) in the injected sample was calculated from the calibration graph. 
Thus the amount of ketoconazole extracted into 2 ml acetonitrile/TEA buffer was
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Figure 6.1: Chromatogram obtained from analysis of tape used to strip the surface 
of treated tissue. Porcine epidermal tissue was treated with 50 /d Nizoral shampoo. 
Following incubation the surface layer was removed by stripping with Sellotape. 
Ketoconazole was extracted from the tape over 16 hours in an 80:20 mixture of acet­
onitrile and TEA buffer, containing tetahydroxybenzophenone as internal standard. 
5/il of the extracted mixture was injected into the chromatographic system. Sep­
aration was performed on a Supelco C18 column, the mobile phase (14-3% THF, 
31-7% TMAH buffer, 55% acetonitrile) was set at a flow rate of0-15mhmin_1. UV 
detection was performed at 232 nm. Ketoconazole was detected at 9-65 minutes, 
the internal standard was detected at 4-66 minutes. The figure annotations refer to 
the elution times (in minutes) of detected compounds. Peak areas of the internal 
standard (eluted at 4.66 minutes) and ketoconazole (eluted at 9.65 minutes) were 
reported as 633608 and 559201 respectively.
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Figure 6.2: Chromatogram obtained from analysis of tape used to strip untreated 
tissue: The surface layer of porcine epidermal tissue was removed by stripping with 
sellotape. The tape was subsequently digested over 16 hours in an 80:20 mixture 
of acetonitrile and TEA buffer, containing tetahydroxybenzophenone as internal 
standard. 5/d of the digestion/extraction mixture was injected into the chromato­
graphic system. Separation was performed on a Supelco C18 column, the mobile 
phase (14-3% THF, 31-7% TMAH buffer, 55% acetonitrile) was set at a flow rate 
ofO-15 ml-min-1. UV detection was performed at 232 nm The internal standard was 
detected at 4.66 minutes. No peaks were detected at around 9-6 minutes, indicating 
that no compounds were removed from the tissue or extracted from Sellotape that 
might have interfered with the determination of ketoconazole. The figure annota­
tions refer to the elution times of detected compounds (in minutes). The peak area 
of the internal standard (eluted at 4.66 minutes) was reported as 604902.
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Figure 6.3: Chromatogram obtained from analysis of 100mg-ml-1 solution of keto­
conazole (prepared in an 80:20 mixture of acetonitrile and TEA buffer, containing 
tetahydroxybenzophenone as internal standard). 5/d of the mixture was injected 
into the chromatographic system. Separation was performed on a Supelco C18 
column, the mobile phase (14-3% THF, 31-7% TMAH buffer, 55% acetonitrile) was 
set at a flow rate of0*15ml*min_1. UV detection was performed at 232 nm, keto­
conazole was detected at 9*50 minutes, the internal standard was detected at 4-59 
minutes. The figure annotations refer to the elution times (in minutes) of detected 
compounds. Peak areas for the internal standard (eluted at 4.59 minutes) and keto­
conazole (eluted at 9.50 minutes) were reported as 73081 and 478680 respectively.
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Figure 6.4: Calibration plot for the determination of ketoconazole (0—100//g-ml_1) 
by HPLC. Ketoconazole was prepared in an 80:20 mixture of acetonitrile and TEA 
buffer, containing lOO/rg-ml-1 tetrahydroxybenzophenone as an internal standard. 
Samples of 5 fi\ were injected into the chromatographic system. Separation was per­
formed on a Supelco C18 column, the mobile phase (14-3% THF, 31-7% TMAH buf­
fer, 55% acetonitrile) was set at a flow rate ofO-15 ml-min-1. UV detection was per­
formed at 232 nm, ketoconazole was detected at 9-6 minutes, the internal standard 
was detected at 4*6 minutes. The ratio of peak areas of ketoconazole and the internal 
standard were plotted against concentration of ketoconazole (y — 0.0104a; +  0.0185, 
r 2 =  0 • 9974).
157
6.3 Results and discussion
calculated and compared to the expected value of 500 fig (100% extraction effi­
ciency). The extraction efficiency of ketoconazole from tape was determined to be 
65%. Concentrations presented in this chapter are adjusted to account for this effi­
ciency, and thus all concentrations represent the theoretical value that would have 
been obtained given a 100% extraction efficiency.
In all cases within this chapter samples were injected in duplicate, and the mean 
value of the ratio of drug:internal standard in each solution was used in all subsequent 
calculations.
6.3.2 Determ ination of ketoconazole in porcine epidermal 
tissue by corneum tape stripping/H PLC
Analysis of previously-frozen porcine tissue was unsuccessful. No ketoconazole was 
detected in any of the tape strips. This is believed to be because freezing tissue alters 
the hydration properties of the skin surface [164], resulting in insufficient adherence 
of the tape to the tissue. Consequently, no stratum corneum was stripped from 
these samples. Thus in all experiments fresh porcine epidermal tissue was used for 
this phase of work.
A quantitative profile of ketoconazole in porcine epidermal tissue by corneum 
tape stripping/HPLC was prepared, as presented in Figure 6.5. The profile demon­
strates the expected distribution of decreasing drug concentration with increasing 
strip number. The graph represents the mean of three experiments. All errors are 
presented on the graph.
6.3.3 Determ ination of ketoconazole in porcine epidermal 
tissue by corneum tape stripping/tissue b lotting w ith  
analysis by MALDI-TOF-M S
Treated tissue was blotted onto matrix coated membranes following sequential tape 
stripping. For each imaged sample the total ion chromatogram (TIC) generated was 
summed to give a resultant ‘averaged’ spectra. Intensities of the protonated mo­
lecule of ketoconazole (m /z  531-533) and the sodium matrix adduct ion (m/z  212) 
were extracted. The calibration graph prepared previously for determination of keto­
conazole (0-0*4 mg*ml-1) by MALDI-TOF-MS (Figure 5.6, presented in Chapter 5) 
was used to relate the ratio of these two values to a concentration of ketoconazole.
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Figure 6.5: A quantitative profile of ketoconazole in porcine epidermal tissue by tape 
stripping/HPLC analysis. Tetrahydroxybenzophenone was employed as the internal 
standard. The tape strip number provides a measure of relative depth within the 
skin.
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Figure 6.6 shows a quantitative profile of ketoconazole in porcine epidermal tissue 
by corneum tape stripping/MALDI-TOF-MS. The profile represents the mean of 
three experiments. All errors are demonstrated on the graph. The profile shows the 
expected trend of diminishing concentration with increasing depth (strip number). 
However, there appears to be an increase in drug concentration between the surface 
blot, and the blot obtained after 5 strips. A similar fluctuation was observed in the 
quantitative profile obtained by MALDI imaging (Chapter 5, Figure 5.8). However, 
given that the data presented in this chapter does not give a measure of the true 
depth, it is not necessarily a comparable fluctuation.
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Figure 6.6: A quantitative profile of ketoconazole in porcine epidermal tissue by tape 
stripping/tissue blotting/ MALDI-MS analysis. Treated tissue was blotted onto 
matrix coated membranes following sequential tape stripping. Whole membranes 
were analysed by MALDI-MS. The ratio of drug:to matrix was calculated from the 
TIC file, and the calibration previously presented in Chapter 5 was used to relate 
this to an equivalent concentration of ketoconazole. Tape strip number provides a 
measure of relative depth within the skin.
Although both the HPLC and MALDI-TOF-MS tape stripping experiments show 
the expected trend of diminishing drug concentration with increasing depth and 
similar concentration ranges, the data has several limitations.
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There are problems associated with the tape stripping technique itself. First, 
the stratum corneum can not be removed entirely by stripping; generally about one 
third of the layer will remain attached as ‘islets’ to the epidermal surface [146]. As 
a result, the corneocytes collected on one tape strip may have been derived from 
different depths, and may therefore have led to an ambiguous representation of drug 
concentration. Another major limitation of the technique is that any tape strip may 
remove different amounts of the stratum corneum at different depths and sites of 
the skin. To account for such variations, it is necessary to determine the tissue mass 
removed with each strip, for example by weighing the pieces of Sellotape before 
and after the stripping procedure. Evaluation of this parameter would also permit 
the relative depth associated with each tape strip to be calculated. Assuming that 
the stratum corneum density is constant (lg /cm 3) across its thickness, then these 
weights can be converted to volumes and, given that the area stripped is constant, to 
the stratum corneum thickness removed. This would enable a plot of concentration 
against relative depth.
It was found in this phase of work that limitations associated with balance sens­
itivity and issues due to static electricity prevented this assessment. However, given 
that the stripping procedure was normalised—and that the type and site of skin did 
not vary—the degrees of error are thought to be constant and therefore the strip 
number has been used as a measure of relative depth. In addition, all limitations 
associated with the tape stripping technique exist in both the HPLC and MALDI- 
MS experiments. Thus it was hoped that these experiments would have enabled a 
calculation of the efficiency of the tissue blotting procedure (efficiency of transfer of 
drug from tissue to membrane) presented throughout this thesis.
It is clear from observation of the two profiles that the MALDI-MS method 
(Figure 6.6) demonstrates considerably more error and variation than the HPLC 
method (Figure 6.5). Maximum errors observed in tape stripping/HPLC methods 
were about ±5% of the mean value, whereas errors of up to ±18% of the mean value 
are evident from the tape stripping-MALDI-MS experiments. However, this high 
degree of variation is only observed with the surface imprint and the imprint made 
after 5 tape strips. All other data points indicate errors comparable with the HPLC 
methods.
161
6.3 Results and discussion
The source of this error in the MALDI-MS experiments is likely to be the blotting 
procedure, and these experiments highlight the need for this process to be stand­
ardised as this is likely to have enormous effect on the quantitative determination of 
drug from membranes. A form of mechanical ‘press’ that exerts a known pressure 
for a set length of time could be developed for further tissue blotting experiments. 
Significant errors observed from the surface imprint and that made after 5 tape strips 
may conversely be associated with erroneous MALDI determination of the drug in 
the presence of excess dosage. It was observed in Chapter 4 that, in some instances, 
suppression of matrix and analyte is observed in the presence of excess drug concen­
tration or shampoo formulation. Repetition of the MALDI-MS experiments with a 
less concentrated tissue treatment would establish if this is a significant factor.
Although both methods demonstrated a similar range of ketoconazole concen­
tration over 20 tape strips, the data collected did not permit a direct comparison of 
the methods. HPLC experiments involved a tissue treatment of 50 /A Nizoral (be­
cause tape could not be loaded with more than 50 fA formulation in the extraction 
efficiency experiments), whereas the MALDI-MS experiments involved tissue being 
treated with 500 fA Nizoral. One would therefore expect the MALDI-MS experi­
ments to have demonstrated up to a ten-fold increase in drug concentration. The 
result obtained may therefore be explained by poor tissue blotting efficiency. Altern­
atively, it is possible that both concentrations fully saturated the diffusion capacity 
of the stratum corneum. The equilibrium constant of ketoconazole across the skin 
barrier would have to be calculated in order to answer this question. This could be 
done using Fick’s second law of diffusion, but would require data on relative depth 
which was not obtained in this phase of work.
Tape stripping-tissue blotting-MALDI-MS experiments should be repeated with 
a tissue treatment of 50 fA Nizoral. Comparison of HPLC vs. MALDI profiles 
obtained may then allow calculation of the blotting efficiency.
It should also be noted that the MALDI concentration profiles presented in this 
chapter and Chapter 5, are calculated from a calibration of ketoconazole in solu­
tion, determined by spot analysis of samples prepared on stainless steel targets. 
It is expected that the ionisation properties of both the drug and matrix in the 
cellulose membrane may be different as compared to conventional spot analysis. 
Calibrations should be repeated by blotting tissue with a variety of known drug
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concentrations and plotting the response of matrix:analyte against original concen­
tration. A comparison of this data with the original calibration and a calibration of 
drug concentrations spotted into a matrix coated cellulose membrane would enable 
assessment of the following parameters:
1. The difference in ionisation efficiency of compounds prepared on stainless steel 
vs. cellulose;
2. The blotting, or transfer efficiency of drug from tissue to membrane.
Future work should also determine the relative depth associated with skin re­
moved by each tape strip. This may enable tape stripping MALDI data to be used 
as a means of validating the profile prepared by imaging MALDI-MS, presented in 
Chapter 5 (Figure 5.6). This may also be achieved by sectioning treated skin to 
known depths by microtoming, removing for example 200/xm, 400/zm, 600/im etc., 
and blotting the remaining tissue onto matrix-coated membranes. A drug concen­
tration at each depth may be calculated from the TIC file and compared to the 
‘vertical’ profile presented in Chapter 5.
6.4 Conclusions
An HPLC method was developed for the determination of ketoconazole recovered 
from tape used to strip porcine epidermal tissue. The optimal method demonstrated 
separation of both the analyte and internal standard from Sellotape matter. A cal­
ibration showing good linearity and precision (y =0*0104:zH-0*0185, r2 =0*9974) 
was prepared for the quantitative determination of ketoconazole. The calibration 
was used to construct a quantitative profile of drug in skin, by plotting drug con­
centration against strip number. The profile demonstrated the expected trend of 
diminishing drug concentration with increasing strip number.
Tape-stripping methods were then employed in conjunction with tissue blotting/ 
MALDI-MS to construct a similar profile. Tissue imprints were created on matrix- 
coated membranes after every 5 tape strips. The concentration of ketoconazole on 
each membrane was estimated by relating the ratio of matrix:analye extracted from 
the TIC file to a calibration prepared from ketoconazole in solution.
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Profiles obtained by the two methods exhibited similar trends of drug distribu­
tion, and similar concentration ranges. However, considerably larger errors were 
evident in the MALDI experiments. This is thought to have been due to variations 
in the blotting procedure and issues arising from ionisation of matrix and drug in 
the presence of excess formulation.
Profiles constructed by the two methods were not directly comparable due to 
variations in the tissue treatment. MALDI experiments involved a ten-fold increase 
in drug administered to the tissue surface, which was not reflected in the resulting 
profiles. It is predicted that only a fraction of drug present in tissue will be trans­
ferred to the membrane, which may account for a drug excess not being observed. 
However it is also possible that an equilibrium constant of drug in skin was achieved 
with both methods, due to an excess of shampoo being administered in each case.
An estimate of the amount of skin removed with each strip should be calculated 
to allow analysis of the change in concentration with relative depth. This in turn 
would permit comparison of the profiles with the that obtained by imaging MALDI- 
MS as presented in Chapter 5.
The tape stripping/ MALDI-MS experiments presented in this chapter should 
be repeated with a tissue treatment of 50 /zl Nizoral, so that data may be compared 
to the HPLC methods developed in this phase of work.
Calibrations for the quantitative determination of ketoconazole should be re­
peated, so that concentrations are calculated from the MALDI response of drug:matrix 
from cellulose, rather than being related to the concentration of ketoconazole in solu­
tion.
In summary, while a successful and useful method of tape stripping/HPLC has 
been developed for permeation depth profiling ketoconazole in skin, further work is 
required in order to use this method to validate the MALDI-MS profiles presented 
in this thesis.
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Chapter 7 
Conclusions and Further Work
Methods for the analysis of drugs in skin by imaging MALDI-TOF-MS have been 
investigated in the work described in this thesis. Different approaches were evalu­
ated in order to address key issues in imaging MALDI experiments, such as: direct 
vs. indirect analysis; substrates for indirect analysis; choice of matrix: layer ho­
mogeneity and application methods; analyte spreading and quantification. Tape 
stripping methods were developed as a strategy for the comparison of the optimised 
MALDI-TOF-MS method with HPLC analysis.
Initial work was conducted using a linear TOF mass spectrometer (Laser TOF 
1500, SAI, Manchester), and involved selection of a suitable test analyte and a com­
parison of direct tissue analysis with the indirect analysis of tissue imprints created 
on a variety of substrates. Determination of aciclovir and piroxicam was unsuccess­
ful, because poor mass accuracy and resolution made it diffucult to differentiate these 
compounds from interfering substances from the sample and matrix in the spectral 
region of interest. Similar problems were encountered by Reyzer et al. [100], where 
conventional MALDI-TOF methods failed to differentiate drug molecules in brain 
tissue from endogenous tissue molecules.
Ketoconazole was selected as a suitable analyte for the development of methods 
for the analysis of drugs in skin by imaging MALDI-MS. cn-CHCA was found to be 
the most suitable matrix for the determination of ketoconazole, and deposition by 
electrospray.
Direct tissue analysis was unsuccessful due to problems associated with matrix 
crystallisation. The presence of an abundant and uniform matrix layer is essential in 
imaging methodology. The MALDI process is dependent on the formation of matrix
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crystals, and the acquisition of useful MALDI images is dependent on the matrix 
layer being both abundant and homogeneous across the entire sample. An uneven 
matrix distribution may lead to ambiguous determination of the analyte within the 
samples: areas in an image or chromatogram indicating an absence of analyte must 
arise from true absence of analyte, rather than an insufficient matrix layer.
Chromatograms and spectra presented in Chapter 2 show that in the majority of 
samples no matrix was detected across the skin surface, and in these circumstances 
the drug molecule could not be detected. This is contrary to the findings of Caprioli 
et al. [101,102], who presented successful determination of peptides and proteins in 
brain tissue coated in a-CHCA by electrospray. It is postulated in this thesis that 
the composition of different tissue types has a major effect on matrix crystallisation. 
The formation of matrix crystals, and the inclusion of analyte within crystals, is 
well documented to be adversely affected by salts [185]. Epidermal tissue is likely 
to contain a higher concentration of salts than brain tissue, which may explain the 
failure of this approach for this application.
Recent reports have demonstrated that sinapinic acid may be a more useful mat­
rix material in imaging experiments, exhibiting superior crystalisation upon tissue 
surfaces as compared to a-CHCA [100,113,168]. In view of this, the direct analysis 
of drug treated skin was re-investigated in Chapter 3, employing sinapinic acid as 
the matrix material. Unfortunately the results obtained demonstrated a total ab­
sence of matrix material on the skin surface. This again implies that tissue type has 
a major effect on matrix crystallisation. It is therefore evident that the tissue type 
has a major effect on the suitability of different approaches in imaging applications. 
It is concluded that while direct tissue analysis has proved useful for the examina­
tion of brain tissue [100-103,113,168], it is not a desirable strategy for MALDI-MS 
imaging analysis of epidermal tissue.
A range of materials was evaluated as tissue blotting substrates for the indirect 
analysis of drug treated tissue. Tissue imprints were created upon C18 beads and 
C18 Envidisc, nitrocellulose, PVDF, cellulose and polyethylene-filled carbon con­
ductive membranes. Tissue treatment was confined within a plastic ring adherent 
to the tissue surface in order to assess the usefulness of the techniques in retaining 
the expected spatial distribution of the analyte. There were problems blotting onto 
C18 beads because the beads became stuck to the tissue and were removed from
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the MALDI target during the blotting procedure. It was also directly observed that 
matrix deposition caused movement of the beads around the target, resulting in 
determination of the analyte at erroneous locations. In addition, the matrix layer 
was found to be inhomogeneous, though this may have been due to the movement 
of matrix coated beads. Given the poor tissue imprint, movement of beads and 
poor matrix layer, C18 beads were not considered an appropriate substrate for this 
application. Similar problems were encountered with the C18 envidiscs, where C18 
beads were observed on the tissue after the blotting procedure, implying creation 
of a poor tissue imprint. In addition the membranes were too thick to be mounted 
within the recess of the specialized MALDI targets, and it was therefore concluded 
that these were not suitable substrates.
The PVDF and nitrocellulose membranes behaved similarly. High analyte intens­
ities were obtained, indicating that the membranes were ideal blotting substrates. 
However, chromatograms and spectra acquired demonstrated both an inhomogen­
eous matrix layer and evidence of analyte spreading. It was concluded that the waxy 
surface nature of these membranes resulted in matrix pooling due to hydrophobic 
repulsion of the matrix solvents, resulting in an uneven layer. Matrix movement 
across the membrane surface prior to solvent evaporation appeared to cause analyte 
speading.
More promising results were obtained with cellulose and carbon membranes. 
Spectra and chromatograms demonstrated sufficient matrix coverage of both sub­
strates. Strong analyte intensities were achieved with both membranes, showing 
usefulness as blotting substrates. Some analyte spreading was evident upon car­
bon membranes, while chromatograms obtained from analysis of tissue imprinted 
cellulose revealed the expected distribution of the analyte molecule.
Scanning electron microspcopy of matrix coated membranes confirmed results 
obtained by MALDI-MS: matrix crystals appeared sparse on C18 envidiscs, nitro­
cellulose and PVDF membranes, while abundant matrix crystals could be formed 
on carbon and cellulose membranes.
These initial investigations demonstrated that there are three major issues that 
must be addressed in the design of a suitable approach for indirect tissue analysis by 
MALDI-MS. First, a successful tissue imprint must be created upon the substrate; 
second, a homogeneous matrix layer must be achieved; and finally, the method of
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matrix application must avoid analyte spreading which would result in an incorrect 
display of the spatial distribution. Formation of a sufficient matrix layer appears 
to be greatly affected by the choice blotting substrate. Cellulose was found to be 
successful due to its absorbent nature, resulting in matrix drying in an even layer. 
Conversely the hydrophobicity of pvdf and nitrocellulose resulted in areas of matrix 
density, but also areas exhibiting a complete absence of crystals. The success of the 
carbon membranes is thought to be attributed to their conductive nature, resulting 
in superior electrospray performance, giving rise to an impressive crystal layer.
Initial work was hampered by poor mass accuracy and resolution of the linear 
TOF instrument, which was therefore deemed unsuitable for imaging. Work presen­
ted in Chapter 2 demonstrated that poor resolution resulted in failure to determine 
two out of three initial test compounds in the presence of interfering substances. In 
addition, fluctuations were observed in the mass determination of both ketoconazole 
and the matrix, which might have proved detrimental in an imaging experiment. 
Mass spectrometric images are simply a display of the distribution of a selected ion 
or range of ions; thus a poor image for the isotopic envelope of ketoconazole (m/z  
531:533) would be obtained if ketoconazole was detected at m /z  530. Increasing 
the mass range displayed, e.g., m /z  529 — 534 to account for this would result in 
an image of poorer quality, as in the majority of cases m /z  529, 530 and 534 may 
not contribute many counts. Ambiguous mass determination may be partially ex­
plained by the axial geometry design of the instrument. Irregularities in sample 
topography result in differing flight times, resulting in erroneous mass determina­
tion. In addition the linear TOF employed only permitted analysis of a single ‘row’. 
The sample plate could not be moved in x  and y dimensions under the laser, thus 
no true images could be acquired. Consequently, despite having proved useful for 
initial method development, it was concluded that this instrument was not suitable 
for imaging analysis.
All subsequent MALDI-MS investigations were conducted on a hybrid quad- 
rupole time of flight instrument (Qstar pulsar z, Applied Biosystems, Foster City, 
USA). Such an instrument configuration offered vast improvements in mass accur­
acy, resolution and sensitivity. In addition, the ion source was orthogonal to the 
detector. This decoupled arrangement is ideally suited to surface analysis as irregu­
larities in sample topography have no effect on the length of flight, and thus no effect
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on the calculated mass. Free movement of the sample plate in x and y locations 
meant that data could be acquired from whole membranes. The instrument was 
fitted with beta test ion imaging software (MDS Sciex, Ontario, Canada).
The first version of the software did not permit the images created to be saved, 
manipulated, or imported into commonly-used applications. The necessary data 
could however be exported from the total ion chromatogram. A computer algorithm 
was designed to convert spot numbers into x  and y locations, permitting construc­
tion of images in alternative software. Images of the distribution of ketoconazole 
and a-CHCA on tissue imprinted cellulose membranes were constructed. Images 
revealed areas where analyte was not detected. Given that similar patterns were 
observed in images of matrix ions, this was concluded to be as a result of failures 
in the electrospray procedure. The images acquired highlighted the aforementioned 
importance of a homogeneous matrix layer. It was found that altering the intensity 
(z) scale of the images resulted in very different displays: it was difficult to display 
both qualitative and quantitative information in the same image. Thus it is im­
portant that the intensity of ions is always taken into account when assessing the 
presence and distribution of compounds of interest. There is an imporatnt caveat 
however: MALDI is not quantitative without some form of data normalisation. In 
Chapter 3, images were acquired demonstrating the superiority of matrix layer and 
analyte inclusion in electrospray sample deposition compared with the dried droplet 
method. Similar findings were presented by Garden et al. [126], who presented 
images of matrix heterogeneity in dried droplet samples.
The analysis of piroxicam and acyclovir was repeated using the Qstar pulsar i. 
The superior mass resolution of the hybrid instrument was demonstrated by the 
successful determination of both compounds. Ions associated with tape and matrix 
that proved problematic when employing the Linear TOF instrument were clearly 
resolved from the protonated analyte molecules. Comparison of the determination 
of ketoconazole with both instruments clearly demonstrated the improvements in 
mass accuracy and resolution offered by the Qstar pulsar i.
The mass determination of ketoconazole was evaluated across a membrane sur­
face. The results obtained demonstrated that the mass did not vary significantly at 
different locations (as was observed using the LaserTOF 1500), demonstrating the 
advantages of an orthogonal ion source (as compared to an axial arrangement). The
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hybrid instrumentation offered the possibility of tandem mass spectrometry, which 
was not employed in work presented in this thesis, but may be highly beneficial 
in further work, where an analyte may be imaged by mapping the dissociation of 
the compound, as demonstrated by Reyzer et al. [100]. In conclusion the results 
demonstrated the suitability of the Qstar pulsar i in imaging applications.
Ion imaging software updates (oMALDI 4.0, 2003) permitted free manipulation 
of the mass spectrometric images (e.g. image rotation, colour display and 3D rep­
resentations). In addition all images created could be saved as picture files. The 
software employed in work presented in this thesis was released at the American So­
ciety for Mass Spectrometry annual conference (ASMS, Nashville, May 2004). Data 
and methods presented in this thesis were released as a technical applications note 
with the software. The technical note is included in Appendix 2 of this thesis.
MALDI-MS imaging was employed in work presented in Chapter 4 to assess the 
success of different methods of matrix application. Results presented in Chapters 
2 and 3 suggested that blotting tissue onto cellulose and carbon membranes may 
be useful as an indirect method of imaging drugs in skin. The membranes were 
investigated further in work presented in Chapter 4. Membranes were coated in 
matrix by electrospray and airspray methodologies. Airspray was found to be the 
superior method, demonstrating a superior matrix layer on both membrane surfaces. 
This approach was also found to be considerably quicker and easier to perform. 
Aispray deposition has been presented as a method of matrix application in several 
recent reports [100,113,168].
The application of matrix to tissue imprinted membranes clearly resulted in 
undesirable analyte spreading. This again does not concur with the findings of 
Caprioli et al. , who presented images of the expected distribution of peptides on 
carbon conductive membranes (matrix was applied by electrospray deposition). The 
success of their experiments may be attributed to the electrostatic properties of the 
membrane, resulting in the proteins being ‘anchored’ to the substrate. This was not 
evident in the analysis of ketoconazole.
The novel method of precoating membranes in matrix prior to the blotting pro­
cedure was investigated. This approach was not found to be suitable for the analysis 
of carbon membranes, as matrix was removed from the substrate during the blotting 
procedure. The method was found to be ideal for the analysis of tissue imprinted
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cellulose membranes. Images depicting the expected distribution of the analyte mo­
lecule were obtained. The author is not aware of any other reports of blotting tissue 
onto matrix-coated substrates in imaging MALDI.
The quantitative determination of ketoconazole (0—0.4mg*ml-1), employing the 
sodium adduct matrix ion as an internal standard was presented in Chapter 5. Re­
latively good linearity and precision was obtained. The use of matrix peaks as 
internal standards in MALDI experiments was first presented by Dally et al. [181]. 
This has enormous benefits in imaging experiments, making it unnecessary to incor­
porate additional compounds as internal standards. All quantitative determinations 
of ketoconazole by MALDI-TOF-MS presented in this thesis are equivalent to con­
centrations of ketoconazole in solution, as measured from analysis of the drug on 
a stainless steel target. Further work must be conducted in order to relate this to 
a true concentration of drug in skin. The blotting efficiency (transfer of drug from 
tissue to membrane) and a calibration of the determination of ketoconazole from 
cellulose must be determined in further work.
A cross sectional imprint of drug treated skin was made upon a matrix coated 
cellulose membrane. A ‘quantitative’ profile of ketoconazole in porcine epidermal 
tissue was prepared from the data obtained. Images demonstrating the spatial 
distribution of the drug molecule were obtained. These images were enlarged to 
reveal individual pixels. Data obtained from spectra relating to individual pixels 
permitted a calculation of the relative drug concentration at each location. This 
permitted construction of a profile indicating drug permeation up to 0.8 mm in 
the skin. Histological images of porcine ear epidermal tissue were prepared by 
conventional haemotoxylin and eosin staining methods. The histological image was 
superimposed upon the mass spectrometric image, demonstrating drug permeation 
up to and including the dermal skin layer. These experiments show the potential 
of MALDI imaging as a method of drug permeation depth profiling. Further work 
should be undertaken to investigate the permeation depth of the drug at different 
time points. In addition the absorption of different drugs must be explored.
A tape stripping method was developed in order to permit a comparison of tissue 
blotting/MALDI-MS methods with HPLC determination of ketoconazole. Corneum 
tape stripping with analysis by HPLC is a well-documented method and it was hoped 
that this phase of work would enable validation of the imaging strategies presented.
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Drug profiles obtained by the two methods exhibited similar patterns of distribu­
tion and similar concentration ranges over 20 tape strips. Unfortunately there were 
limitations with the data collected that prevented a direct comparison of the two 
methods. Tissue was not treated with the same amount of drug in the two experi­
ments. It is essential therefore that the tape stripping MALDI-MS experiments are 
repeated, with the same tissue treatment as administered in the HPLC experiments, 
in order to assess the utility and validity of the methods developed. As previously 
discussed, it is important that true drug concentrations on the cellulose membranes 
be determined and tissue blotting efficiency assessed. This would enable data col­
lected by imaging MALDI-MS analysis of tissue imprinted cellulose membranes to 
be related to a true concentration of drug at different tissue depths.
Work presented in this thesis reveals that there are a variety of factors that influ­
ence the design and success of a MALDI imaging experiment. The tissue type under 
investigation determines whether direct or indirect analysis is the optimal approach. 
This is due to the ability to form a matrix layer on the sample. As discussed, form­
ation of matrix crystals differs on different tissue types, which is possibly associated 
with their different salt contents. The choice of substrate for indirect analysis is 
governed by the feasibility of achieving a homogeneous matrix layer, which is prob­
ably the most important step in any imaging experiment. While some membranes 
are ideal blotting substrates and enhance mass spectral data quality [123-125], the 
failure to create an even layer of matrix upon them may result in unsuitability for 
imaging applications. The surface property of a membrane clearly has great ef­
fect upon matrix layer homogeneity. In addition other physical properties, such as 
electrical conductivity, affect the choice of matrix application method.
The method of matrix application depends upon both the substrate, and the 
analyte. For example, application of matrix onto peptide-imprinted carbon mem­
branes did not induce analyte spreading [101,102]. This was not true for the analysis 
of drugs. Thus the solubility of the analyte in matrix solvents, and adherence of the 
analyte on substrate, should both affect experimental design. Whether the matrix 
is applied before or after the blotting procedure is dependent upon the substrate, 
and the matrix layer upon it. Blotting onto a matrix coated carbon membrane was 
not found to be successful. Conversely blotting onto a matrix coated cellulose mem­
brane was found to be the optimum approach. Full impregnation of the membrane
172
with matrix was thought to be the reason for success of this strategy. Thus the 
matrix layer was not residual upon the membrane surface, and was therefore not re­
moved during tissue blotting. In conclusion, matrix layer homogeneity and analyte 
speading caused by matrix deposition are the major issues in MALDI imaging.
Successful ionisation of an analyte in the absence of matrix material may there­
fore be the key to the greater success of the technique. Desorption/ionisation follow­
ing a pulsed laser has been demonstrated on porous silicon (desorption/ionization 
on porous silicon, DIOS) [186,187]. Porous silicon is a UV-absorbing semiconductor 
with a large surface area and is produced through electrochemical anodization or 
chemical etching of crystalline silicon [188]. The structure of porous silicon provides 
a scaffold for retaining solvent and analyte molecules, and the UV absorptivity per­
mits transfer of the laser energy to the analyte. The technique has demonstrated 
widespread use for the analysis of low molecular weight compounds, where inter­
ference from matrix ions in MALDI has often proved problematic. Further work is 
suggested to investigate the utility of such a substrate in imaging-MS. For this to be 
useful a successful tissue imprint must be achieved upon the silicon and the analyte 
must be ionized from the structure.
Anchoring or adhering the analyte to a substrate in imaging MALDI may also 
prove useful in preventing problems of migration associated with matrix application. 
Use of substrates or ‘chips’ with affinity for proteins is gaining widespread use in 
disease state profiling and analysis of proteins in complex mixtures. The technique, 
so called surface enhanced laser desorption ionization (SELDI), is described as com­
bining sample clean up or enrichment with MALDI-TOF-MS [189-191]. A major 
advantage of such an approach is the elimination of possibly interfering compounds 
prior to mass spectral analysis. Following application of the complex sample to the 
target (which is coated with an active chemical surface (e.g. hydrophobic, hydro­
philic, anionic or cationic), non-specifically bound matter is washed away prior to 
matrix application. Surfaces may also be prepared with antibodies to the analyte 
of interest offering enhanced sensitivity or specificity. It is postulated that blotting 
treated tissue onto such a surface may provide a means of reducing analyte spreading 
in imaging MALDI.
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A ppendix A: Other Applications
Methods presented in this thesis have been applied to the study of potato tuber and 
leaf sections, in collaboration with Professor Mike Burrell, University of Sheffield. 
The primary aim of this work was to acquire MALDI images of the distribution of 
endogenous molecules associated with primary metabolism in plants.
Materials
Trifluoroacetic acid (AR grade) and a-CHCA were purchased from Sigma-Aldrich 
(Dorset, UK). Methanol was HPLC grade, purchased from Fisher Scientific (Lough­
borough, UK). Cellulose membrane spacers were obtained from Goodfellow (Hunt­
ingdon, UK). The potato tuber and leaf sections were supplied and prepared by 
Professor Mike Burrell, at the University of Sheffield.
Instrumentation
Matrix application was conducted using a suction feed airspray device (Badger 150 
Suction Feed air brush (The Air Brush Company, Lancing, West Sussex, UK)). Mass 
spectrometric analyses were performed on an Applied Biosystem Qstar pulsar i hy­
brid quadropole time of flight mass spectrometer, fitted with an orthogonal MALDI 
source and ion imaging software, as discussed in Chapter 3 of this thesis.
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M ethods
A cross section of potato tuber was prepared with a scalpel. A photo of the sec­
tion is presented in Figure 7.1. The potato section was subsequently blotted onto a 
cellulose membrane, pre-coated in 25mg-ml_1 ct-CHCA (prepared in methanol con­
taining 0.1% TFA) matrix material by airspray deposition. Methods for membrane 
preparation are given in Chapter 4 of this thesis.
Figure 7.1: Digital photograph of the potato tuber section that was blotted onto 
matrix coated cellulose membranes.
A cross section of potato leaf was also blotted onto a matrix coated cellulose 
membrane. The membranes were mounted in the recess of a specialised MALDI 
target (VoyagerDE, Sciex, Ontario) and analysed by imaging mass spectrometry in 
the Qstar pulsar i. Mass spectra were aquired every 0.25 mm. The laser was fired 
for 2 seconds at 14 fiJ and a repetition rate of 20 Hz at all locations.
175
Results
MALDI images of the distribution of ions relating to the protonated molecules and 
sodium and potassium adducts of glucose,and glucose-6-phosphate were inconclus­
ive. Images acquired indicated that the molecules were not present, or not success­
fully ionised. Standards of these molecules were analysed by conventional MALDI- 
TOF-MS on stainless steel spot targets, with a-CHCA. Analyses were performed on 
the Qstar pulsar i. No ions relating to the protonated molecules and sodium and 
potassium adducts of glucose or glucose-6-phosphate were detected. These results 
show that neither glucose nor glucose-6-phosphate can be determined by MALDI- 
TOF-MS with a-CHCA matrix material.
An image of the sodium adduct of sucrose in an imprint of potato tuber section 
(m/z  381) was obtained, presented in Figure 7.2. The image demonstrates that 
the distribution of sucrose was confined around the edge of the section, the outer 
cortex. The apparent ‘outline’ in the image showed good similarity to the shape of 
the section (Figure 7.1).
Examination of mass spectra corresponding to pixels in the image showed the 
presence of a peak at m / z  852. The range m / z  851-853 was processed in the 
ion imaging software. Images were created showing the distribution of this ion in 
imprints of potato leaf (Figure 7.3) and tuber (Figure 7.4) section. In both cases the 
images are a good anatomical fit of the original sections. The ion detected at m / z  
852 ion is thought to be the sodium adduct of acetoacetyl-CoA, an intermediate 
in flavanoid biosyntheis and terpenoid metabolism. Further experiments should be 
conducted in order to permit confirmation of this identification. Product ion spectra 
from the precursor ion, m / z  852 by tandem mass spectrometry should be acquired.
Conclusions
Methods developed for the analysis of drugs in skin by imaging MALDI-TOF-MS 
have been successfully transferred to the study of endogenous small molecules in 
plant tissue.
Potato tuber and leaf sections were blotted onto cellulose membranes precoated 
in a-CHCA by airspray deposition. MALDI images showing the distribution of
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Figure 7.2: MALDI image of the distribution of an ion observed at m / z  381. This 
is thought to be the potassium adduct of sucrose. A cross section of a potato tuber 
was blotted onto a cellulose membrane pre-coated in a-CHCA.
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Figure 7.3: MALDI image of the distribution of an ion observed at m / z  852. This 
is thought to be the sodium adduct of aceto-acetyl-CoA. A cross section of a potato 
leaf was blotted onto a cellulose membrane pre-coated in a-CHCA.
Leaf lamina
Vascular bundles
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Figure 7.4: MALDI image of the distribution of an ion observed at m / z  852. This 
is thought to be the sodium adduct of acetoacetyl-CoA. A cross section of a potato 
tuber was blotted onto a cellulose membrane pre-coated in a-CHCA.
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sucrose and acetoacetyl-CoA (by mapping the potassium or sodium adducts re­
spectively) were successfully acquired by this method. The images presented show 
good anatomical homology to the original tissue sections. Both molecules appear 
to be more dominant in the outer cortex of potato tubers. Acetoacetyl-CoA is ob­
served most dominantly in the outer cortex of the tuber section, and in the vascular 
bundles of the leaf section.
Further work is recommended to explore the use of alternative matrices for the 
analysis of glucose and glucose-6-phosphate. Preliminary results obtained at Shef­
field Hallam University indicate that THAP (containing 10% ammonium citrate) 
may be a useful matrix for the analysis of glucose-6-phosphate. This matrix has 
shown success for the analysis of other phosphate containing molecules, e.g., oligo­
nucleotides. This should be investigated further and methods should be developed 
for imaging MALDI employing THAP (10% ammonium citrate).
Tandem mass spectrometry should be used to permit identification of the mo­
lecule detected at m / z  852.
This work shows that the methods developed in this thesis have widespread 
potential, showing success in mapping both drugs in skin, and molecules involved 
in primary metabolism in potato sections. Thus the technique may be useful in the 
study of both animal and plant tissues, with potential applications in many fields 
of research.
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A ppendix B
Presentations
Some of the work in this thesis has been published or presented as posters or talks 
at various conferences.
Publications
Bunch J, Clench MR, Richards DS. (2004) Determination of pharmaceutical com­
pounds in skin by imaging matrix-assisted laser desorption ionisation mass spectro­
metry. Rapid Communications in Mass Spectrometry, 18: 3051-3060.
Oral presentations
The Analysis of Pharmaceutical Compounds in Skin by Imaging MALDI-TOF-MS. 
Royal Society of Chemistry Analytical Research Forum, University of Central Lan­
cashire, 2004.
The Analysis of Low Molecular Weight Compounds in Animal and Plant Tissue by 
Imaging MALDI-TOF-MS. Applied Biosystems invited talk, American Society of 
Mass Spectrometry, Nashville, USA, 2004.
MALDI-MS Imaging to Reveal Metabolite Profiles in Potato Tubers. Society for 
Experimental Biology, Heriot Watt University, Edinburgh, 2004.
The Analysis of Low Molecular Weight Compounds in Biological Tissue by MALDI- 
TOF-MS. Royal Society of Chemistry Analytical Research Forum, University of
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Sunderland, 2003.
Posters
The Analysis of Pharmaceutical Compounds in Biological Tissue was presented at:
The International Conference of Mass Spectrometry, Edinburgh, 2003
The American Society of Mass Spectrometry, Montreal, Canada, 2003
The British Society of Mass Spectrometry, Loughborough, 2002
Royal Society of Chemistry Analytical Research Forum, Kingston University, 2002.
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Introduction
Mass Spectrometric techniques have been developed recently for the examination of 
biological tissue samples. Tandem mass spectrometry has been employed for the 
detection of pharmaceutical 
compounds1 and also mass 
spectrometric 'images' have
been produced that show the2spatial distribution of peptides , 
proteins2 and drugs3&4 in tissue.
We present here methods for 
the detection of a topically 
applied pharmaceutical
formulation in porcine epidermal 
tissue by MALDI-TOF-MS.
Figure 1 shows the structure of 
Ketoconazole, the active 
ingredient in Nizarol® shampoo.
Method
Porcine epidermal tissue was treated with "Nizoral", a medicated shampoo containing 
ketoconazole as active ingredient. Following a one-hour incubation at 37°, all excess 
formulation was washed from the surface. A cross-section of the drug-treated tissue was 
then blotted onto a cellulose membrane that had been precoated in matrix (a-CHCA) 
using airspray deposition. Alternatively, the tissue surface was treated with Nizoral within a 
triangular former, and subsequently blotted onto a matrix-coated membrane. Sample 
membranes were then mounted into the recess of specialised MALDI targets with 
adhesive tape. All samples were analysed by MALDI-TOF-MS using an Applied 
Biosystems/MDS Sciex QSTAR® Pulsar i hybrid quadrupole time of flight mass 
spectrometer fitted with an oMALDI™ ion source and MALDI imaging software.
Ketoconazole (C26H28Cl2N40 4 ) FW 531.44
Figure 1. Ketoconazole is a widely used anti- 
fungal agent available in a variety ol 
formulations. All work presented in this poster has 
been conducted using the form sold as Nizoral6 
shampoo which is also prescribed for treatment for 
certain fungal conditions in skin.
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Principles of Imaging Mass Spectrometry
The initial step in MALDI imaging involves application of a thin layer of matrix to the 
sample. The chemistry of the sample can then be imaged by rastering the laser beam 
across the sample surface and acquiring mass spectra from each point. Three- 
dimensional images may be obtained by plotting the spatial dimensions of x and y versus 
absolute ion intensity, which is considered proportional to analyte concentration. In 
addition, quantification can be achieved by incorporation of an internal standard.
Results
Detection of the protonated molecule 
was readily achievable by this MALDI 
imaging technique. Figure 2 shows 
tissue after Nizoral shampoo was 
applied within a triangular former. 
After treatment, the skin was blotted 
onto a membrane precoated in a -  
CHCA by airspray deposition. The 
image demonstrates that spatial 
information is retained when the 
blotting technique is employed.
Figure 2. MALDI image of the distribution of 
the protonated molecule [M+Hf at m/z 532 
on cellulose membrane.
Science
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Mass spectra shown in Figures 3 and 4 show detection of the drug within the dimensions 
of the triangular former, and not outside it.
J
Ketoconazole detected
Figure 3. Mass Spectrum Acquired Within the Triangular Former
1 46 0620 p-172.0443
2U.0153
190 059
No drug detected
j 31 7.1 079 381 1 023
Figure 4. Mass Spectrum Acquired Outside the Triangular Former
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Ion images demonstrating the permeation of the applied compound into the skin have 
been achieved by imaging a cross sectional imprint of treated tissue. Figure 5 shows an 
image of tissue after treatment with Ketoconazole. The treated tissue cross-section was
blotted onto cellulose membrane, precoated in a-CHCA by airspray deposition. The
image shows the ‘vertical’ distribution of the protonated drug molecule. Figure 6 shows 
the same data as presented in Figure 5, after rotation through 90°, giving a clear picture of 
the apparent change in drug concentration with depth. This provides a useful semi-
quantitative display of the drug in skin.
Figure 5. MALDI image of the distribution of 
the protonated molecule [M+HJ* at m/z532 of 
Ketoconazole in a vertical section of porcine 
skin
Figure 6. MALDI image of the distribution ot 
the protonated molecule [M+Hf at m/z532 ot 
Ketoconazole in a vertical section of porcine 
skin, after rotation by 90°
R atio  o f d ru g  to  m a trix  (0-0 .4m gm  I'1)
Figure 7 shows a calibration 
graph for the determination of 
ketoconazole (0-0.4 mgmM). 
This graph was constructed 
using the intensity of the Na 
adduct of a-CHCA ion at m/z 
212 as an "internal standard".
1.2
1cwE
M 0.8cajc5o<trco
o2
0.6
0.4
cOJ
c 0.2
00 0.05 0.1 0.15 0.2 0.25 0.450.3 0.35 0 4
Cone ketoconazole (mgml'1)
Figure 7. Calibration Plot for the Determination 
Ketoconazole
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The straight-line equation was used to produce a quantitative profile of drug concentration 
against tissue depth (Figure 8) by examination of an enlarged two-dimensional display of 
Figure 4 and spectra acquired during the imaging run (as demonstrated in Figure 9).
R ela tiv e  D ep th  in Skin (m m )
Figure 8. A Quantitative Profile of Ketoconazole in Porcine Epidermal 
Tissue. Constructed from examination of selected spectra acquired during an 
imaging run, knowledge of vertical spacing between spectra, and the straight 
line equation from the calibration plot.
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Figure 9. Enlarging the image reveals pixels, each of which corresponds to an 
individual mass spectrum. The ratio of drug to matrix in these spectra can be used 
to calculate the concentration of drug at each location by rearranging the straight 
line equation obtained from the calibration plot.
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Conventional Haematoxylin and Eosin staining and microscopy methods were employed 
to obtain a histological image of the porcine epidermal tissue, shown in Figure 10. Thus 
the drug profile obtained indicates permeation into the dermal skin layer.
Epidermis
Dermis
Connective!
Tissue!
Figure 10. Superimposing the mass spectrometric image over a histological image 
reveals that the drug is absorbed into the dermal skin layer
Conclusion
These preliminary investigations indicate that this novel approach may be used to obtain 
qualitative and quantitative information on the absorption of topically applied 
pharmaceutical compounds. Images have been produced showing the dermal uptake of 
ketoconazole in porcine epidermal tissue, and the methods employed have been proven to 
retain the spatial distribution of the analyte molecule. Use of the sodium adduct of the 
matrix ion as an internal standard yields a calibration graph with a relatively good degree 
of precision and linearity. The calibration graph, combined with examination of individual 
image pixels and their corresponding spectra, has permitted construction of a quantitative 
profile of ketoconazole concentration against skin depth. Histological images reveal that 
this equates to drug permeation up to and including the dermal skin layer.
www.appliedbiosystems.com
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Determination of pharmaceutical compounds in skin 
by imaging matrix-assisted laser desorption/ionisation 
mass spectrometry
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Matrix-assisted laser desorption/ionisation (MALDI) quadrupole time-of-flight mass spectrometry 
(Q-TOFMS) has been used to detect and image the ^ distribution of a xenobiotic substance in skin. 
Porcine epidermal tissue was treated with 'Nizoral', a medicated shampoo containing ketoconazole 
((±)-l-acetyl-4-[p-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(imidazol-l-ylmethyl)-l,3-dioxolan-4-yl]methoxy] 
phenyllpiperazine) as active ingredient. Following incubation for 1 h at 37°C all excess formulation 
was washed from the surface. A cross-section of the drug-treated tissue was then blotted onto a cel­
lulose membrane, precoated in matrix (a-cyano-4-hydroxycinnamic acid (CHCA)), by airspray deposi­
tion. In separate experiments the tissue surface was treated with Nizoral within a triangular former, 
and subsequently blotted onto a matrix-coated membrane. Sample membranes were then mounted 
into the recess of specialised MALDI targets with adhesive tape. All samples were analysed by MAL- 
DI-TOFMS using an Applied Biosystem 'Q-star Pulsar i' hybrid Q-TOF mass spectrometer fitted 
with an orthagonal MALDI ion source and imaging software. Detection of the protonated molecule 
was readily achievable by this technique. Treatment of th e;tissue within a template gave rise to 
images depicting the expected distribution of the drug, demonstrating that this technique is capable 
of producing spatially useful data. Ion images demonstrating the permeation of the applied com­
pound into the skin were achieved by imaging a cross-sectional imprint of treated tissue. A calibra­
tion graph for the determination of ketoconazole was prepared using the sodium adduct of the matrix 
ion as an internal standard. This enabled construction of a quantitative profile of drug in skin. Con­
ventional haematoxylin and eosin staining and microscopy methods were employed to obtain a his­
tological image of the porcine epidermal tissue. Superimposing the mass spectrometric and 
histological images appeared to indicate drug permeation into the dermal tissue layer. Copyright 
©  2004 John Wiley & Sons, Ltd.
A percutaneously delivered therapeutic agent, whether 
directed at the systemic circulation or the local tissues, 
must traverse the stra tu m  corneum  (the upper layer of the 
epidermis (which is itself the upper layer of skin)). Despite 
an insufficient knowledge of the precise mechanism of skin 
penetration it is clear that both the physiochemical and 
structural properties of the penetrating molecules and the 
internal structure and composition of the skin membrane 
are involved in the process. Absorption across the stratum  
corneum  is a passive process of diffusion, with the stratum
Correspondence to: M. R. Clench, Biomedical Research Centre, Sheffield Hallam University, Howard Street, Sheffield SI 1WB, UK.E-mail: m.r.clench@shu.ac.ukContract/grant sponsors: Pfizer Global R&D; The British Mass Spectrometry Society.
corneum  behaving as a semi-permeable membrane. In prin­
ciple there are three routes of diffusion: intercellular diffu­
sion through the lipid matrix; transcellular diffusion 
through the corneocytes; and pilosebaceous diffusion along 
the sweat pores and hair follicles that 'pierce' the stra tu m  
corneum }
Methods for analysing dermal xenobiotic absorption 
include skin extraction measurements,2 horizontal sectioning 
(corneum tape stripping),3 quantitative skin autoradiogra­
phy,4'5 and spectroscopic methods such as ATR-FTIR,6'9 
fluorescence,7,8 remittance9 and photothermal.2,10 However, 
inherent problems such as the requirement of a labelled 
compound and issues such as sensitivity or the loss of spatial 
information limit the usefulness of these techniques for the 
permeation depth profiling of drug compounds in skin.
The use of mass spectrometry to obtain images started 30 
years ago with the advent of imaging secondary ion mass 
spectrometry (SIMS). In imaging SIMS the surface of the
Copyright ©  2004 John W iley & Sons, Ltd.
sample is bombarded with high energy ions—this leads to the 
ejection (or sputtering) of neutral and charged (+ /—) species 
from the surface. The ejected species may include atoms, 
clusters of atoms and molecular fragments. In traditional 
SIMS it is only the positive ions that are mass-analysed. Since 
the technique utilises a beam of atomic ions (i.e. charged 
particles) as the probe, it is a relatively easy matter to focus the 
incident beam and then to scan it across the surface. Thus the 
detector response for a selected mass at each raster spot 
becomes a pixel in the image. The use of an ion beam results in 
sub-micron spatial resolution. Imaging SIMS has been used 
in a range of pharmaceutical applications including monitor­
ing drugs at the cellular and sub-cellular level. New 
developments apply SIMS to organic compounds and 
metabolites of low mass (<500 u) in biological samples.11 
However, a major limitation is the mass range that may be 
analysed by this technique.
Recently, imaging using matrix-assisted laser desorption/ 
ionisation mass spectrometry (MALDI-MS) has become a 
subject of interest. The initial step in MALDI-MS imaging 
involves application of a thin layer of matrix to the sample. 
The chemistry of the sample is then imaged by moving the 
sample under a stationary laser and acquiring mass spectra 
from each point. Three-dimensional images may be obtained 
by plotting the spatial dimensions of x and y versus absolute 
ion abundance, which is considered to be proportional to 
analyte concentration.
MALDI has been used for the imaging both of biological 
samples12-18 and of thin layer chromatography (TLC) 
plates,19,20 with the method of matrix application to such 
samples additionally requiring that the spatial distribution of 
the analyte in the sample be maintained. A number of 
methods of matrix application have been assessed to fulfil 
these criteria, including indirect matrix deposition,19 brush­
ing of the sample with a supersaturated matrix solution,20 
and electrospraying.12'20
Caprioli and co-workers developed MALDI imaging 
techniques to identify and profile peptides and proteins in 
biological tissue.12 Methods of direct tissue analysis and 
indirect analysis (blotting onto a layer of Cl 8 beads or a 
cellulose membrane) were compared. Analysis of Cl 8 blots 
was found to be the superior method.
Optimum results were achieved by electrospraying the 
matrix onto the samples. In agreement with the findings of 
Mowthorpe et al.,zo this approach minimised analyte spread­
ing and allowed the mapping and localisation of specific 
compounds within tissue sections.
In a subsequent study the Caprioli group investigated the 
use of a carbon-filled polyethylene membrane for tissue 
blotting prior to MALDI analysis.13 This type of membrane 
was selected because of its electrical conductivity and protein 
adhesion properties. The method produced unique protein 
profiles. This group has reported improvements in the rate of 
image acquisition, indicating that such a technique may lend 
itself to automated high-throughput analysis.14
The use of a range of membranes for matrix support in 
MALDI, e.g. nylon,21 poly(vinylidine difluoride),22 nitrocel­
lulose23 and polyethylene,24 has been reported. The use of 
such membranes to enhance the MS analysis of proteins has 
been reviewed by Vestling et al.25
Troendle and colleagues26 have demonstrated the detec­
tion of pharmaceutical compounds in animal tissue. Matrix 
was applied to the tissue surface by pipetting and electro­
spraying. In these experiments MALDI quadrupole ion trap 
mass spectrometry was employed to detect the anti-cancer 
drug paclitaxel in a human ovarian tumour. The anti­
psychotic drug spiperone was also detected in spiked 
sections of rat liver tissue.
Images of pharmaceutical compounds in tissue have 
previously been acquired.19 An anti-tumour drug was 
detected and imaged in mouse tumour tissue by monitoring 
the dissociation of the protonated drug. A second drug was 
detected in rat brain following oral administration. Matrix 
was applied to intact tissue by either spotting small volumes 
of the matrix in selected areas, or by coating the entire surface 
by airspraying.
' Methods of tissue preparation and matrix application for 
the direct analysis of tissue samples by MALDI-TOFMS have 
been reviewed by Schwartz et a l 27 MALDI imaging has also 
been used as a general method for assessing matrix 
application in MALDI.28
The detection25 and imaging18 of low molecular weight 
compounds in tissue, together with the imaging of drugs on 
TLC plates20,21 and of proteins in tissue, by MALDI-MS12-17 
shows promise that these methods may be used as a means of 
mapping drugs in biological systems. Thus imaging with 
MALDI-MS may have widespread application in future 
pharmaceutical and medical research.
The work presented in this paper demonstrates novel 
sample preparation for imaging MALDI-MS, involving 
precoating cellulose membranes in matrix prior to tissue 
blotting. Methods for the semi-quantitative analysis and 
imaging of a topically applied anti-fungal agent (ketocona­
zole RMM 531.44) in porcine epidermal tissue by MALDI- 
TOFMS are presented.
EXPERIMENTAL
Materials
Trifluoroacetic acid (AR grade) and a-cyano-4-hydroxycin- 
namic acid (CHCA) were purchased from Sigma-Aldrich 
(Poole, UK). Methanol was HPLC grade, purchased from 
Fisher Scientific (Loughborough, UK). Porcine ears, Nizoral 
shampoo (20mg/g ketoconazole, ((±)-l-acetyl-4-[p-[[(2R,4S)- 
2-(2,4-dichlorophenyl)-2-(imidazol-l-ylmethyl)-l,3-dioxolan- 
4-yl]methoxy]phenyl]piperazine); manufactured by Janssen 
Cilag, High Wycombe, UK), and cellulose membranes were 
obtained commercially.
Instrumentation
All mass spectrometric analysis was performed using an 
Applied Biosystems (Foster City, CA, USA) hybrid quadru­
pole time-of-flight instrument (QStar) fitted with an orthogo­
nal MALDI ion source and beta test imaging software 
supplied by MDS Sciex (Concord, Ontario, Canada). The 
nitrogen laser used has an elliptical spot size of 100 x 150 pm 
and an available power range of 0-58.4 pj.
Confocal microscopy was performed on a Zeiss 510 CSLM, 
equipped with an argon laser. Phase contrast images were 
acquired with an objective lens (x20).
Copyright ©  2004 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2004; 18: 3051-3060
Scanning electron microscopy (SEM) was performed using a 
Phillips XL40 scanning electron microscope, fitted with a 
tungsten wire filament. The working distance (from the bottom 
of the column to the sample surface) was 10 mm. An electron 
gun potential of 15 kV was employed in all experiments.
Matrix investigation
Initial experiments were undertaken to assess the suitability 
of various matrices for the analysis of ketoconazole.
Matrix assessment was based on solubility in methanol (in 
order to facilitate the spraying of the matrix), and the 
behaviour of a pre-mixed matrix/analyte solution during 
MALDI-TOFMS analysis on a conventional stainless steel 
target. Assessment was made according to the following 
criteria:
• The absence of interfering peaks in the spectral region of 
interest;
•  The reproducibility of analyte signal intensity from laser 
spot to spot over the target;
• High analyte signal intensity for the pharmaceutical 
analyte.
A range of common organic acid matrices was investi­
gated. It was found that CHCA provided the best spectral 
results, analyte signal intensity and reproducibility for the 
detection of ketoconazole, and it was therefore selected for 
use in these investigations.
Tissue treatment
A 'confined treatment area' was created on the tissue surface 
by protecting the skin around the application site with adhe­
sive tape sealed with barrier cream to give a 'triangular' treat­
ment area. The tissue was treated with 500 pL Nizoral 
shampoo (2% ketoconazole) inside the area of the former 
and incubated for 1 h at 37°C. These experiments were used 
to assess the success of the technique in displaying spatially 
relevant information. Alternatively, 500 pL of Nizoral were
+TOF MS: 300  MCA s c a n s  from S a m p le  2 (b ac k g ro u n d )  of Jose .wif f  
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applied to the centre of a 2 cm2 piece of tissue, which was 
then incubated as before.
After incubation the tissue surface was rinsed with 
deionised water to remove any excess formulation.
Membrane preparation and tissue blotting
Conventional cellulose membranes were coated in CHCA 
matrix material by airspray deposition. The methodology 
adopted involved the use of a Badger 150 suction-feed air 
brush (The Air Brush Company, Lancing, UK). Matrix solu­
tion (25mg/mL) was applied to the membrane using five 
cycles of the air brush, where one cycle comprises five passes 
of the air brush over the sample, giving an estimated total 
matrix usage of approximately 375 mg per sample. The mem­
branes were dried under a heat lamp for 5min between 
each cycle.
The epidermal surfaces of tissue samples treated within a 
former were subsequently blotted (pressed) onto the matrix- 
coated cellulose membrane. Samples treated without the 
former were bisected and a 'cross-sectional' imprint created 
upon the membrane. All membranes were mounted in the 
recess of a specialised MALDI target prior to MS analysis.
Sample preparation for optical 
and electron microscopy
Optical microscopy
Samples for optical micrcoscopy were prepared by micotom- 
ing to an approximately 15 pm thick section. They were sub­
sequently mounted onto a polylysine-coated microscope 
slide (BDH, Poole, UK) and stained using a conventional 
Harris haematoxylin and eosin (H&E) staining protocol.29
Electron microscopy
Samples for SEM were sputter-coated with a thin layer of 
gold prior to examination using standard procedures. In
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Figure 1. Mass spectrum acquired at a position on the membrane where no drug was blotted. No interfering 
peaks were observed.
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order to maintain electrical contact between the surface of the 
membrane and the sample holder (to minimise surface char­
ging) a thin line of silver-conducting paint was applied from 
one comer of the membrane to the underlying sample stage.
Imaging the membrane
The area on the target where the membrane was mounted 
was selected within the software and then imaged as follows:
The target was moved in x and y dimensions at set increments 
of 0.2 mm while firing the laser for 2 s at each location, at a 
laser repetition rate of 20 Hz. Thus mass spectra were 
acquired at sequential increments in a 'snake-like' pattern 
over the entire two-dimensional area. This created a data 
set of several thousand mass spectra. The software capabil­
ities enabled ion images to be created by selecting appropri­
ate mass ranges (i.e. m /z 531-533); thus the distribution, and
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Figure 2. Mass spectrum acquired at a position on the membrane where drug-treated tissue was 
blotted. Ketoconazole was detected at m /z 531.19.
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Figure 3. The background spectra can be subtracted from the sample spectra to emphasise 
the presence of the drug.
Copyright ©  2004 John Wiley & Sons, Ltd. Rapid Commun. Mass Spectrom. 2004; 18: 3051-3060
relative ion abundances, were displayed as two- and three- 
dimensional colour images, hence creating x, y, z plots of 
location vs. abundance of the selected ion/ions.
RESULTS AND DISCUSSION 
MALDI-Q-TOF analysis of membranes
Mass spectra were acquired from a variety of positions on the 
blotted membrane. Areas corresponding to regions outside 
the treated tissue imprint showed an absence of interfering 
peaks in the mass region of interest (Fig. 1). Mass spectra 
acquired within the region of the tissue imprint showed 
detection of the analyte with high ion abundances (Fig. 2). 
'Background' spectra (obtained from a co-ordinate where 
no drug was present) (Fig. 1) were subtracted from the sam­
ple spectra (obtained from a co-ordinate where treated tissue 
was blotted) (Fig. 2) and the resultant spectra (Fig. 3) show 
drug-associated peaks in better detail. These mass spectra 
demonstrate that the most abundant matrix ion observed is
the sodium adduct (m/z 212), which is concurrent with the 
images obtained.
Assessment of matrix coverage
The success of matrix coverage on cellulose membranes by 
airspray deposition was assessed by the degree of homogene­
ity of matrix material over the membrane, and the abundance, 
size and distribution of matrix crystals at various locations.
MALDI images for the protonated matrix ion at m /z 190, the 
sodium and potassium adducts at m /z  212 and 228, 
respectively, and the matrix dimer at m /z  379, were obtained 
(Fig. 4). The images reveal that the matrix coverage is 
relatively dense and uniform in comparison with previously 
reported methodologies for matrix application.28 The sodium 
adduct appears to be the most abundant ion, and shows the 
highest ion abundances over the imaged area.
Scanning electron microscopy (SEM) was performed at a 
range of magnifications in order to obtain images showing 
density of coverage and images depicting individual matrix 
crystals. At 500 x magnification (Fig. 5) it is observed that the
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Figure 4. MALDI images of CHCA on a cellulose membrane, (a) The protonated molecule (m/z 190); (b) the sodium 
adduct (m/z 212); (c) the potassium adduct (m/z 228); and (d) the protonated matrix dimer (m/z 379).
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Figure 5. SEM image of matrix-coated cellulose membrane 
acquired at a magnification of 500x. Coverage appears to be 
dense and relatively even.
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Figure 6. SEM image of matrix-coated cellulose membrane 
acquired at a magnification of 3000x. Matrix crystals are 
abundant and exhibit characteristic rosette shapes asso­
ciated with CHCA crystals.
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Figure 7. MALDI image of the distribution of the isotopic 
envelope of the protonated molecule [M+H]+ (m/z 531 -533) 
of ketoconazole. Tissue was treated with Nizoral within a 
triangular former. The skin was blotted onto a cellulose 
membrane, precoated in CHCA by airspray deposition. 
Image demonstrates retention of spatial information when 
the blotting technique is employed.
Figure 8. MALDI image of the distribution of the isotopic 
envelope of the protonated molecule [M+H]+ (m/z 531 -533) 
of ketoconazole in a vertical section of porcine epidermal 
tissue. In this case the treated tissue was bisected and a 
cross-section was blotted onto cellulose membrane, pre­
coated in CHCA by airspray deposition. Image shows 
‘vertical’ distribution of the protonated drug molecule.
matrix coverage is abundant and homogeneous. At 3000x 
magnification (Fig. 6) typical rosette-shaped crystals are seen. 
Thus it was concluded that both the methodology adopted 
for matrix deposition and the membrane material were 
suitable for this application.
Figure 9. MALDI image of the distribution of the isotopic 
envelope of the protonated molecule [M+H]+ (m/z 531 -533) 
of ketoconazole in a vertical section of porcine epidermal 
tissue. In this case the treated tissue was bisected and a 
cross-section was blotted onto cellulose membrane, pre­
coated in CHCA by airspray deposition. Image shows 
‘vertical’ distribution of the protonated drug molecule. This 
is the same data as shown in Fig. 8 and the image has been 
rotated through 90°, giving a clear picture of the apparent 
change in drug concentration with depth.
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Calibration Plot (0.25-1.75 mg/mL)
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Figure 10. Calibration plot for the determination of ketoconazole (0.25-1.75 mg/mL) 
constructed using the abundance of the Na adduct of CHCA at m/z 212 as an ‘internal 
standard’ (y =  1.0699x +  0.3566, 1^  =  0.9224).
MALDI images of membranes
Experiments involving treatment within a triangular former 
were used to assess whether or not spatial resolution is main­
tained when pre-coated membranes are employed. Figure 7 
shows an image produced by plotting the abundance of the 
ion for the protonated molecule of ketoconazole following 
application to porcine skin through a triangular former. As 
can be seen, the triangular shape is maintained and this was 
taken as evidence of the validity of the proposed methodology.
Figure 8 shows an image generated of ketoconazole 
distribution in a 'vertical' skin section following blotting of 
the bisected tissue cross-section onto a precoated cellulose 
membrane. The apparent localisation of the drug in the 
uppermost layers of the skin is clearly observable.
In order to clearly see the apparent depth of penetration the 
image shown in Fig. 8 can be rotated via 90° using the
supplied software. This is shown in Fig. 9. This form of 
presentation allows a quantitative assessment of the data.
Quantification of drugs in skin
The use of matrix peaks as an 'internal standard' for the nor­
malisation of ketoconazole signals has been investigated. 
This procedure was used in order to compensate for varia­
tions in matrix coverage. Examination of spectra obtained 
from analysis of (pre-coated) tissue-imprinted cellulose 
membranes reveals that the most abundant and consistent 
matrix peak observed is the sodium adduct of CHCA (m/z 
212) (Figs. 4,5 and 6).
An initial calibration graph for the concentration range 
0.25-1.75 mg/mL ketoconazole was prepared by plotting the 
ratio of m /z  531-533:212 against drug concentration (Fig. 10). 
The calibration represents the mean value of 20 samples and
Calibration Plot (0-0.4mg/mL)
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Figure 11. Calibration plot for the determination of ketoconazole (0-0.4 mg/mL) constructed using 
the abundance of the Na adduct of CHCA at m/z 212 as an ‘internal standard’ (y =  2.7441 x, 
r ^  0.9686).
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Figure 12. A 2D representation of the data presented in Fig. 8 was enlarged within the software to reveal pixels. Each pixel 
within the image corresponds to an individual mass spectrum. The ratio of drug to matrix in these spectra was used to 
calculate the concentration of drug at each location by rearranging the straight line equation obtained from the calibration plot 
shown in Fig. 11.
their associated error. All analyses were performed using an 
automated search pattern to acquire data from within the 
sample spots.
The ratio of drug to matrix observed on tissue-imprinted 
membranes is consistently under 0.5, indicating that a more 
effective calibration range would be 0-0.4 mg/mL. The 
calibration was repeated for this range to ensure a more 
accurate interpretation of results (Fig. 11). Good linearity 
(r2 =  0.9686) and precision (average standard deviation = 
0.055 (n = 20)) were achieved.
The straight line equation from Fig. 11 was then used to 
calculate the concentration of ketoconazole in a vertical 
profile as follows: The data set used to construct the 3D
images was displayed in two dimensions and magnified in 
the software in order to observe individual pixels. Each pixel 
in the image corresponds to a spectrum acquired in the 
imaging run. Thus the abundances of the protonated analyte 
and sodium matrix adduct ions were extracted from spectra 
acquired in a sequential, vertical fashion, as illustrated in 
Fig. 12. The ratio of the peaks was calculated and the straight 
line equation from the calibration was used to calculate the 
concentration of drug at each location.
Knowledge of the degree of vertical spacing between 
spectra enables the data to be presented as a profile of drug 
concentration against increasing depth, as shown in Fig. 13. 
The drug is detected up to 0.8 mm into the skin.
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Figure 13. A quantitative profile of drug in skin constructed from examination of 
selected spectra acquired during an imaging run.
Copyright ©  2004 John Wiley & Sons, Ltd. Rapid Commutt. Mass Spectrom. 2004; 18: 3051-3060
im a g in g  i v i a l u i  or compounds m skin m w
Figure 14. Confocal microscope image of a cross-section of 
porcine skin. Sample prepared by conventional H&E staining 
methods.
In order to relate the profile to skin structure, conventional 
H&E staining was performed on a cross-section of porcine 
epidermal tissue. The section was imaged by confocal
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microscopy and the histological image obtained is demon­
strated in Fig. 14. The original MALDI image (Fig. 8) was 
enlarged to reveal individual pixels (each representing a
0.2 mm2 area) and this was superimposed upon the histolo­
gical image, as shown in Fig. 15. This demonstrates drug 
permeation up to and including the dermal skin layer. No 
drug is detected in the underlying connective tissue. All 
labelled concentrations are equivalent to the concentration of 
ketoconazole in solution. Thus further work must be under­
taken in order to calculate a true concentration in skin. This 
may be achieved by preparing calibrations of different drug 
concentrations on cellulose membranes, calibrations of 
different drug concentrations applied to the skin surface 
and blotted onto a membrane, and hence determining the 
blotting efficiency itself.
There may be concern over the possibility of smudging 
during the blotting procedure resulting in a loss in quality of 
spatial information. It is therefore essential to optimise 
methods for this blotting procedure, so that they are 
normalised or automated to ensure reproducibility. How­
ever, the data shown here appear to confirm that, at our 
current spatial resolution of 100 pm, smudging is not 
significant.
CONCLUSIONS
This programme of work has demonstrated that imaging 
MALDI-MS is a potentially powerful tool for studying phar­
maceutical compounds in biological systems.
To date there has been limited exploration of the use of 
imaging MALDI in biomedical applications. Ion beam
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Figure 15. The mass spectrometric image is superimposed upon a histological image to reveal that the drug is absorbed into the 
dermal skin layer.
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approaches such as SIMS have been utilised in similar 
applications, but suffer limitations such as mass range and 
sensitivity. Caprioli and co-workers have introduced the use 
of imaging MALDI for studying peptides, proteins, and 
drugs in tissues. The authors are unaware of any other 
research utilising imaging MS in percutaneous depth 
profiling. The work presented in this paper introduces the 
possibilities of this technique in such an application.
The use of lasers in imaging MS has several advantages 
over using ion beams alone, such as high sensitivity, selective 
ionisation, and quantification. However, while imaging 
MALDI experiments have yielded better quality spectra 
and can detect a higher mass range than SIMS, the lateral 
resolution needs to be greatly improved.
Successful detection and imaging of drug compounds on 
and under the skin surface have been achieved by the indirect 
analysis of tissue-imprinted cellulose membranes by 
MALDI-TOFMS. The methods developed have yielded 
high-quality spectra and images of the drug molecule. The 
method of pre-coating cellulose membranes in matrix by 
airspray deposition gives rise to a relatively abundant and 
homogeneous layer of matrix crystals compared with other 
methodologies investigated. Treatment through a triangular 
former shows that the method is capable of maintaining the 
spatial distribution of the analyte. Images have been 
generated showing the dermal uptake of the drug molecule 
in skin, and show the expected trend of diminishing drug 
concentration over increasing depth.
Calibration graphs for the determination of ketoconazole 
have been prepared using the sodium matrix adduct ion as an 
internal standard. A relatively good degree of linearity and 
precision has been achieved. The linear relationship obtained 
has permitted calculation of the concentration of ketocona­
zole at different skin depths by examination of individual 
spectra acquired during an imaging run. Histological images 
reveal that this equates to drug permeation up to and 
including the dermal skin layer.
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